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Characterization of molecular targets for differential regulation of the type I and III 
interferon induction and signalling pathways by rotavirus NSP1  
Gennaro Iaconis 
Abstract 
Rotavirus (RV) is the leading cause of severe dehydrating diarrhoea in infants, infecting 
almost every child by 3-5 years of age and causing approximately 590,000 gastroenteritis-
associated deaths world-wide both in developed and developing countries. The virus infects 
the young of all mammalian species and cross-species infections and zoonosis events have 
been reported. However, RV is host replication-restricted during heterologous infection for 
reasons that are not fully understood. 
Type I and type III interferons (IFNs) constitute the first line of defence against viral infection. 
Their expression is triggered when specific viral components (Pathogen-Associated 
Molecular Patterns – PAMPs), such as dsRNA, are detected within the cells by specific host 
proteins, Pattern Recognition Receptors (PRR). Once secreted, IFNs bind their specific 
receptors inducing the expression of interferon stimulated genes (ISGs), establishing an 
antiviral state. 
RV non-structural protein 1 (NSP1), exhibits the greatest sequence variability of any of RV 
protein. Although non-essential for RV replication in cell culture, NSP1 has been suggested 
as a virulence factor modulating the host innate immunity. RV NSP1-mediated ability to 
modulate the IFN response is conserved between strains infecting different species, 
however, it has been reported that targets within the induction and signalling pathways vary 
between strains. NSP1 derived from viruses infecting monkeys (RRV, SA) and mice (EW) 
appear to preferentially target IRF-3 to induce its proteasome-mediated degradation, while 
NSP1 of porcine origin (OSU) targets β-TrCP, preventing NF-κB activation. In contrast, NSP1 
from RV strain UKtc infecting cattle appears to target both IRF-3 and β-TrCP. 
In order to establish if the observed RV host-range restriction is related to the ability of NSP1 
to selectively target different components of the IFN pathways, Y-2-H analysis were 
performed. A panel of NSP1 derived from RV infecting different mammal species were tested 
for their binding ability against components of the IFN induction pathway. Indeed NSP1 
showed a strain-dependent ability to interact with IRF-3. 
A series of luciferase reporters have shown that NSP1 was able to downregulate the 
induction of type I and type III IFNs at their transcriptional level and how this downregulation 
varied between NSP1 derived from different strains. In addition, NSP1 appeared to target 
the IFN signalling pathway, blocking ISGs transcription. 
Moreover, NSP1 showed a strain-dependent expression level.  





1.1.1 Historical Background 
Diarrheal disease is one of the predominant cause of death in children under 
the age of five years in developing countries (Estes et al., 2007; Martella et al., 2010). 
The availability of clean water and adequate hospital treatment are key factors in 
determining the severity of diseases (Parashar et al., 2003). In developed countries 
advanced sanitary conditions play a pivotal role in reducing transmission, however 
prevalence of infection is still very high (Tucker et al., 1998). 
Until the end of the sixties diarrheal diseases due to viral infection were not 
reported (Yow et al., 1970). Only in 1969, Mebus’s group reported the presence of 
virus particles, 65nm in diameter, in the faces of animals previously inoculated with 
bacteria-free filtrates of diarrhoeic faces (Mebus et al., 1969), and in 1971 they were 
able to successfully cultivate Nebraska calf diarrhoea virus (NCDV) in primary foetal 
bovine cell culture (Mebus et al., 1971). These early works in animals received little 
attention until electron-microscopic examination of biopsy material from children 
with acute non-bacterial gastroenteritis revealed the presence of orbivirus-like 
particles within epithelial cells of the duodenal mucosa (Bishop et al., 1973). This first 
report was rapidly followed by others in which virus particles, morphologically 
indistinguishable from calf reo-like virus, were detected in the feces of children with 
gastroenteritis in England (Flewett et al., 1973), Australia (Bishop et al., 1974), 
Canada (Middleto.Pj et al., 1974), and the U. S. (Kapikian et al., 1974). Shortly 
afterwards, it became clear that rotaviruses were an important etiological agent of 
diarrhoea in infants and young children, causing up to the 50% of the gastroenteritis-
related hospitalisation. Later in the in the eighties, the first successful cultivation of 
human rotaviruses in African green monkey cells MA104 was reported, facilitating 
the investigation of the virus at the molecular level (Wyatt et al., 1980), allowing 
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further examination of the rotavirus replication cycle, epidemiology, pathogenesis 
and the nature of host resistance. 
1.1.2  Classification 
1.1.2.1  Reoviridae 
Rotaviruses (RV) constitute the genus of Rotavirus, one of the 16 genera of 
Reoviridae, together with Aquareovirus, Cardoreovirus, Coltivirus, Crabreovirus, 
Cypovirus, Dinovernavirus, Fijivirus, Idnoreovirus, Mimoreovirus, Mycoreovirus, 
Orbivirus, Orthoreovirus, Oryzavirus, Phytoreovirus and Seadornavirus (International 
Committee on Taxonomy of et al., 2012). The viruses of this family have a double-
stranded RNA (dsRNA) genome divided in to 10, 11 or 12 segments, encapsidated 
within a non-enveloped icosahedral particle with a diameter spanning between 60 
and 100nm. Reoviridae family can be further classified into two sub-families, based 
on the presence or the absence in the inner capsid (the core) of a “turret”- like 
protein, situated on the surface of the icosahedral core particle, one at the each of 
the five-fold axes. The Spinareovirinae (Spinae from Latin spike) sub-family contains 
Reoviridae members (Aquareovirus, Coltivirus, Cypovirus, Fijivirus, Orthoreovirus, 
Idnoreovirus, Dinovernavirus, Oryzavirus, Mycoreovirus) which show spikes or turrets 
on the surface of the core particle. In contrast, members of the Sedoreovirinae 
(Cardoreovirus, Mimoreovirus, Rotavirus, Orbivirus, Phytoreovirus, Seadornavirus), 
show a relatively smooth morphology (Sedo from Latin smooth). 
Members of the Reoviridae family are the largest and the most diverse group 
of dsRNA viruses in terms of host range, infecting different species including human 
(Rotavirus), animals (African horse sickness viruses) and plants (rice dwarf virus) 
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Table 1. Feature of members of the Reoviridae family. 
Reoviridae genus Number of genome    segments Hosts 
Spinareovinae 
Aquareovirus 11 fish, molluscs 
Coltivirus 12 Mammals, arthropods 
Cypovirus 10 Insect 
Dinovernavirus 9 Insects 
Fijivirus 10 Plants, insects 
Idnoreovirus 10 or 11 Insects 
Mycoreovirus 11 or 12 Fungi 
Orthoreovirus 10 Vertebrates 
Oryzavirus 10 Plants 
Sedoreovirinae 
 
Cardoreovirus 12 Crustaceans 
Mimoreovirus 11 Marine photosynthetic protists 
Orbivirus 10 Mammals, birds, arthropods 
Phytoreovirus 12 Plants, insects 
Rotavirus 11 Human and Vertebrates 
Seadornavirus 12 Human, cattle, pig 
Division of the Reoviridae family into two subfamilies based on the presence or absence of a turreted-




RV are classified serologically by a scheme that allows for the presence of 
multiple groups (serogroups, based on viral protein 6 -VP6- reactivity) and of multiple 
serotypes within each group (based on viral protein 4 -VP4- and viral protein 7 -VP7- 
neutralizing epitopes) (Estes et al., 2007). RV are divided into seven distinct groups 
(A-G), now designated RVA (rotavirus A), RVB (rotavirus B), RVC (rotavirus C) etc. RVA, 
RVB, and RVC strains have been found in both humans and animals. To date, RV of 
groups D, E, F, and G have been found only in animals (Trojnar et al., 2010). RV falling 
into each of the seven groups can be identified by cross-reactive antibodies to the 
viral structural protein 6 (VP6). The particular group a virus belongs to can be 
determined by a number of serological tests such as immune-fluorescence (IF) 
(Pedley et al., 1986), enzyme-linked immunosorbent assay (ELISA) and 
immunoelectron-microscopy (IEM) (Estes et al., 2007). Viruses within each group are 
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capable of genetic reassortment, however, such mechanisms do not occur between 
viruses in different groups, and thus RV groups are considered unique species (Yolken 
et al., 1988). 
The group A rotaviruses (RVA) have been studied most in depth because few 
strains belonging to the other groups have been successfully cultured in vitro 
(Matthijnssens et al., 2011) and serotype A viruses are important paediatric and 
animal pathogens (Martella et al., 2010; J. T. Patton, 2012). Within the RVA group, 
virus isolates have been divided into serotypes. This classification is based on plaque 
reduction or fluorescence foci reduction neutralization assays using hyper-immune 
serum prepared in antibody-negative animals targeting the outer capsid proteins, 
VP7 and VP4 (Hoshino et al., 1996). Based on of this, currently 32 G-serotypes (G1 - 
G27) (G for glycoprotein VP7) and 74 P-types (P for protease sensitive protein VP4) 
have been described for RVAs (Crawford et al., 2017). Among G-serotypes, G1-4 and 
G9 are the most common human strains worldwide (Angel et al., 2012; Gentsch et 
al., 2005; Santos et al., 2005). RV are classified by a binary system similar to the one 
used for influenza viruses, in which distinct types of VP4 and VP7 are recognised (D. 
Y. Graham et al., 1985; Hoshino et al., 1984). The advent of deep sequencing has 
allowed a further classification of RVA, with the possibility to relate serotypes to 
genotypes. To integrate the P-serotype and genotype designation, an open Arabic 
number following P is used to denote serotype, an Arabic number in brackets is used 
to indicate genotype. To identify a specific virus first the P (VP4) number as 
determined by serotyping, then followed by the designated genotype number in 
brackets, after which the G (VP7) number is given. For example, using this system, 
the human Wa isolate is designated P1A[8]G1. 
In April 2008, a new system of classification was developed for group A RV, 
based on nucleotide sequence. The system assigned a specific genotype to each of 
the 11 segments of the RV genome (VP7-VP4-VP6-VP1-VP2-VP3-NSP1-NSP2-NSP3-
NSP4-NSP5/6 genes) based on nucleotide identity cut-off percentages (Maes et al., 
2009) (Table 2). Today RV classification is classified as followed: RV group/species of 
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origin/ country of identification/ common name/ year of identification/ G- and P-type 
(Matthijnssens et al., 2011). 
Table 2. Nucleotide identity percentage cut-off values defining genotypes for 11 RV gene segments 
of rotavirus A (RVA). 
Gene product Percentage identity 
cut-off values 
Genotypes Name of genotypes 
VP7 80% 27 G types Glycosilated 
VP4 80% 37 P types Protease sensitive 
VP6 85% 18 I types Inner capsid 
VP1 83% 9 R types RNA-dependent RNA 
polymerase 
VP2 84% 9 C types Core protein 
VP3 81% 8 M types Methyltransferase 
NSP1 79% 18 A types Interferon Antagonist 
NSP2 85% 10 N types NTPase 
NSP3 85% 12 T types Translation enhancer 
NSP4 85% 15 E types Enterotoxin 




RVs are the predominant etiological agent of acute viral gastroenteritis in the 
young of a wide range of mammalian and avian species (Tate et al., 2016). Until the 
discovery of RVs, only a small portion of severe diarrheal illness in children was 
associated with a specific etiological agent (Yow et al., 1970). With the development 
of world-wide accurate diagnosis, it has become clear that RVs are the major 
etiological agent of serious diarrheal in the young world-wide (Walker et al., 2013). 
By the age of 5 years, almost every child has encountered a RV infection, with the 
highest incidence of infection occurring between 6 and 24 months of age (Angel et 
al., 2012).  Factors such as healthcare system and access to clean water lead to a 
dramatic difference in severity of disease in developed and developing countries. The 
impact of RV infection on infant mortality is 82% greater in poor regions of Asia, 
Africa and Latino America (Bresee et al., 2005; Parashar et al., 2009; Parashar et al., 
2006b; WHO, 2016). In the U.S. RVs cause about 5% to 10% of all diarrheal episodes 
in children under the age of 5 years, with 3 million cases reported, 500,000 visits to 
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a medical centre, 70,000 hospitalisations and 20-40 deaths (Desai et al., 2011; Fischer 
et al., 2007; Parashar et al., 2006a). Similar results have been published in 
epidemiological studies in Europe (Soriano-Gabarro et al., 2006). Hospital-based 
studies in developing countries have indicated that overall RVs are the leading cause 
of life-threating diarrhoea, causing more than 100 million episodes, 2 million 
hospitalisations and approximately 500,000 deaths in children younger than 5 years 
(Lanata et al., 2013; Parashar et al., 2003; Rheingans et al., 2009) (Figure 1). Adults 
are frequently re-infected with RV, as suggested by the high titre of RV antibodies 
that can be found throughout (Lausch et al., 2017). Usually these subsequent 
infections are asymptomatic, with minimal, moderate or no effects. RVs have been 
reported to be the cause up to 36% of the cases of the diarrhoea affecting adult 
travellers (Sheridan et al., 1981) and symptomatic infection can also occur in parents 
and carers of children with RV gastroenteritis, immunocompromised persons and 
elderly adults. 
Group A rotaviruses are the major cause of disease in humans, however, 
group B (C. M. Chen et al., 1985; Sanekata et al., 2003; Su et al., 1986) and C also 
infect humans (Bridger et al., 1987; Bridger et al., 1986), whereas, sero-groups D and 
E have been reported to successfully infect only animals (Trojnar et al., 2010).  
The transmission of human RV is complex and differs greatly geographically. 
During the early stages of infection, the virus is highly contagious because of the low 
infectious dose that is sufficient to productively infect a susceptible individual (van 
Gaalen et al., 2017). The virus is shed for several days at a very high concentration 
(>1012 particles/gram) in the stool and vomit of infected individuals (Ward et al., 
1984) and because RV particles are highly resistant to environmental inactivation 
(temperature, pH) (Keswick et al., 1983), they may persist on contaminated surfaces 
for several months. The faecal-oral route of transmission is the major one observed 
for RV infection. However, a respiratory route of transmission is suggested by 
temporal patterns of disease in temperate zones, with clear distinct winter peaks of 
incidence (van Gaalen et al., 2017). 




Figure 1. Map showing the global child deaths due to RV infection.  
The burden of RV disease is unevenly distributed between developed and developing countries, 
probably for socioeconomic and epidemiological reasons, with the majority of deaths occurring in 
the developing countries (WHO, 2016). 
 
1.1.4 Pathogenesis and pathology 
The understanding of RV pathogenesis is based primarily on studies in animal 
models. In vivo, RV infects mainly mature enterocytes in the mid and top section of 
the villi of the small intestine, suggesting that fully differentiated enterocytes express 
molecules required for efficient infection and replication (Ramig, 2004). However, 
studies have demonstrated that RV can replicate in the liver, the biliary system and 
pancreas (Desselberger, 2014). In animal models, infection can have different 
outcomes, ranging from a few visible lesions of the intestine, to more severe 
pathology, as enterocyte vacuolization, villus blunting and crypt hyperplasia (Ramig, 
2004). Severity of intestinal infection depend on both host and viral factors. Based 
on the relationship occurring between the virus and the host, two types of infection 
are possible, homologous and heterologous. Homologous strains (strains generally 
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isolated from the host species in question) tend to replicate efficiently, often causing 
diarrhoea at a very low inoculation dose, and spread efficiently in that host. In 
general, heterologous strains (not routinely isolated from that host in question but 
found frequently in another host species) replicate poorly compared to the 
homologous strains (Sen et al., 2009). The replication rate for both homologous and 
heterologous strains seems to depend on the age of the animal at infection. 
Loss of the absorption function of damaged intestinal villus enterocytes has 
been addressed as the major contributing factor to RV-induced diarrhoea (Estes et 
al., 2007). Another study suggested that the diarrhoea resulted from epithelial 
damage caused by villus ischemia (Osborne et al., 1988). However, studies in animal 
models have shown that diarrhoea was observed before the detection of damaged 
villi. The fact that gut lesions often do not correlate with the presence of diarrhoea 
suggest an alternative mechanism of diarrhoea induction. Later in infection, 
intracellular events, probably involving non-structural protein 4 (NSP4), cause the 
release of Ca2+ from the endoplasmic reticulum. This results in disruption of the 
microvillar cytoskeleton and increased permeability of the membrane to Ca2+ (Ramig, 
2004; Tian et al., 1994). Furthermore, the enteric nervous system (ENS) in the 
intestinal wall has also been shown to be involved in RV-induced diarrhoea (Lundgren 
et al., 2000). 
 
1.1.5 Rotavirus vaccine 
RV infection is ubiquitous among mammals and the virus can acquire the 
ability to spread from animals to humans (Desselberger, 2014). However, RVs are 
usually replication restricted in heterologous host species, resulting in poor 
replication and reduced virulence compared to the homologous species (Sen et al., 
2009). This host range restriction and the observation that natural infection can 
protect against severe RV-induced acute and recurrent gastroenteritis (RVGE) (Angel 
et al., 2012) were the basis for the development of the three live-oral-attenuated 
vaccines, Rotashiled (Wyeth), Rotarix® (GSK) and RotaTeq® (Merck). Rotashield was 
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the first one to be licensed in U.S., however, in 1998 was withdrawn due to a 
potential link between first vaccination and intussusception (Kapikian et al., 2005). 
The two other vaccines released later in 2006, showed no significant risk of 
intussusception (Angel et al., 2007). RotaRix® (designed as RV vaccine 1, RV1), was a 
monovalent vaccine derived from a virulent human G1P[8] strain attenuated by 
passaging in cell culture (Bernstein et al., 1999; Phua et al., 2005). RotaTeq® 
(designed as RV vaccine 5, RV5) was a pentavalent vaccine, containing a bovine strain 
and bovine-human mono-reassortant strains containing the common human RV G 
and P types (G1, 2, 4 and P[8]).  
RV1 and RV5 are globally licensed and protect against strains that are not 
included in the vaccine reassortment (Armah et al., 2010; Leshem et al., 2014; Patel 
et al., 2012; Steele et al., 2012), however, the exact mechanism of protection remains 
unclear. 
 
1.1.6 Virion Structure 
The morphological appearance of RV by negative-stain electron microscopy is 
distinctive. The term “rotavirus” was given to the particle due to the sharply defined 
outline of the outer layer that resembled the rim of a wheel (rota from Latin means 
wheel) (Flewett et al., 1974). 
RV is a non-enveloped icosahedral, triple-layered virus of approximately 100 
nm in diameter (Trask, Ogden, et al., 2012). The triple-layered particles (TPLs) are 
composed of an outer layer characterized by the presence of protein spikes that 
protrude from the surface, an intermediate layer and an inner core. The use of cryo-
electron microscopy (cryoEM) and high-resolution image processing techniques (x-
ray crystallography) have allowed a detailed reconstitution of the particles to near 
atomic level (Settembre et al., 2011). All three layers show an icosahedral 
organization: a T=13l (levo) for the two outer layer, while the innermost exhibits a 
unique T=1 icosahedral organization.  
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Starting from the inside of the virion, the architecture of the inner layer 
surrounding the viral genome is organized in 120 copies of VP2 proteins organized in 
dimers (Labbe et al., 1991; Lawton et al., 1997; Z. Li et al., 2009). Of the two subunits, 
one (VP2A) points towards the fivefold axis, while the other (VP2B), fills the space 
between VP2A (Z. Li et al., 2009), forming a decameric cap structure at the fivefold 
axis. The N-terminus of VP2 points towards the viral genome, where it is thought to 
interact with the dsRNA genome having shown RNA-binding capability (McDonald et 
al., 2011; Steger et al., 2018). Within the core the dsRNA genome is thought to exist 
in a super-coiled conformation around one of the 12 copies of the transcriptional 
complex (TC). TCs are formed by the viral protein 1, VP1, the RNA dependent RNA 
polymerase (RdRp) and the viral protein 3, VP3, the capping enzyme, found at the 5-
fold axes (Jayaram et al., 2004). 
The VP2 layer is surrounded by 780 molecules of VP6 proteins organized in 
260 trimers (Z. Li et al., 2009). The particle formed by the inner core and the external 
VP2 shell is referred as double layered particle (DLP) and is about 705Å in diameter 
(Desselberger et al., 2013). DLPs are transcriptionally active, but not infectious, and 
they are the structure delivered into the host cell upon infection (Desselberger et al., 
2013). VP6 may provide structural integrity for RV, enhancing long-term stability of 
the particle (Zeng et al., 1996). 
The outer layer is formed by VP4 and VP7: the first forms spikes that protrude 
from the virion surface while the second is a glycoprotein that constitutes the surface 
of the particle. VP7 is organized in 260 trimers, giving a T=13 icosahedral shape of the 
shell (Estes et al., 2007). Sixty spikes composed of dimers of VP4 protrude for a length 
of around 120Å from the smooth surface and inward about 80Å (Z. Li et al., 2009). 
VP7 interacts with the tips of VP6 trimers underneath to stabilize the outer most 
shell. VP4 is shown to be implicated in cell attachment and penetration (Diaz-Salinas 
et al., 2013; Y. Li et al., 2018; Trask et al., 2013), haemaglutination (Fiore et al., 1991), 
neutralization and virulence, and interacts with both VP6 and VP7 (Trask, Ogden, et 
al., 2012). VP4 is subject to proteolytic cleavage, resulting in two distinct but still 
associated sub-units, VP8* (28kDa) and VP5*(60kDa) (Trask et al., 2013). 
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A distinctive feature of the virion particles is the presence of 132 aqueous 
channels that span the 2 outer layers and link the outer surface with the inner core. 
There are three types of channels based on their position and size. There are twelve 
type-I channels with a diameter of 40 Å that run from the core of the virus to the 
outer surface. Sixty type-II channels are found at each of the pentavalent position of 
the fivefold axis. Another set of sixty type-III channels, 140Å in depth and 50Å wide 
at the outer surface of the virus. Type-I and –III channels are thought to import 
metabolites required for RNA transcription (Desselberger, 2014; Gridley et al., 2014), 
while type-I are believed to be conduits for the export of messenger RNA (mRNA) 











Figure 2. Rotavirus structure. 
Architectural features of RV. (A) PAGE gel showing 11 dsRNA segments comprising the RV genome. 
The gene segments are numbered on the left and the proteins they encode are indicated on the 
right. The migration pattern observed, with segments grouped following a 4-2-3-2 scheme, is 
characteristic of RVA. (B) Cryo-EM reconstruction of the RV triple-layered particle. The spike protein 
VP4 is coloured in orange and the outermost VP7 layer in yellow. (C) A cutaway view of the RV TLP 
showing the inner VP6 (blue) and VP2 (green) layers and the transcriptional enzymes (shown in red) 
anchored to the VP2 layer at the five-fold axes. (D) Schematic depiction of genome organization in 
RV. The genome segments are represented as inverted conical spirals surrounding the transcription 
enzymes (shown as red balls) inside the VP2 layer in green. (E and F) Model from Cryo-EM 
reconstruction of transcribing DLPs. The endogenous transcription results in the simultaneous 
release of the transcribed mRNA from channels located at the five-fold vertex of the icosahedral 
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1.1.7 Genome organization  
The RV genome is divided into eleven segments of double-stranded RNA 
(dsRNA). The genome segments range from 667 (segment 11) to 3302 base pairs 
(segment 1) (Estes et al., 2007). In general the genome sequences of the dsRNA are 
A+U rich (from 58% up to 67%) and all segments are completely base paired (Estes 
et al., 2007).  
Analysis of the viral genome of the group A viruses using a polyacrylamide gel 
electrophoresis (PAGE) revealed a characteristic migration pattern: four high-
molecular weight segments (1 to 4), two middle size segments (5 and 6), a peculiar 
triple of segments (7 to 9) and two smaller fragments (10 and 11) (Clarke et al., 1981) 
(Figure 2-A). When this pattern, 4-2-3-2, is not observed, the virus analysed may be 
an avian serotype, a non-group A virus, a group A that was subjected to 
rearrangement or a new unique virus. Analysis of genomic electropherotypes could 
be a potential rapid technique for the genotypic characterization of the virus during 
outbreaks, however, because distinct RNA patterns can arise by different 
mechanisms (re-assortment, mutation, rearrangements) and RNA segments of 
different sequences may co-migrate, these profiles are not useful as a definitive 
criterion for classification of a virus strain. 
Although some genes possess additional in-phase (genes 7, 9 and 10) or out-
of-phase (gene 11) ORFs, evidence to date indicates that all segments are 
monocistronic, except gene 11 that encodes for two non-structural proteins, NSP5 
and NSP6 (Desselberger, 2014). The open reading frame of each segment is flanked 
by 5’ and 3’ untranslated regions (UTRs) that are variable in length. UTRs are believed 
to play a role in genome replication, genome packaging and in the regulation of gene 
expression as a consequence of either their primary nucleotide sequences or their 
secondary structures. Although UTRs are not completely conserved among the 
different genome segments (and often differ in their length), terminal consensus 
sequences are common to all eleven genome segments: the 5’-terminal consensus 
5’-GGC(A/U)7−3’ and the 3’-terminal consensus 5’-U(G/U)3(A/G)CC-3’. A work by Di 
   
25 
 
Lorenzo et al showed the 5’-UTR of several (but not all) genome segments of RV 
contain an inhibitory motif (IM) that downregulates expression of RV cDNAs when 
expressed from a T7 polymerase-encoding recombinant vaccinia virus (De Lorenzo et 
al., 2016). The positive strand has a conserved 5’-cap sequence m7GpppG(m)Gpy but 
it lacks a 3’- poly-A tail (Imai et al., 1983). However, the 3’-end of the positive sense 
has the conserved sequences 5’-UGUGACC-3’ as the minimal essential promoter for 
the negative strand RNA strand synthesis (J. T. Patton et al., 1996; Wentz, Patton, et 
al., 1996). For RV, as for all members of Reoviridae family, the positive strand mRNA 
has two functions: it is used for translation of viral proteins and also serves as 
templates for the synthesis of minus strand during genome replication (Ayala-Breton 
et al., 2009; J. T. Patton et al., 2004). Moreover, each mRNA must also contain a signal 
sequence that is unique to it alone, because each segment needs to be distinguished 
from the others during genome packaging. However, these sequences remain 
unknown.  
1.1.8 Gene-protein coding assignments  
The RV genome encodes six structural proteins, VP1-VP4, VP6 and VP7, and 
six non-structural proteins, NSP1-NSP6. The viral proteins VP5* and VP8* are 
generated by the proteolytic cleavage of VP4 (Trask et al., 2013). Both the genome 
segments and the corresponding proteins are numbered based on their migration 
order on PAGE from the slowest to the fastest (Figure 2). But the absolute migration 
order of cognate genes does vary among viral strains. 
The protein coding assignment for each segments were determined by (1) in 
vitro translation using mRNA or denatured dsRNA (Mason et al., 1980; McCrae et al., 
1983), (2) analysis of reassortant viruses (Gombold et al., 1985b; Gombold et al., 
1987; Kantharidis et al., 1988; M. Liu et al., 1988), and (3) immunological studies with 
specific antibodies (Both et al., 1983; Dyall-Smith et al., 1983) . 
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1.1.9 Rotavirus proteins 
1.1.9.1 Rotavirus structural proteins (VPs) 
1.1.9.1.1 VP1 (core) 
Encoded by the gene segment 1, VP1 is a 125kDa basic protein which 
constitutes a minor component of the viral core. Several studies have proposed VP1 
as the RNA dependent RNA polymerase (RdRp) (Estrozi et al., 2013). The use of a 
baculovirus expression system has shown that a core-like particle containing VP1, 
VP2 and VP3 is able to transcribe RNA, as is a core-like particle containing VP1 and 
VP2 only. However, a core-like particle expressing VP2 alone or VP2 and VP3 is not 
able to transcribe RNA (Zeng et al., 1996), indicating the essential role of VP1 in RNA 
transcription. Furthermore, it has been shown that prototype temperature-sensitive 
mapping mutations within VP1 are not able to produce RNA at non-permissive 
temperatures (D. Chen et al., 1990). The nucleotide-binding activity of VP1 was 
established using cross-linking experiments. VP6 active particles (DLP) expressing 
VP1 and photosensitive nucleotide analogue [α-32P] azido-adenosine triphosphate 
were unable to transcribe RNA in the presence of light (Valenzuela et al., 1991). VP1 
specifically binds the 3’ end of viral RNA containing the cis-acting replication signals 
(J. T. Patton et al., 1996). VP1 functions as both a viral replicase and transcriptase (J. 
T. Patton, 1995), and its activity appears to be dependent on the presence of VP2 
(Mansell et al., 1990). 
1.1.9.1.2 VP2 (core) 
VP2 is a 92 kDa protein that constitutes 12% of the viral core (M. K. Estes et 
al., 1989). It forms the innermost of the three protein layers, encapsidating the 
dsRNA genome, VP1 and VP3 (Settembre et al., 2011). VP2 has been shown to have 
sequence-dependent RNA binding activity and to associate with both ssRNA and 
dsRNA, but showing higher affinity for ssRNA rather than dsRNA (Boyle et al., 1986), 
facilitating its role in viral replication and encapsidation (Boyle et al., 1986; Mansell 
et al., 1990). Potential binding domains have been mapped between amino acids 1-
132 (Labbe et al., 1994) and between amino acids 517-636 (Landschulz et al., 1988). 
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VP2 is highly immunogenic, and serum antibodies to this protein are a good indicator 
of prior infection (Lopez-Guerrero et al., 2018). 
1.1.9.1.3 VP3 (core) 
VP3 is an 88kDa protein localised in the core of the viral particle. A baculovirus 
expression system expressing core-like particles has shown that VP3 binds to the N-
terminus of VP2, which is the domain of VP2 that binds RNA (Labbe et al., 1994; Zeng 
et al., 1998). It has been demonstrated that VP3 exhibits a sequence-independent 
affinity for ssRNA, but not for dsRNA (Boyle et al., 1986; J. T. Patton et al., 1999). VP3 
is found in early replication intermediates in the viroplasms and associated with viral 
mRNA during early stages of viral replication cycle (J. T. Patton et al., 1990). This could 
be due to the guanylyltransferase capping activity of VP3, which places a 5’ cap onto 
viral mRNA (M. Liu et al., 1992). This activity has been demonstrated to be non-
specific with VP3 being able to cap any RNA initiating with either guanine or adenine 
residues. However, VP3 does preferentially bind uncapped RNA rather than capped 
RNA (J. T. Patton et al., 1999). VP3 has also been shown to have methyltransferase 
activity (D. Chen et al., 1999). Recent studies have shown how VP3 plays a role in 
subverting the host immune response targeting MAVS in a host-range-restricted 
manner (Ding et al., 2018). Moreover, it has been shown that VP2 cleaves the IFN-
inducible 2′,5′-oligoadenylate (2-5A) synthetases (OASs), thereby preventing 
activation of RNase L (Silverman et al., 2014; R. Zhang et al., 2013). 
1.1.9.1.4 VP4 (outer capsid protein) 
VP4 is an 88kDa protein found in the outer most layer of the virus, where it 
forms sixty spikes which protrude from the virion surface (Anthony et al., 1991; 
Prasad et al., 1994). Each spike is a trimer, where two VP4 molecules form a rigid 
structure and the third is flexible (Mathieu et al., 2001). VP4 is the haemagglutinin 
(Fiore et al., 1991; Kalica et al., 1978; Prasad et al., 1990; Shaw et al., 1993) and it has 
been proposed to be the viral protein involved in cell attachment (S. K. Mohanty et 
al., 2017; Ruggeri et al., 1991). Moreover, VP4 has been implicated in growth 
restriction in cell culture (Greenberg et al., 1983), enhancement of viral infectivity 
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due to the cleavage of VP4 into VP8* and VP5*, virulence (Offit et al., 1986), 
neutralisation and protective immune responses (Offit et al., 1986). Studies in mice 
have shown how VP4 is the major determinant in modulating disease pathogenesis 
(Walther et al., 2015; W. Wang et al., 2011). The C-terminus of 'free' VP4 was 
identified as interacting with actin microfilaments (Condemine et al., 2018). The 
acting-binding domain is highly conserved in rotavirus strains from species A, B and 
C suggesting that actin binding and remodelling is a general strategy for rotavirus 
exit. 
1.1.9.1.5 VP6 (inner capsid protein) 
VP6 is a non-glycosylated protein which forms the inner shell of the virion and 
accounts for 50% of the total viral proteins (Estes et al., 2007). It can spontaneously 
associate into trimers and biochemical and 3-dimensional structural analysis 
experiments have shown that this is the native form adopted by the protein within 
the viral particle (Gorziglia et al., 1985; Prasad et al., 1988; Sabara et al., 1987). 
Deletion mutagenesis experiments have mapped a region essential for trimerisation 
to between amino acid 246 and 314 (Affranchino et al., 1997). VP6 shows great 
sensitivity to pH, and variation of few degrees lead to disaggregation of the trimers 
into round particles or hexamers (Tosser et al., 1992). The resulting single-layered 
particle lacks RNA-transcriptase activity which can be restored by the addition of VP6 
to the core particle, indicating that VP6 is required for viral-transcriptase activity 
(Bican et al., 1982; Charpilienne et al., 2002; Sandino et al., 1986). VP6 interacts with 
VP2, VP4 and VP7 (Charpilienne et al., 2002; Mathieu et al., 2001). It is highly 
immunogenic and antigenic and contains RV group and subgroup determinates 
(Lopez-Guerrero et al., 2018). VP6 is used as primary antigen detection in routine 
diagnosis of RV disease (Lappalainen et al., 2017).  
1.1.9.1.6 VP7 (outer capsid protein) 
VP7 forms the smooth outer surface of the mature virion, and constitutes 30% 
of the viral proteins (Estes et al., 2007). There are 780 copies of VP7 associated in 
trimers (Prasad et al., 1988). It is known to be the major neutralisation antigen 
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(Sabara et al., 1985) and it is the G-serotype determinant of RV classification 
(Greenberg et al., 1983). VP7 is a glycoprotein with three potential sites for N-linked 
glycosylation, although only two of these appear to be used in different strains 
(Kouvelos et al., 1984). The N-glycosylation takes place in the host, when the protein 
is inserted into the membrane of rough endoplasmic reticulum (RER) (Kabcenell et 
al., 1985). The ORF of gene 9 that encodes VP7 has three potential ORFs. The first 
one which transcribes for the full length protein (376 amino acids) has a sub-optimal 
Kozak consensus sequence. The second ORF is -90 base downstream and it has a 
much stronger Kozak sequence. There is a potential third ORF downstream, however, 
this is found only is some strains. VP7 has been shown to interact with VP4 and NSP4 
within infected cells and these interactions appear to be crucial for the formation of 
the outer layer (Maass et al., 1990). Moreover, there is some evidence that suggests 
that VP7 binds to calcium ions and this may play a role in maintaining the stability of 
the virion (Cohen et al., 1979).  
 
1.1.9.2 Rotavirus non-structural proteins (NSPs) 
1.1.9.2.1 NSP1 
Non-structural protein 1 (NSP1), previously known as NS53, is a 55kDa basic 
protein transcribed by segment 5. NSP1 exhibits the greatest sequence variability of 
any of the RV proteins, being much higher than even the outer capsid proteins VP4 
and VP7. This amino acid sequence variability is particularly evident among virus 
strains that infect different animal species (Dunn et al., 1994). The open reading 
frame (ORF) of gene 5 of group A RV can vary considerably among different virus 
strains. As a result, NSP1 protein ranges in size from 486 to 496 amino acids for 
mammalian RV isolates, to 577 amino acids for avian isolates. In contrast with the 
overall sequences variability, sequencing analyses have identified highly conserved 
residues or regions, especially in the first 150 amino acids rather than the C-terminus 
(Bremont et al., 1993; Mitchell et al., 1990). The first 55 nucleotides, which include 
the 5’-UTR and the sequence transcribing for the first eight amino acids are highly 
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conserved (Hua et al., 1994). The region between amino acids 42 and 72 in the N-
terminus of the protein has been found to be conserved among most RV strains. This 
region is rich in cysteine and has been shown to contain two potential zinc fingers 
domains (Hua et al., 1994; Okada et al., 1999). Although the majority of the NSP1 
sequences available are from isolates belonging to group A, the N-terminus cysteine 
rich region has been found in group C RV but not in group B (Bremont et al., 1993). 
The consensus sequence for the cysteine domain is C-X2-C-X3-H-X-C-X2-C-X5-C 
(Bremont et al., 1993; Hua et al., 1994; Mitchell et al., 1990). Other conserved regions 
span through the sequence of NSP1: a short sequence (15-30 residues each) of basic 
amino acids in proximity of the N-terminus (Hua et al., 1994), a cluster of acid amino 
acids in the last 15 residues (Hua et al., 1994; Mitchell et al., 1990), and eleven 
isolated proline residues throughout the entire length of the gene (Hua et al., 1994). 
Moreover, sequence analyses have identified conserved regions of NSP1 with RNA-
binding activity: in vitro experiments have confirmed its capacity to bind the 5’ ends 
of all 11 RV mRNA strands (Hua et al., 1994). 
Phylogenetic analyses have revealed that NSP1 sequences resolve within two 
classes, termed class I and II (Arnold et al., 2011). It has been shown that NSP1 is 
implicated in counteracting the host immune response upon viral infection (Arnold 
et al., 2009; Bagchi et al., 2010; Barro et al., 2005, 2007; Di Fiore et al., 2015; Feng et 
al., 2009; Morelli, Ogden, et al., 2015). These phylogenetic analyses have revealed a 
kind of correlation between the NSP1 origin and the modality of IFN down-regulation. 
NSP1 members falling into class I seem to modulate IFN activation preferentially 
targeting interferon regulatory factors 3, 5 and 7 (IRF-3, IRF-5 and IRF-7). In contrast, 
NSP1 falling in class II seem to down-regulate IFN expression modulating NF-κB 
activation. However, some exceptions are observed within the two groups, as 
described later in this chapter (1.3). The amino acids sequence variability among 
different strains could underline adaptations to down-regulate the IFN response in 
different host species. Despite the sequence divergence, the presence of 
evolutionary conserved regions could constitute a selective advantage in animal 
infection. 
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Immunofluorescent staining of RV infected cells has shown that NSP1 is 
localized into the cytoplasm (Graff et al., 2002) and it associates with the 
cytoskeleton when analysed by sub-cellular centrifugation (Hua et al., 1994). NSP1 
does not appear to be essential for RV replication in cell culture as mutants encoding 
truncated version of the protein can still replicate but produce smaller virus plaques 
(Kanai et al., 2017; K. Taniguchi et al., 1996).  
 
NSP1 is one of the least abundant non-structural proteins, with a half-life of 
45 min in infected cells (Mitzel et al., 2003). In BSC-1 cell lines infected with rhesus 
RV (RRV), NSP1 was not detectable after 9 hours, and at 12 hpi the protein 
represented less than 0.1% of total protein synthesis (Johnson et al., 1989). 
Experiments using a vaccinia expression system have shown that in BSC-1 cells in 
absence of other RV proteins, the susceptibility of NSP1 to proteasome degradation 
is the major determinant of the viral protein stability (Pina-Vazquez et al., 2007). 
However, the sensitivity of NSP1 to proteasome-mediated degradation can be fully 
reversed by viral gene products, either viral proteins alone or in combination with 
viral mRNAs. Based on the knowledge that NSP1 binds in vitro to all eleven viral 
mRNAs and to other viral proteins, it has been proposed that such interaction could 
affect the susceptibility of NSP1 to be degraded (Brottier et al., 1992; Hua et al., 
1994). 
1.1.9.2.2 NSP2 
As with all dsRNA viruses, RV do not release their genome in infected cells 
preventing the activation of the immune system. Two hours post infection, those 
cells are characterized by the presence of cytoplasmic occlusion bodies, defined as 
viroplasms (Altenburg et al., 1980). These viroplasms have been shown to be sites 
for dsRNA synthesis and replication, the packaging of viral dsRNA into new cores and 
the early steps of viral morphogenesis which result in the formation of the double-
layered particle (Fabbretti et al., 1999; J. T. Patton et al., 1997; Wentz, Zeng, et al., 
1996). The major component of these bodies is NSP2 (known also as NS35) (Fabbretti 
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et al., 1999; Petrie et al., 1984), a 35kDa basic protein encoded by gene segment 8. 
It assembles in octamers (Schuck et al., 2001) which is the functional form of the 
protein (Kattoura et al., 1994; Z. F. Taraporewala et al., 2002). Early studies using 
temperature sensitive mutants have shown that NSP2 is essential for viroplasms 
formation (Ramig et al., 1984) and virus replication (Gombold et al., 1985a). 
Viroplasms assembly appears to be driven by the interaction of NSP2-NSP5 
(Afrikanova et al., 1998), without the requirement of any other viral protein 
(Eichwald et al., 2004; Fabbretti et al., 1999). The interaction of NSP2 with NSP5 
seems to be essential, because when NSP2 is transiently expressed alone tends to 
diffuse homogeneously in the cytoplasm (Eichwald et al., 2004; Fabbretti et al., 
1999). In RV infected cells, NSP2 appears to be present in two different dorms that 
differentially interacts in a phosphorylation-dependent manner with NSP5 (Criglar et 
al., 2014). Cytoplasmically dispersed NSP2 (dNSP2), is first detected in small puncta 
throughout the cytoplasm of infected cells and colocalizes with NSP5 in nascent 
viroplasms, and accumulates rapidly in the RV-infected cell at early times post-
infection. The second previously known form, viroplasmic NSP2 (vNSP2) is detected 
only in viroplasms, and the amount steadily increases as viroplasms mature and 
increase in size. It has been shown that NSP2 exhibits great affinity to microtubules 
(Cabral-Romero et al., 2006; Eichwald et al., 2012). This interaction could lead to the 
association of the viroplasms with the microtubules network and its subsequent 
virus-induce de-polymerization (Cabral-Romero et al., 2006; Martin et al., 2010). 
Studies using siRNA to knock down the expression of NSP2 have shown that the loss 
of the viral protein leads to inhibition of viroplasms formation, genome replication, 
virion assembly and synthesis of other viral proteins (Silvestri et al., 2004). Cross-
linking assays have shown that NSP2 binds to VP1, (Arnoldi et al., 2007). The 
interaction with the viral RdRp could be due to the multifunctional ability of NSP2, 
being involved in genome replication and packaging. Enzymatic studies have revealed 
that NSP2 possess nucleoside triphosphates (NTPase) (Z. Taraporewala et al., 1999; 
Vasquez-Del Carpio et al., 2006), RNA triphosphates (RTPase) (Z. F. Taraporewala et 
al., 2001; Vasquez-Del Carpio et al., 2006) and helix-destabilizing activity (Carpio et 
al., 2004).  




NSP3 is a slightly acid protein of 36kDa which can be found distributed in the 
cytoplasm or associated with the cytoskeleton of infected cells (Mattion et al., 1992). 
NSP3 is organized in two domains, the N-terminal domain that binds the 3’-
consensus sequence of all viral mRNA, “GACC” (Poncet et al., 1993; Poncet et al., 
1994), and a dimerization domain, localised between amino acids 163 and 237. 
Initially NPS3 was reported to function primarily in the shut-off of cellular protein 
expression following viral infection (Padilla-Noriega et al., 2002). In eukaryotes, 
protein translation is initiated by the eukaryotic initiation factor 4E (e1F4E) which 
binds to the 5’-cap structure of the mRNA. Subsequently, the mRNA poly-A tail is 
recognised by poly-A binding protein (PABP). This is followed by the interaction of 
e1F4E and PABP and the subsequent circularisation of mRNA which is required for 
efficient initiation of translation (Imataka et al., 1998; Tarun et al., 1995). To interrupt 
this process, it is believed that NSP3 first recognises the consensus sequence of the 
viral mRNA and then interacts with e1F4G taking over the position of PABP and host 
mRNA  evicting them from the cellular translational complex (Gratia et al., 2015) and 
blocking host protein synthesis (Gratia et al., 2016). However, contrasting results 
have shown that knock down of NSP3 using RNAi technology had little or no effect 
on the overall viral gene expression (Montero et al., 2006).  
1.1.9.2.4 NSP4 
NSP4 is a 28kDa protein transcribed from genome segment 10. It is a 
transmembrane protein that localises in the ER. NSP4 has been shown to be 
implicated in viral morphogenesis and pathogenesis (Ericson et al., 1982; Kabcenell 
et al., 1985). It is both co-translationally and post-translationally glycosylated (Au et 
al., 1989; Kabcenell et al., 1985). The protein is characterized by three hydrophobic 
domains (H1, H2 and H3) localised in the N-terminus (Bergmann et al., 1989). The H2 
domain contains a predicted transmembrane domain that spans into the ER 
membrane, while H3 appears to lie on the cytoplasmic side of the ER membrane and 
is implicated in the recruitment of the DLPs to the ER lumen (Jagannath et al., 2006). 
The C-terminus is hydrophilic and forms an extended cytoplasmic domain. It has been 
   
34 
 
proposed that the C-terminus contains the signal to mediate the transport of the DLP 
into the ER (Au et al., 1993; Taylor et al., 1992). Cross-linking experiments have 
shown that NSP4 oligomerizes in dimers and tetramers (Maass et al., 1990) and it is 
involved in the removal of the transient membranes from the DLPs budding through 
the ER. NPS4 also contains a VP4 binding domain, suggesting a potential role in the 
assembling of the virions outer layer (Au et al., 1993).  
The second function of NSP4 appears to be related to its secretion from virus 
infected cells and the establishment of the viral pathogenesis. NSP4 was the first viral 
endotoxin documented and its effects were first observed when purified NSP4 
proteins were inoculated intraperitoneally and caused age-dependent diarrhoea in 
mice (Tian et al., 1996).  
The mechanism by which NSP4 destroys epithelial cells is believed to happen 
through paracrine pathways which leads in the end with the secretion of intra-
cellular calcium (Ca2+) and chloride ions (Diaz et al., 2012). The interaction of NSP4 
with cellular integrins activates a cascade of events resulting in the release of Ca2+ 
from the ER and accumulation into the cytoplasm, causing disruption in the 
homeostasis of Ca2+ (Sastri et al., 2014). Moreover, NSP4 appears to act as viroporin, 
creating a Ca2+ channel leading to the export of Ca2+ from the cell (Pham et al., 2017). 
Cytoplasmic Ca2+ concentration plays a pivotal role in live cell osmosis and its 
disruption results in dysfunctional cellular molecules which leads to the death of 
bystander epithelia. Furthermore, Ca2+ stabilizes the outer capsid of the virion and 
induces cell death (Ruiz et al., 2005). It has been proposed that the secretion of water 
and loss of electrolytes from the cells that contribute to the onset of diarrhoea can 
be triggered by the sudden changes in Ca2+ concentration (Pham et al., 2017). 
 The amino acid sequences of NSP4 is highly conserved within groups, with 
98% homology in RVA  (S. L. Lin et al., 2003)and 93% in RVB (Guzman et al., 2005). 
However, this identity is much lower between groups, with less than 10% sequence 
identity occurring between group A and group B NSP4 (Guzman et al., 2005). In 
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contrast with the sequence variability, there is a high level of secondary sequence 
similarity (Guzman et al., 2005). 
 Immunization against NSP4 has been shown to be able to induce immunity 
that protects animals and children from viral challenge (Iosef et al., 2002; Malik et 
al., 2008). Anti-NSP4 antibodies have also been reported to be sufficient to block RV-
induced diarrhoea in mice (Hou et al., 2008). 
1.1.9.2.5 NSP5 
NSP5 is the primary translational product of gene segment 11 (Mattion et al., 
1991). It is a dimer which is post translationally O-glycosylated and phosphorylated 
(Afrikanova et al., 1996). NSP5 has shown to be able to bind ssRNA and dsRNA with 
equal affinity (Vende et al., 2002) and also to interact with the viral proteins VP1, VP2 
and NSP2 (Afrikanova et al., 1998; Berois et al., 2003). Interaction with NSP2 has been 
reported to be sufficient to form viroplasm-like structures (Criglar et al., 2014). 
Recently it has been reported that interactions of NSP5 with NSP2 and VP5 is able to 
drive the recruitment of all the other viral protein to the viroplasms (Contin et al., 
2010). This suggests a potential role of NSP5 in orchestrating the formation of 
viroplasms, the recruitment of the other viral proteins and viral RNA packaging 
(Martin et al., 2013). NSP5 expression has bene shown to be essential for virus 
replication. siRNA experiments knocking-down expression levels of NSP5 in infected 
cells have been shown to reduce the number on viroplasm-associated proteins, result 
in a decrease in the synthesis of structural and non-structural proteins and a 
reduction of genomic dsRNA and infectious viral particles (Campagna et al., 2005; T. 
Lopez, Rojas, et al., 2005; Vascotto et al., 2004). 
1.1.9.2.6 NSP6 
NSP6 is encoded by a +1 alternative reading frame in gene segment 11. NSP6 
ORF is completely positioned within the ORF of NSP5 (Mattion et al., 1991). The 
encoded protein is of 12kDa, with a length of 92 to 98 amino acids, depending by the 
viral strain. NSP6 appears to be expressed at low level, with high turnover rate 
(Mattion et al., 1991; Rainsford et al., 2007). 
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Yeast-2-hybrid and co-immunoprecipitation experiments have shown an 
interaction between NSP6 and NSP5, and both proteins appear to localize into the 
viroplasms (Torres-Vega et al., 2000). However, this interaction has not been 
confirmed in virus-infected cells (Torres-Vega et al., 2000). The C-terminal region of 
NSP5 has been shown to be essential for the interaction with NSP6 and to be involved 
in dimerization and phosphorylation (Torres-Vega et al., 2000). Sequences analysis 
of gene 11 from different virus isolates has revealed that NSP6 is not encoded by all 
RV strains (Kojima et al., 1996; Wu et al., 1998). The absence of the start codon of 
NSP6 in two human strains, the truncated form of NSP6 found in porcine OSU (S. A. 
Gonzalez et al., 1989) and lapine (Gorziglia et al., 1989) and the absence of NSP6 
reading frame in group B and group C (Trojnar et al., 2010) suggest that NSP6 may 
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1.1.10 Rotavirus replication cycle 
RV replicate entirely in the cytoplasm and have a lytic replication cycle (Estes 
et al., 2007). Most of the data generated on the replication cycle were obtained from 
studies with permissive cell lines. In monkey kidney cells (MA104), the virus reaches 
a maximum yield after 10 to 12 hpi (McCrae et al., 1981). However in polarized 
intestinal epithelial cells (Caco-2) the replication appears to be much slower with a 
maximum virus yield detected at 20 to 24 hpi (Jourdan et al., 1997). Both cell lines 
are highly permissive and Caco-2 cells in particular are thought to reflect RV in vivo 
infection (Ciarlet et al., 2001). In vivo, the natural cell tropism for RV are mature 
enterocytes at the tip of the villi of the small intestine (Boshuizen et al., 2003), 
suggesting these cells express specific receptor(s) for virus attachment (Ma et al., 
2014). However, extra -intestinal spread of virus also occurs in human and all animal 
models, demonstrating a wider range of host cells and additional receptors may be 
involved (Yu et al., 2015). RV have been reported to replicate in the liver, the biliary 
system and pancreas (Saxena et al., 2016). 
The general features of RV replication based on studies on permissive cells 
line are summarised as followed: (a) In vitro cultivation of most RV strains required 
an extra step characterized by the addition of exogenous proteases to the culture 
medium to ensure the activation of the virus through the proteolytic cleavage of VP4, 
(b) the replication is completely cytoplasmic, and occurs in virus-synthesised 
structures, defined viroplasms, (c) the virus supplies all the enzymes required for the 
replication of the genomic dsRNA, the host lacks these enzymes, (d) viral mRNA 
transcripts are used both to translate viral proteins and as template for the 
production of negative-strand RNA, (e) replication occurs in nascent sub-viral 
particles, viroplasms (free dsRNA of free negative-stranded ssRNA is generally not 
found in infected cells), (f) sub-viral particles are produced in association with 
viroplasms, and these particles mature by budding through the membrane of the ER, 
(g) intracellular levels of calcium are important for controlling virus assembly and 
stability and (h) infectious particles (TLPs) are released by cells lysis (Long et al., 
2017). 




Figure 3. Rotavirus replication cycle. 
RV virions attach to the surface of target cells sialic acids through VP8*, resulted from the cleavage 
of VP4 into VP5* and VP8* respectively. Once internalised, it is believed that variation in Ca2+ induce 
the uncoating of the TLPs and the release of DLPs. Loss of the outer shell activates the RdRp 
complexes (VP1 and VP3) that transcribe capped positive-sense RNA ((+)RNAs) from each of the 11 
double-stranded RNA (dsRNA) genome segments. (+)RNAs serve either as mRNAs for synthesis of 
viral proteins by cellular ribosomes or as templates for synthesis of negative-sense RNA ((–)RNA) 
during genome replication. Two early-translated viral proteins, NSP2 and NSP5, interact to form 
large inclusions, defined viroplasms, where viral genome replication and assembly of new viral sub-
particles take place. Through and undefined mechanism, new DLPs acquire a temporary outer 
membrane budding through the ER. Intermediate membrane displacement by VP7 leads the 
formation of mature TLPs that exit the cell by host cell lysis or by non-classical vesicular transport. 
TPLs released in the gut are exposed to trypsin-like proteases that cleave VP4 into VP5* and VP8*, 
producing a fully infectious virus (Trask, McDonald, et al., 2012). 
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1.1.10.1 Virus attachment 
RV attachment appears to be mediated by conformational changes occurring 
on the viral surface proteins upon interaction with host receptors (Estes et al., 2007). 
RV attachment and entry are a multi-step processes which involve sialic acid 
containing receptors in the preliminary step to cell attachment and coordinated 
interactions with multiple receptors during the post attachment step (Ma et al., 
2014). TLPs particle have been reported to be the only viral form that is able to 
successfully infect cell (Long et al., 2017). Cell attachment involves conformational 
changes of the proteins of the outer capsid, VP4 and VP7 (Trask et al., 2013). VP4 is 
sensitive to proteolytic cleavage by proteases present in the gut of the host. Once 
activated, VP4 results in two distinct but still associated sub-units, VP5* and VP8* 
(Diaz-Salinas et al., 2013). It is believed that the virus attachment is mediated by VP4 
(Trask et al., 2013) or by its cleavage product, VP5*(Zarate et al., 2000). However, 
previous works have shown how the cleavage of VP4 seems not to be required for 
cell binding (Clark et al., 1981; Fukuhara et al., 1988), neither is the glycosylation of 
VP7 (Petrie et al., 1983). A variety of potential receptors have been reported to be 
involved in binding process, including N-acetylneuramic acid (sialic acid), several 
integrins (α2β1, αvβ3, α4β1 and αxβ2) and the heat shock cognate (hsc70) (Ma et al., 
2014; Yu et al., 2015). It has been proposed that during the early stages an interaction 
occurs between VP8* and sialic acid receptors (Hu et al., 2012; S. Lopez et al., 2004). 
It has been shown that VP8* of human and not human RV strains origin, goes under 
structural rearrangement upon glycan receptor binding (Yu et al., 2015). The intrinsic 
structural flexibility of VP8* could provide crucial advantage in RV adaptation to 
intestinal replication in hosts which express different cellular glycans. Recently has 
been shown that VP8* that A-type HBGAs are receptors for human rotaviruses, 
although rotavirus strains vary in their ability to recognize these antigens (Bohm et 
al., 2015; Yu et al., 2015). VP8*- receptors interaction triggers a conformational 
change in VP4 to form the trimeric VP5* that through their DGE domains interact 
with integrin α2β1 (Fleming et al., 2011; K. L. Graham et al., 2003). After the initial 
interactions, VP8*- sialic acid receptors and VP5*- α2β1, another three host proteins 
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seem to be involved in many interactions: (i) the KID domain of VP5* and the ligand 
binding domain of hsc70 (Guerrero et al., 2002; Zarate et al., 2003), (ii) the CNP 
region of VP7 and integrin αvβ3 (Zarate et al., 2004), and (iii) the GRP domain of VP7 
and integrin αxβ2 (K. L. Graham et al., 2003). However, the exact orders of these 
interactions remain unclear. 
1.1.10.2 Penetration 
Following the attachment to the cell surface, the virus initiates the 
internalization of the viral particle. Efficient entry of RV into cells requires 
conformational rearrangements of the spike proteins to facilitate membrane 
penetration. It has been reported that trypsinized particles enter the cells more 
rapidly than untreated (Kaljot et al., 1988). Observations made by EM of RV-infected 
cells have shown that the viral particles were associated with coated pits and 
internalized in coated vesicles, suggesting that the virus entry was achieved via 
endocytosis (Ludert et al., 1987). However, the same experimental techniques have 
reported that trypsin-treated viral particles entered the cells by direct membrane 
penetration. In these studies untreated particles were removed by the plasma 
membrane be endocytosis, giving a non-productive infection (Suzuki et al., 1985). 
Later experiments using drugs that inhibited the acidification of the endosome and 
the transport of endocytic vesicles have shown no effect on the infectivity, suggesting 
that endocytosis is not involved in virus entry (S. Lopez et al., 2006; Ludert et al., 
1987). By contrast, it has been reported that an inhibitor of the vacuolar proton-
ATPase pump, bafilomic A, is able to block RV infectivity, supporting the endocytic 
mechanism for virus entry (Chemello et al., 2002). Another mechanism of direct 
penetration of the cell membrane has been proposed for RV internalization. This was 
based on the observation that RV infection induces a rapid permeabilization of the 
cell membrane (Kaljot et al., 1988). Taken together these studies suggest that 
different viral strains rely on different mechanisms for internalization (Arias et al., 
2015), but the exact mechanisms of each pathway remains unclear. Recent studies 
have shown that virions bind tightly upon contact with a cell, becoming relatively 
immobile on the cell surface in less than a minute. Within about  5 minutes  of  
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attachment,  the   particles become  inaccessible  to  EDTA  (which  releases  accessible 
virions from the cell by dissociating VP7). In 5-7 min upon cell attachment, DLPs are 
released into the cytoplasm (Abdelhakim et al., 2014). 
1.1.10.3 Uncoating 
The uncoating process of RV consists of the removal of the outermost layer 
proteins, VP4 and VP7, and the delivery of the transcriptionally active double-layered 
particles (DLPs) into the cytoplasm of infected cells (Abdelhakim et al., 2014). This 
process can be achieved in vitro by the use of chelating agents such as EDTA or EGTA 
(Cohen et al., 1979). In vivo it has been proposed that VP4 and VP7 are solubilized 
within endocytic vesicles because of the low calcium concentration (Salgado et al., 
2018). In support to that, the employment of the calcium ionophore A23187 seems 
to prevent the uncoating of porcine strain OSU (Ludert et al., 1987). However, 
treatment of cells with A23187 appears to have no effect on the uncoating of some 
strains, as rhesus RRV and monkey SA (Cuadras et al., 1997). Therefore, as for viral 
entry, the importance of calcium levels for the uncoating process might vary between 
different strains.  
1.1.10.4 Transcription 
The incoming RV double-layered particles (DLPs) contain the genomic dsRNA 
which is used for both the translation of viral proteins and as a template for the 
synthesis of new dsRNA genome (Long et al., 2017). To initiate transcription, 
transcriptase complexes (TCs), which are formed of one copy of VP1 and VP3 each, 
utilize ATP (Spencer et al., 1981) and viral dsRNA to generate capped, positive sense 
single-stranded RNA ((+)ssRNA) (Lawton et al., 2001). The first is the RNA dependent 
RNA polymerase (RdRp) (Estrozi et al., 2013), the latter is the capping enzyme, with 
guanylyltransferase and methyltransferase activities (D. Chen et al., 1999; M. Liu et 
al., 1992). It has been proposed that there are 12 VP1-VP3 heterodimers, one at each 
five axes fold anchored to the inner surface of the single-layered particle (SLP) by 
interactions with VP2 (Estrozi et al., 2013). EM experiments have shown that the viral 
genome is organised into ordered concentric layers within the core structure and it 
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is been suggested that it winds around the TCs in spiral (Prasad et al., 1996). The 
nascent RNA transcripts are capped at their 5’-ends (m7GpppG(m) ) (Lawton et al., 
2001) and exit the viral core through the type I channels in the VP2 layers (Periz et 
al., 2013). The transcription of each gene segment in different equimolar amount 
suggests that each TC unit functions independently (Gridley et al., 2014). There is also 
evidence that there is a quantitative and temporal control of viral gene expression at 
both transcriptional and translational level (Gridley et al., 2014; Long et al., 2017).  
1.1.10.5 Translation 
The viral mRNA exits the double-layered particle (DLP) and hijacks the host 
translational machinery, recruiting cellular ribosomes for the translation of the 
twelve viral proteins (S. Lopez, Oceguera, et al., 2016). For efficient translation, 
cellular mRNAs are circularized through the heterotrimer of eIF4E (eukaryotic 
translation initiation factor 4E) which binds the cap structure at the 5’of cellular 
mRNA, cellular poly-A binding protein (PABP) which binds the polyadenylated 3’-end, 
and eIF4G (eukaryotic initiation factor 4G), a scaffold protein (Imataka et al., 1998; 
Preiss et al., 1998). 
RV mRNAs are capped but lack polyadenylation sequence. Nevertheless it has 
been shown that the last four bases of its mRNA (GACC) act as a translational 
enhancer. The lack of poly-A sequence implies a different mechanism for the 
circularization of viral mRNA. It has been shown that NSP3 regulates viral protein 
production shutting off cellular mRNA, leading to preferential translation of viral 
mRNA. The N-terminus of NSP3 interacts specifically with the 3’-consensus sequence 
(UGACC) of viral mRNA (Gratia et al., 2016), while its C-terminus interacts with eIF4G 
as does PAPB, but with higher affinity (Contreras-Trevino et al., 2017). It has been 
reported that NSP3-iF4G complex interacts with a cellular protein, RoXaN (RV X 
associated with NSP3) (Vitour et al., 2004). RoXaN is a novel cellular protein 
containing at least five zinc binding domains, a paxillin leucine-aspartate repeat (LD) 
motif facilitating protein-protein interactions, and another protein-protein 
interaction domain called the tetratricopeptide repeat region (TRR) (Vitour et al., 
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2004). Complex consisting of NSP3, RoXaN and elF4G can be detected in RV-infected 
cells, indicating that RoXaN is involved in translation regulation. PAPB is known to 
shuttle between the nucleus and the cytoplasm: the lack of free eIF4G which is mostly 
bound to NSP3 due to the greater binding affinity of the viral protein, results in an 
immediate shuttle back of PAPB into the nucleus. All these events lead to 
enhancement of translation of RV mRNA and to the concomitant impairment of 
translation of cellular mRNAs. 
1.1.10.6 Viroplasms formation and genome replication 
The kinetics of the synthesis of positive and negative stranded RNA has been 
studied in RV-infected cells. Positive and negative RNAs are initially found during the 
first four hours of infection (Ayala-Breton et al., 2009). Following a small linear 
increment of the synthesis of both RNAs, a logarithmic increase is observed later 
during the infection. This trend reflects the peculiarity RV replication cycle that can 
be divided into two waves of transcription. The first one occurs upon the infection 
with the delivery of double-layered particles (DLPs) into the cytoplasm of infected 
cells. DLPs produce a small amount of mRNA, which is translated and replicated, 
producing new DLPs. When new DLPs are assembled, these transcribe viral genome, 
initiating a secondary amplified wave of transcription. 
RV proteins and RNA accumulate in cytoplasmic foci, called viroplasms which 
are sites of genome replication and DLPs assembly (Criglar et al., 2014). Viroplasms 
appear 2 to 3 hpi (Stacy-Phipps et al., 1987). The non-structural proteins NSP2 and 
NSP5 coordinate the formation of the viroplasms. It has been shown that those two 
viral proteins are able to self-assemble in viroplasms-like structure when co-
transfected together (Criglar et al., 2014). Experiments with RNAi that knocked-down 
the expression of either NSP2 or NSP5 confirmed the importance of viroplasms 
formation in RV replication. The experiments showed how knocking-down of either 
NSP2 or NSP5 resulted in a reduction in viral mRNA, proteins and progeny (T. Lopez, 
Rojas, et al., 2005; Silvestri et al., 2004). Replication and packaging within viroplasms 
happen in steps, during which a number of distinct replication intermediates (RI) can 
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be found, the pre-core RI, the core RI and the double-layered RI (Gallegos et al., 1989; 
Z. F. Taraporewala et al., 2004). The pre-core RI appears to be formed by viral RNA, 
the structural proteins VP1 and VP3 and the non-structural proteins NSP1 and NSP3. 
The core RI contains all the structural proteins found within the RV single-shelled 
particle (VP1, VP2 and VP3) and the non-structural proteins NSP2 and NSP5. The 
double-layered RI is identical to the core RI but it includes the VP6 proteins (Gallegos 
et al., 1989). Recently published results hypothesize that within viroplasms two 
different species of positive sense RNAs are produced. One which exits the 
viroplasms and act as mRNA to translate viral proteins and another that is retained 
within the particle and is utilised as template for minus strand synthesis and 
formation of dsRNA (Silvestri et al., 2004). 
Cis-acting signals involved in genome replication have been identified in the 
5’- and 3’-UTR regions and it is believed that they act by complementary binding to 
promote RNA replication (De Lorenzo et al., 2016). 
Although in vitro replication systems have shown that the structural proteins 
of the cores (VP1, VP2, and VP3) are capable of synthesizing dsRNA (D. Chen et al., 
1994; J. T. Patton et al., 1997), only replication systems that include NSP2 and NSP5 
are able to package the dsRNA into cores (J. T. Patton et al., 2000). NSP6 may also be 
involved in genome packaging because it is located within viroplasms and interacts 
with NSP5 (R. A. Gonzalez et al., 1998; Mattion et al., 1991). 
1.1.10.7 Virion assembly, maturation and release 
The selective packaging mechanism which leads to the presence of equimolar 
genome segments within the infectious particle remain unknown for RV as for all the 
members of Reoviridae (McDonald et al., 2016). Recent results based on the study of 
Bluetongue virus (BTV), a 10-segmented genome virus belonging to the genus of 
Orbivirus, suggested the presence of specific signals within the RNA sequences that 
drive the RNA-RNA interactions necessary for the presence of a single copy of each 
segment within the viral particle (Boyce et al., 2016). Biochemical and structural 
studies of RV replication suggest that the selection 11 distinct RNA segments must 
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involve interactions occurring between RNA segments and viral proteins (Fajardo et 
al., 2015): these RNA-RNA and RNA-proteins interactions require the binding of NSP2 
with RNA strands, the subsequent remodelling of RNA structure which stabilize 
interaction between RNA molecules (Borodavka et al., 2017; Borodavka et al., 2016). 
RV morphogenesis is a process that involves the sequential assembly of the 
VP2 layer being applied to the pre-core particle, followed by the coating with the VP6 
layer to form double-layered particle (DLPs). Once generated, DLPs move from the 
cytoplasm to the lumen of the ER where they acquire the VP7 external layer, forming 
mature TLPs. EM experiments have shown that the viral core (VP1, VP2 and VP3) 
accumulate in viroplasms (Garcés Suárez et al., 2018). The assembly of VP1 and VP2 
is dependent on both their high affinity for ssRNA and their interaction with NSP2 
and NSP5 (Arnoldi et al., 2007; Colomina et al., 1998; J. T. Patton et al., 2006). VP2 
forms the structural basis of the viral core and the simultaneous associations with 
VP1 and VP3 direct the formation of a functional core (Zeng et al., 1998). The 
formation of DLPs is achieved by adding VP6 to the viral core. Co-expression of VP2 
and VP6 in insect cells results in the formation of DLPs, indicating the intrinsic ability 
of VP6 to associate with the viral core (Zeng et al., 1996). During DLPs formation in 
infected mammalian cells, it has been observed that VP6 accumulates in the exterior 
region of viroplasms which allowing its association with newly assembled viral cores 
to form DLPs that move from the periphery of the viroplasms toward the ER (T. Lopez, 
Camacho, et al., 2005). 
NSP4 acts as an intracellular receptor on the membrane of the ER membrane 
where it binds newly made DLPs released from viroplasms and mediates their 
budding into ER lumen. This process leaves a transient membrane around the DLPs 
that will be replaced by the final addition of VP7 and VP4 (T. Lopez, Camacho, et al., 
2005). It has been proposed that the removal of the transient envelop is mediated 
by variation in calcium concentration (Poruchynsky et al., 1991). Calcium appears to 
be involved also in RV maturation: studies in cell maintained in low level of Ca2+ have 
revealed decreased RV production and the inability of the virus to bud through the 
ER (Poruchynsky et al., 1991; Shahrabadi et al., 1986).  
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The release of infectious triple-layered particles (TLPs) appears to be cell-
specific, with substantial differences occurring in differentiated and undifferentiated 
cell lines. In MA104, undifferentiated green money kidney epithelial cell lines, virus 
release seems to happen through cytolysis (Musalem et al., 1985; Perez et al., 1998). 
In contrast, in Caco-2, differentiated human colon cell lines, virions have been shown 
to be released from the apical surface of the cells through a vesicular transport 
process that bypass the Golgi system (Gardet et al., 2007; Jourdan et al., 1997). The 
apical release has been reported to involve actin and lipid rafts (Gardet et al., 2007; 
Sapin et al., 2002). However, it has been reported that the infection of Caco-2 cells 
could lead to the disruption of the cellular cytoskeleton, in particular the actin 
network (Brunet et al., 2000). The same effect was reported when NSP4 was 
exogenously expressed (Berkova et al., 2007). In addition, RV infection causes 
alteration in tight junctions, independently on the effect on cytoskeleton (Dickman 














The ability to sense and respond to the environment is crucial to life. Cells 
respond to stress in a variety of ways activating pathways ranging from promoting 
cells survival to eliciting programmed cell death. Typically, signalling pathways act to 
alter transcriptional responses to generate both transient and/or sustained changes. 
Rapid changes in gene expression are mediated by transcriptional factors (TFs) such 
as members of interferon regulated factors (IRF)-family or nuclear factor kappa-light-
chain-enhancer of activated B cells (NF-κB) that induce production of interferon 
(IFNs) and subsequent expression of a variety of interferon stimulated genes (ISGs) 
(R. E. Randall et al., 2008; Schneider et al., 2014). Thus the activation of IFN 
represents one of the first barriers of innate immunity that viruses face during 
infection. IFNs are biologically active signalling proteins that are produced and 
secreted by host cells upon pathogen recognition, with 3 major functions. First, they 
induce an antimicrobial state in infected and surrounding uninfected cells, limiting 
the spread of infectious agents, such as viral pathogens. Second, they modulate the 
innate immune response promoting antigen presentation and natural killer cell 
functions. Third, they activate the adaptive immune system and consequently 
contribute to immunological memory (Ivashkiv et al., 2014). 
Human interferon classification is based on the type of receptors through 
which they signal. Three major types have been identified: (1) Type I (IFNα, β, ε, κ, δ, 
ζ and ω) that binds to IFN α/β receptors (IFNAR), (2) Type II (IFNγ) that binds to 
interferon-gamma receptors (IFNRG) and (3) Type III (IL-28A, IL-28B , IL-29) that binds 
to a complex consisting of the interleukine 10 receptor beta (IL10RB) and interferon 
lambda receptor 1 (IFNLR1). 
Type I IFNs, including multiple IFN-α isoforms and IFN-β (IFNα/β) are a key 
component of the host-defence against viral infections and possess potent antiviral 
properties. Recently type III IFN-λ has also been shown to have a non-redundant role 
in antiviral responses (Wells et al., 2018). Innate immune cells, such as macrophages 
and plasmacytoid dendritic cells are the primary producers of IFN-α (Cao et al., 2007), 
   
48 
 
while non-immune cells, such as fibroblasts and epithelial cells produce IFN-β 
(Ivashkiv et al., 2014). 
The early IFN response occurs when specific viral components, defined as 
pathogen-associated molecular patterns (PAMPs), are recognized in infected cells by 
specific host proteins called pattern recognition receptors (PRRs) (Mogensen, 2009; 
R. E. Randall et al., 2008). PAMPs are molecular structures such as glycoproteins, 
lipopolysaccharides, proteoglycans and nucleic acid motifs that are broadly shared 
by different microorganisms (R. E. Randall et al., 2008). Nucleic acids (RNA, mRNA, 
replication intermediates and dsRNA) make up the largest class of PAMPs and 
depending on their form, length and localization they are detected by different PRRs. 
Members of the PPR family can be distinguished by ligand specificity, cellular 
localization and activation of unique, but downstream converging, signalling 
pathways (Takeuchi et al., 2010). Two major classes of PPRs are specifically activated 
by RNA viruses and they include the cytosolic retinoic acid-inducible gene-like 
receptors (RLRs) and membrane-bound Toll-like receptors (TLRs) (Said et al., 2018). 
Toll-like receptors comprise a gene family of only 10 members in humans (12 
in mice). These receptors cover an impressive range of PAMPs involved in the 
recognition of parasites, fungi, bacteria, and viruses (Vidya et al., 2018). Members of 
the RLR family, such as RIG-I and MDA5, sense cytoplasmic 5’-uncapped dsRNA and 
transmit this signal to MAVS (VISA/Cardif/IPS-1) which induces phosphorylation and 
activation of IRF-3/-7 NF-кB. These transcriptional factors migrate into the nucleus 
where, along with c-jun/ ATF-2 bind to and activate the promoters of type IFN genes, 
ultimately leading to IFN expression. Recently, it has been shown that nucleotide-
binding oligomerization domain-containing (NOD)-like receptors (NLRs) can also 
detect infection with RNA viruses (Kim et al., 2016). 
IFNs can act in both an autocrine and paracrine manner binding to their 
heterodimeric transmembrane receptors (IFNAR) in infected and surrounding 
uninfected cells. Engagement with IFNAR leads to the activation of signal transducer 
and activator of transcription 1 (STAT1) and STAT2 which dimerise and associate with 
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IRF-9. This trimolecular complex, called IFN-stimulated gene factor 3 (ISGF3) moves 
into the nucleus where it binds to its cognate DNA sequences, activating the 
transcription of ISGs and establishing an antiviral state, which slows down the 
replication and the spread of the virus. To date hundreds of ISGs have been 
characterized that often target conserved aspects of viral infection and replication 
cycle, such as the use of the host cell translation machinery. It has been showed that 
ISGs are also involved in apoptosis (Kotredes et al., 2013), inhibition of cell growth 
and innate and adaptive immune cell activation (Kamada et al., 2018). Some of the 
most well-studied antiviral genes induced by type I IFNs include the adenosine 
deaminize acting on RNA, 2΄,5΄-oligoadenylate synthetase, RNase L and Myxovirus 
Resistance Gene A (MxA) proteins (R. E. Randall et al., 2008; Schneider et al., 2014; 
Schoggins et al., 2011). 
Similar to type I IFNs, type III IFNs are induced following stimulation of PRRs. 
In humans this family of cytokines consists of 3/4 members, IFN-λ1 (IL-29), IFN-λ2 (IL-
28A) and IFN-λ3 (IL-28B). Recently it has been reported that human hepatocytes upon 
viral infection produce a new type-III interferon that was not reported before, IFN-λ4 
(Prokunina-Olsson et al., 2013). This interferon is a frame-shift variant of IFN-λ3. Type 
III IFNs are structurally separate from type I IFN and also bind to a different class of 
receptors. Type III IFNs signal through a heterodimeric cellular surface receptor 
complex composed of two chains: IFNLR1 and IL-10RB (Wack et al., 2015). The IL-
10RB chain is also an essential component of the receptor complexes for IL-10, IL-22, 
and IL-26 (Donnelly et al., 2004), however, the IFNLR-1 is a unique receptor complex 
that is used only by INF-λ. IL-10RB shows a broad expression pattern (Josephson et 
al., 2001), whereas in contrast IFNLR-1 shows much more restricted cellular 
distribution. Several studies showed how fibroblast, splenocytes, bone marrow 
derived macrophages (Lasfar et al., 2006) and endothelial cells (Sommereyns et al., 
2008) do not respond to IFN-λ due to lack/low expression of IFNLR-1. However, 
epithelium-rich organs such as the stomach (Doyle et al., 2006), intestine (Brand et 
al., 2005; Kotenko et al., 2003), skin (Zahn et al., 2011) and lung (Ioannidis et al., 
2012) show high expression of IFNLR-1 and high response to IFN-λ. IFNLR-1 shows 
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expression mainly in epithelial cells, however, some responses to IFN-λ are also 
reported in non-epithelial cells. Among these cells, conventional or classical dendritic 
cells (cDCs) (S. Zhang et al., 2013) and plasmacytoid dendritic cells (pCDs) (Yin et al., 
2012) express IFNLR-1 and are IFN-λ-stimulation sensitive. IFN-λ binds initially to the 
IFN-λR1 chain, and the binary complex formed by the association of IFN-λ with the 
IFN-λR1 chain causes a rapid conformational change that facilitates recruitment of 
the second receptor chain, IL-10RB, to the complex. Once the assembly of the ternary 
complex is complete, the receptor-associated Janus tyrosine kinases, Jak1 and Tyk2, 
mediate trans-phosphorylation of the receptor chains which results in the formation 
of phosphotyrosine-containing peptide motifs sites for latent preformed cytosolic 
STAT proteins, including STAT1 and STAT2. Signalling of type III IFN, as for type I IFN, 
results in the formation of a transcription factor complex known as IFN-stimulated 
gene factor 3 (ISGF3) (Schneider et al., 2014). Once assembled, ISGF3 translocates to 
the nucleus where it binds to IFN-stimulated response elements in the promoters of 
various ISGs. Signal transduction and gene activation profiles are almost 
indistinguishable from those of type I IFN. Moreover its ubiquitous expression has 
made it difficult to attribute a specific non-redundant role to type III IFN. However, 
the spectrum of responsive cells is different with the expression of type III IFN 












Figure 4. Detection of viral RNA in intestinal epithelial cells and induction of innate responses.  
Following cells infection, RV double-layered particles are released into the cytoplasm, triggering 
transcriptions. Despite replication and virus packaging take place within the virioplasms, a population 
of dsRNA or uncapped mRNA are released and sensed by specific host proteins, Pattern Recognition 
Receptors (PRRs). Two major classes of PPRs include the cytosolic retinoic acid-inducible gene-like 
receptors (RLRs) and membrane-bound Toll-like receptors (TLRs). Members of the RLR family, such as 
RIG-I and MDA5, sense cytoplasmic dsRNA through a conserved DExD/H-box helicase and C-terminal 
domain (CTD). RIG-I recognizes 5′-triphosphorylated blunt ends of short (<300 bp) dsRNA, whereas 
MDA5 lacks end specificity and binds to internal sites on long (>1000 bp) dsRNA. Upon ligand binding, 
RIG-I and MDA5 signal through the mitochondrial antiviral sensor protein MAVS (VISA, Cardiff or IPS-
1). MAVS leads to the activation of Tbk1 or IKKε and the subsequent phosphorylation of IRF-3/-7. IRF-
3 is constitutively expressed in cells, where it accumulates at elevated levels in the cytoplasm. In 
contrast, IRF-7 is present in most cells at low levels, and its expression is amplified by type I IFN. Both 
IRF-3 and IRF-7 reside in inactive forms in the cytoplasm and undergo activation through 
phosphorylation. These active forms of IRF-3 and IRF-7 undergo dimerization and are imported to the 
nucleus, where they interact with specific promoters to enhance the transcription of IFN. MAVS also 
induces the activation of NF-кB. NF-κB regulation is governed by a number of positive and negative 
elements. In the “resting” state, NF-κB dimers are held inactive in the cytoplasm through association 
with IκB proteins. Incoming stimuli from MAVS induces the phosphorylation of IκB by Iκκα and Iκκβ. 
Phosphorylated IκB becomes a target of β-TrCP that induces its ubiquitination and degradation. Free 
NF-κB dimers can then translocate to the nucleus, bind specific DNA sequences and promote 
transcription of target IFNs genes. IFNs bind to heterodimeric transmembrane receptors, IFNAR. 
Cellular responses to IFNAR ligation are cell-type and context-dependent and can vary during the 
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course of the immune response. Engagement of IFNAR activates the receptor-associated protein 
tyrosine kinases Janus kinase 1 (JAK1) and tyrosine kinase 2 (TYK2), which phosphorylate the latent 
cytoplasmic transcription factors STAT1 and STAT2. Tyrosine-phosphorylated STAT1 and STAT2 
dimerize and associate with IRF-9. This trimolecular complex, ISGF3, translocate to the nucleus, binds 
to its cognate DNA sequences, activating the transcription of ISGs and establishing an antiviral state. 
STAT1 can also translocate to the nucleolus as active homodimers and it can stimulate expression of 
a sub-set of ISGs (S. Lopez, Sanchez-Tacuba, et al., 2016).  
 
 
1.2.1 Toll-like receptors 
Toll-like receptors (TLRs) are a family of innate immune receptors acting in the 
frontline detection of viral PAMPs. The human TLR multigene family comprises 10 
members, of which TLR2, -3, -4, -7, and -8 are thought to be of importance in the 
recognition of structural components of RNA viruses, including viral double-stranded 
RNA (dsRNA), single-stranded RNA (ssRNA), and surface glycoproteins (Vidya et al., 
2018). 
TLRs are transmembrane glycoprotein receptors with an N-terminal 
extracellular PAMP-binding region and a C-terminal intracellular signalling region. All 
TLRs contain an extracellular leucine-rich repeat (LRR) domains which participate in 
ligand recognition, and an intracellular TIR (Toll-interleukin (IL)-1 receptor) domains. 
It is believed that the extracellular ligand recognition induces the TLR dimerization, 
bringing together the cytoplasmic TIR domains. This leads to the induction of the 
downstream signalling processes. The activation of the TLRs leads to the expression 
of 3 major pathways: mitogen-activated protein kinases (MAPKs), one or more IRFs 
and NF-κB (De Nardo, 2015) (Figure 5).  
RNA virus infections can induce up-regulation of type I IFN expression via 
TLR3, TLR7 and TLR8. TLR7 and TLR8 recruit a TIR-containing adaptor named myeloid 
differentiation primary response gene 88 (MyD88) to the cytoplasmic TIR domain of 
the receptor (Figure 5) . MyD88 consists of a TLR-binding TIR domain in the C-terminal 
portion and a death domain in the N-terminal part, and through the latter it forms a 
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complex with two interleukin-1 receptor-associated kinases (IRAKs), IRAK-4 and 
IRAK-1. Upon activation, IRAK-4 phosphorylates IRAK-1, that once activated binds the 
C-terminal domain of TNF receptor-associated factor 6 (TRAF6). The IRAK-1/TRAF6 
complex then dissociates from the TLR. Upon activation TRAF6 polyubiquitinates the 
tumour growth factor beta (TGF-β) activated kinase 1 (TAK1) and the IκB kinase 
gamma (IKKγ, known also as NEMO) (Oeckinghaus et al., 2011; C. Wang et al., 2001). 
IKKγ subsequently associates with IKKα and IKKβ (Hinz et al., 2012), leading to the 
IKK-mediated phosphorylation of IκB on specific serine residues in a conserved 
degron motif (DSGΦxS [Φ, hydrophobic residue](Kanarek et al., 2012). Under resting 
condition, IκB proteins sequester inactive NF-κB complexes in the cytoplasm 
(Kanarek et al., 2012). Phosphorylated IκB is a substrate for SCFβ-TrCP, an E3 ubiquitin 
ligase of the Skp-Cullin-F-box (SCF) family that recognizes this phosphodegron 
through its F-box subunit, β-transducin repeat-containing protein (β-TrCP) (Ghosh et 
al., 1998). Polyubiquitinated IκB is targeted for proteasome-mediated degradation, 
releasing NF-κB. The family of NF-κB is composed of two sub-families, the NF-κB 
proteins and the Rel proteins (Kanarek et al., 2012). They all share a conserved 300 
amino acid long amino-terminal Rel homology domain (RHD). Sequences within the 
RHD are required for dimerization, DNA binding, IκB interaction and nuclear 
translocation (Baldwin, 1996; Ghosh et al., 1998). The Rel subfamily includes c-Rel, 
RelB, RelA (known also as p65) (Oeckinghaus et al., 2009). 
Members of the NF-κB sub-family include p105 and p100. These two proteins 
need to be activated through proteolysis or arrested translation, generating p50 from 
p105 (Moorthy et al., 2006) and p52 from p100 (Giardino Torchia et al., 2013) 
respectively. However, the active forms of these proteins are not usually able to 
activate transcription, except when they form dimers with members of Rel sub-family 
(Oeckinghaus et al., 2009). Only p65, c-Rel, and RelB possess C-terminal 
transactivation domains (TADs) that confer the ability to initiate transcription. 
Although p52 and p50 lack TADs, they can positively regulate transcription through 
heterodimerization with TAD-containing NF-κB subunits or interaction with non-Rel 
proteins that have transactivating capability. Alternatively, p50 and p52 homodimers 
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can negatively regulate transcription by competing with TAD-containing dimers for 
binding to κB sites. These p50 and p52 dimers may also constitutively occupy some 
κB sites and thus enforce an activation threshold for certain NF-κB target genes 
(Hayden et al., 2012). The activation of NF-κB dimers is the result of IKK-mediated, 
phosphorylation-induced degradation of the IkB inhibitor, which enables the NF-кB 
dimers to enter the nucleus and activate specific gene expression. 
Unlike TLR7 and TLR8, TLR3 does not require MyD88. Upon ligand binding, 
TLR3 brings together the TIR domains of TLR3s leading to the recruitment of TIR 
domain-containing adaptor protein inducing IFN-β (TRIF) (Vidya et al., 2018). TRIF 
recruits TRAF6 and RIP-1 (receptor-interacting protein 1) and activates NF-κB, 
following the same TAK-1 dependent pathway as TLR7 and TLR8. In addition, it has 
been shown that the complex TRIF/TRAF6/RIP-1 can activate NF-κB in a TAK-1 
independent way (Meylan et al., 2004). TRIF also recruits TRAF3 and associates with 
the complex TANK/NEMO IKKγ. This complex recruits TBK1 that once activated 
associates with IKKε. TBK1/IKKε subsequently phosphorylates IRF-3 that then 
dimerizes and translocates to the nucleus to initiate transcription of type I IFNs 









Figure 5. Recognition of double stranded RNA and activation of NF-кB and IRFs by Toll-like 
receptors. 
Following activation, Toll-like receptors (TLRs) 7 (TLR7) and 8 (TLR8) recruit the adaptor protein 
myeloid differentiation primary response gene 88 (MyD88) to the cytoplasmic TIR domain of the 
receptor. MyD88 initiates a signalling cascade involving IL-1R associated kinase (IRAK) and TNFR-
associated factor 6 (TRAF6) proteins, which converge at the activation of the IκB kinase (IKK) family 
members. Once activated, they lead to the IKK-mediated phosphorylation of Iκβ, that when 
phosphorylated becomes the substrate for β-TrCP, an E3 ubiquitin-ligase enzyme that induces its 
proteasome-mediated degradation. Upon the degradation of Iκβ, NF-κB dimers can translocate into 
the nucleus, activating gene expression. Alternatively, TRAF6 can associate with TRAF3 recruiting 
TBK1 that phosphorylates and activates IRF-3. In contrast, TLR3 does not require MyD88. Upon 
activation, TLR3 recruits TRIF that activates the complex TRAF6-/RIP-1 (receptor-interacting protein 
1) and activates NF-κB, following the same TAK-1 dependent pathway as TLR7 and TLR8 (Thwaites 
et al., 2014). 
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1.2.2 RIG-I receptors 
The RIG-I-like receptors (RLRs) include the retinoic acid-inducible gene I 
product (RIG-I), melanoma differentiation-associated antigen 5 (MDA5), and 
laboratory of genetics and physiology 2 (LGP2). RIG-I receptors play a major role in 
pathogen detection and defence. They sense RNA-virus infection and are involved in 
establishing and modulating antiviral immunity (G. Liu et al., 2018). RLRs belong to 
the family of aspartate-glutamate-any amino acid-aspartate/histidine (DExD/H)-box 
helicases and detect viral RNA ligands or processed self RNA in the cytoplasm to 
trigger innate immune responses and inflammation (G. Liu et al., 2018). RLRs are 
critical sensors of viral infection and in many cell types detection of intracellular 
pathogens relies on a tight collaboration with TLRs. However, the possible interplay 
between these two systems has not been elucidated. 
Although TLR-mediated signalling pathways are relatively well characterized 
in human pDCs (Bao et al., 2013), the expression and the functional importance of 
RLRs in this cell type have been poorly characterised. Initial data from murine models 
indicated that pDCs preferentially use the TLR system rather than RIG-I for the 
detection of viral infections (H. Kato et al., 2005) and unlike monocytes, pDCs express 
only marginal levels of RIG-I under steady-state conditions (Ablasser et al., 2009). 
Recent data have shown how the expression of RIG-I is rapidly and dramatically up-
regulated upon stimulation of TLR7 or TLR9. Moreover, the ability of pDCs to detect 
5′-triphosphate double-stranded RNA (5′-ppp-dsRNA) seems to take place only 
following the activation by endosomal TLRs (Szabo et al., 2014). RLRs cooperate in 
signalling crosstalk networks with Toll-like receptors and other factors involved in the 
induction of innate immune responses and the modulation of the adaptive immune 
response (Kawai et al., 2008). 
 




Retinoic acid-inducible gene I (RIG-I) contains a ssRNA/dsRNA (ss/dsRNA)-
binding C-terminal domain (CTD) which, when unbound, functions as a repressor 
domain (RD) (Gack, 2014). During viral infections, the detection of viral components 
leads to the exposure of two repeats of a cysteine-aspartic protease (caspase)-
recruiting domain (CARD)-like region at the N-terminus. This CARD domain can 
interact with proteins containing the same motif leading to the activation of 
downstream signalling pathways. RIG-I has a DExD/H helicase motif and an ATP-ase 
binding domain in its middle portion. Under resting conditions, the CARD domain is 
unexposed. However, during viral infection the RD recognises non-self RNA 
structures (associated with viral replication) such as ds RNA and 5’-triphosphate RNA 
(Gack, 2014). It has also been shown that RIG-I detects triphosphorylated blunt ends 
of short (<300 bp) dsRNA (Holloway et al., 2013; Hiroki Kato et al., 2008). The 
recognition of non-self RNA combined with the ATP binding unmasks the CARD 
domain of RIG-I, allowing its interaction with the CARD domain mitochondrial 
antiviral-signalling protein (MAVS) (Kawai et al., 2005). 
1.2.2.2 MDA5 
Melanoma differentiation-associated antigen 5 (MDA5) shows a high degree 
of homology to RIG-I. They exhibit the same overall domain structure, with 23 and 
35% amino acids identities in N-terminal CARD and C-terminal helicase domain 
respectively (Dias Junior et al., 2018). MDA5 is able to detect long segments of dsRNA 
but it lacks the specificity for 5’-triphospate ends present in RIG-I. MDA5 has been 
shown to be important for the recognition of Sendai virus, rabies virus, dengue virus 
and RV (Faul et al., 2010; Fredericksen et al., 2008; Loo et al., 2008; Sen et al., 2011). 
1.2.2.3 LGP2 
Laboratory of genetics and physiology 2 (LPG2) shows 31% and 41% amino 
acids identities to the helicase domain of RIG-I and MDA5 respectively (Hansen et al., 
2011) but completely lacks the region encoding CARD, prejudicing its ability to 
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transmit the signal downstream to MAVS. It has been shown that LPG2 binds to 
dsRNA 5’-triphosphate signatures and it could compete with RIG-I binding of dsRNA, 
acting as negative feedback (Pippig et al., 2009). In contrast, it has been reported that 
MDA5 ability to detect long dsRNA is augmented in presenceof LGP2 (Pippig et al., 
2009). The absence of the CARD motif and the strong inhibition of the virus-induced 
gene activation suggest that LPG2 could act as negative feedback regulator 
(Yoneyama et al., 2005). 
1.2.3 MAVS 
Signalling via RIG-I and MDA5 converges to mitochondrial antiviral-signalling 
protein (MAVS), known also as VISA (virus-induced signalling adapter), IPS-1 
(interferon promoter stimulator) or Cardif (Vazquez et al., 2015). Once activated, 
MAVS recruits TNF receptor-associated death domain (TRADD), initiating two distinct 
pathways. In one, TRAAD forms a complex with the FAS-associated death domain 
(FADD) recruiting RIP-1 for the nuclear translocation of NF-κB (as described above in 
section 1.2.1). In the other pathway, MAVS/TRADD complexes recruit TRAF3, which 
together with TANK and IKKγ/NEMO initiates the activation of IKKs, ending in the 
phosphorylation and nuclear translocation of IRF-3, as reported for TLRs (Vazquez et 
al., 2015). The convergence of RLR and TLR signalling on MAVS leads to the activation 
of a similar profile of gene expression, inducing synthesis and release of IFN and pro-
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1.2.4 Regulation of the IFN: promoters and induction 
1.2.5 Structure of the promoter of Type I IFN 
The induction of type I IFN is regulated primarily at the transcriptional level, 
wherein IFN regulatory factors (IRFs) play a central role (T. Taniguchi et al., 2001). 
The promoter region of type I IFN (IFN-β and IFNα/β) contains at least 4 regulatory 
cis-elements, termed positive regulatory domains (PRDs) I, II, III and IV (Goodbourn 
et al., 1988) (Figure 6). The PRD I and PRD III elements found within the promoter 
region of IFN-β are recognised and activated by members of the IRF family (IRF-3, 
IRF-7) (Leblanc et al., 1990; T. Taniguchi et al., 2001). Within the same regions, PRD 
II and PRD IV recognition elements were identified: these sequences are activated by 
NF-κB and ATF-2/c-JUN respectively (Fujita et al., 1989). The promoter region of IFN-
α is characterised by PRD I and PRD IV elements. Within the same region, PRD III-like 
elements (PRD III-LEs) have been identified: these sequences could bind to other 
transcriptional factors of the IRF family, however the exact nature remains unclear 
(Raj et al., 1989; Ryals et al., 1985). 
IFN-β, the prototypical type I IFN, is induced by the combined actions of the 
transcription factors AP-1, IRF-3, IRF-7 and NF-κB. The binding sites for each set of 
transcription factors are localized in close proximity to each other and IFN-β 
expression requires the cooperative binding of all activators in a complex, the 
enhanceosome (Panne, 2008; Thanos et al., 1995).  
1.2.6 Structure of the promoter of Type III IFN 
Although IFN-λ (IL-28A, IL-28B, IL-29) differ genetically from type I IFN, their 
similar antiviral functions gives reason to assume that their expression is regulated 
in a similar fashion and that their promoter sequences share common features. Both 
IFN-λ1 and IFN-λ3 promoter elements present IRFs and NF-κB binding sites (Osterlund 
et al., 2007). In contrast with type I, they present alternative binding sites for IRFs, 
IFN-stimulated response elements (ISREs) (Figure 6). In contrast with type I IFN, only 
IRF-3, IRF-7 and NF-κB are required for type III IFN induction (Odendall et al., 2014; 
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Onoguchi et al., 2007). However, recent studies have identified a distal NF-κB binding 
site (-1137. -1182) responsible for a potent induction of IFN-λ (Thomson et al., 2009). 
In the same work, they have showed how a depletion of NF-κB RelA protein 
significantly reduced the expression of IFN-λ. Importantly, while IFN-β is induced by 
coordinated action of a multifactor enhanceosome, and IFN-α expression is activated 
by multiple IFN regulatory factor (IRF)-binding cis-promoter elements, the type III 
IFNs are induced through independent actions of IRFs and NF-κB, with the latter 
having a predominant role (Iversen, Ank, et al., 2010; Iversen & Paludan, 2010).  
 
Although both IFN-λ and IFN-β are induced downstream of PRR sensing and 
activation of MAVS, IFN-λ production is favoured when activated MAVS localizes to 
the peroxisome, whereas IFN-β production is dominant when MAVS localizes to the 
mitochondria (Odendall et al., 2014). The relative abundance of peroxisomes in 
epithelial cells suggests a mechanism for preferential production of IFN-λ instead of 
IFN-β in response to viral infection at epithelial surfaces. 
IFN-λ regulation is more flexible than IFN-α/β, which could allow expression 
of type III IFNs in response to a wider range of stimuli compared with type I IFNs. 
Such flexibility will potentially render expression of type III IFNs less sensitive to 
microbial evasion strategies targeting the IRF pathway. Thus, the mechanisms 
governing type III IFN expression play an important part in dictating the biology of 









Figure 6. Schematic representation of the promoter regions of type I and type III interferon. 
The precise transcription of IFN gene is often controlled by more than one specific activator. Several 
activators can bind together in close proximity, forming an “enhanceosome” at the enhancer binding 
sites of genes, to stimulate transcription. The highly evolutionarily conserved enhancer of interferons 
span in a compact 55 bp stretch upstream of the coding sequence and comprises 4 regulatory cis-
elements namely the positive regulatory domains (PRDs) I-IV. Upon virus infection, the PRDs have 
been shown to facilitate the cooperative assembly of a multiprotein regulatory complex involving NF-
кB (RelA/p50), IFN regulatory factors (IRF) 3/7 and activating transcription factor (ATF) 2/c-Jun to form 
a stable enhanceosome complex. In contrast with resemblance in the pattern of induction and 
biological activity of type I and type III interferon, the structure of their the 5-‘UTR are different. IFN-
β promoter region contains the binding site sequences for IRF-3 and IRF-7 (PDR-III and PDR-I 
respectively), however, for an efficient induction, the activation of NF-кB (PDR-II) and ATF2 c-Jun (PDR-
IV) is required. By contrast, the promoter region of IFN-α presents the binding sites for IRF-7 (PRD-I) 
and ATF2 c-Jun (PDR-IV). Compared to type I, the induction of type III interferon is driven by the 
transcriptional activity of NF-кB (PDR-II). INF-λ1 has two NF-кB binding sites and one for IRF-3. IFN-λ3 
present one binding site for IRF-3 and one for NF-кB. Moreover, in contrast with type I, type III 
interferons promoter region present alternative binding sites for IRFs, defined IFN-stimulated 
response elements (ISREs). Assembling of the enhanceosome in correspondence of the binding 
sequences leads to the recruitment of histone acetyl transferases (HATs) and RNA polymerase II 
machinery to the promoter in correspondence of the TATA box, which constitutes the site of 
preinitiation complex formation, the first step in eukaryotes transcription. 
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Type I and III IFNs are produced following recognition of viral ligands, most 
prominently nucleic acids, by a wide range of pattern recognition receptors. These 
pathways involve TLRs, RLRs, MAVS and TBK1, as described in 1.2.1. However, the 
subcellular localization of MAVS determines which IFN species is produced. MAVS is 
an adapter of the RLR pathway that was first identified as being localized on 
mitochondria and was later shown to also localize to peroxisomes and mitochondrial-
associated endoplasmic reticulum membranes. From peroxisomes, MAVS is able to 
induce ISGs and control viral infections independently of type I IFNs. In addition, the 
function and abundance of peroxisomes and mitochondria determines the quality of 
the IFN response. Increasing peroxisomal abundance or inhibiting mitochondrial 
function favours the expression of type III over type I IFNs (Odendall et al., 2014). 
This observation could reflect what happens physiologically in epithelia. Indeed, 
polarization of epithelial cells increases peroxisome abundance and type III IFN 
responses to viral infections, while the number of mitochondria and type I IFN 
expression are unaffected.  
Despite differences in the enhanceosome sequences and in the temporal and 
spatial activation of IFN-β and IFN-λ, a two-step model for their induction has been 
proposed. In this model, early-induced IFNs exercise a positive feedback for the 
induction of later IFNs in order to establish a robust and long-lasting immune 
response (Figure 7). This model also underlines the essential role of IRF-3 in both 
early and late phases of IFN induction. In early phase, which is mostly IFN 
independent, IRF-3 senses the incoming infection and induces the transcription of 
early-stage IFN (IFN-β and IFN-λ). During the late phase of infection IRF-3 is critical 
for 2 reasons: for the augmentation of the early-stage induced IFN, and for the full 
procurement of all IFN family members (IFN-α) by cooperating with IRF-7, underling 
the essential role of IRF-7 in the late induction phase (Hwang et al., 2013; Sato et al., 
1998; Sato et al., 2000). 
 
 




Figure 7. Schematic representation of the biphasic mechanism of IFN gene induction mediated by 
IRF-3 induced IRF-7. 
The expression of IRF-7 is ubiquitous, however, it is totally dependent on IFN signalling, whereas 
IRF-3 expression is constitutive and remains essentially unaffected by virus and IFNs. In the early 
phase, constitutively expressed IRF-3 is activated by virus infection, and this activation results in 
activations of type I and type III IFN. In this phase, IRF-7 is expressed only at very low levels by 
spontaneous IFN signalling. Induction of IFN results in a strong induction of IRF-7 expression 
through activation of ISGF3 by IFN signalling. Thus, in the late phase, IRF-3 and IRF-7 cooperate with 
each other for amplification of IFN gene induction, resulting in the full procurement of the normal 
mRNA induction profile of the IFN gene subfamily (Sato et al., 2000). 
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1.2.7 JAK / STAT pathway  
The Janus kinase/signal transducers and activators of transcription (JAK/STAT) 
pathway is a complex signalling pathway involved in development and in maintaining 
homeostasis in animals (Aaronson et al., 2002; Darnell, 1997). Extracellular signalling 
polypeptides, such as growth factors or cytokines, are recognized by specific 
transmembrane receptors or receptor complexes on target cells leading to fast 
reprogramming in gene expression. In mammals, there are seven STAT genes, STAT1, 
STAT2, STAT3, STAT4, STAT5A, STAT5B, and STAT6, with different distribution among 
tissues. 
 In the absence of specific extracellular signals, STAT proteins are normally 
inactive in the cytoplasm. After receptor-binding interaction, they are rapidly 
activated and recruited to the intracellular domain of the cytoplasmic –associated 
protein from the JANUS kinase (JAK) (Leonard, 2001). In mammals there are 4 JAK 
kinases: Jak1, Jak2, Jak4 and Tyk2. JAK activation occurs upon ligand –mediated 
conformational changes. When two JAK proteins are brought into closer proximity, 
they trans-phosphorylate, creating a STAT docking site. Once activated JAKs is able 
to phosphorylate additional targets, including STATs. STATs are latent transcription 
factors that reside in the cytoplasm until activated. Phosphorylation of STATs on 
tyrosine residues leads to STAT homo- and hetero-dimerization and subsequent 
translocation to the nucleus by importin α-5 (also called nucleoprotein interactor 1) 
or the Ran nuclear import pathway. Once in the nucleus, STAT recognises target 
promoter sequences, increasing the transcription of the cognate gene (Aaronson et 
al., 2002; Darnell, 1997) (Figure 4).IFN-mediated activation of the JACK/STAT 
pathway is mechanistically distinct from the majority of STAT pathways. In this 
pathway, upon the phosphorylation of STATs by JAK, STAT1 and STAT2 form a 
heterodimer that binds interferon regulatory factor 9 (IRF-9) forming the 
heterotrimeric complex Interferon-stimulated gene factor 3 (ISGF3) (Fu et al., 1990; 
Kessler et al., 1990). The ISGF3 transcriptional factor enters the nucleus and binds to 
the IFN stimulated response element (ISRE) to activate the transcription of interferon 
stimulated genes (Holloway et al., 2014). 
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1.3 Modulation of the host innate immunity by rotavirus NSP1 
The importance of innate immunity in controlling viral replication means that 
most viruses have evolved strategies to counteract IFN-mediated innate responses, 
including interference with components of the IFN induction and/or signalling 
pathways. In common with other dsRNA viruses, RV do not release their genomic 
RNA when it enters cells, preventing recognition by PPRs and the subsequent 
activation of IFN induction pathway through this route (Estrozi et al., 2013). However, 
during transcription, the RNA-capping activity of VP3 is not completely efficient, 
which results in populations of uncapped and partially capped viral transcripts that 
can activate the host innate immune response through RLRs and TLRs (Uzri et al., 
2013). Moreover, it has been shown that VP4 and VP8* can activate NF-κB through 
a TRAF2-NF-κB-inducing kinase signalling pathway (LaMonica et al., 2001)VP4 and 
VP8* both contain three TNFR-associated factor (TRAF) binding motifs. When 
expressed in vivo VP4 and VP8* both caused a 5 to 7 fold increase in NF-κB activity 
and upregulated TRAF2-mediated NF-κB activation. This suggests that RV actively 
changes cellular signalling and directly affects cellular transcriptional responses.  
Although the virus is capable of triggering IFN production, infection of 
permissive cell lines with wild type (wt) RV strains does not result in high levels of IFN 
transcription or secretion, suggesting that the virus encodes proteins that antagonize 
the IFN induction pathways (Feng et al., 2009). The key viral protein involved in the 
downregulation of IFN expression is the non-structural protein 1 (NSP1) (Arnold, Sen, 
et al., 2013). Consistent with the role in down-regulating the type I IFN response, the 
loss of a complete NSP1 (ORF) has been found to produce a slow growth phenotype 
in cell culture (Silvestri et al., 2004). The presence of the RING domain to drive the 
proteasome-mediated degradation of the target proteins (Graff et al., 2007), a high 
specificity for its substrate and auto-regulation via self-ubiquitination support the 
hypothesis that NSP1 has E3 ubiquitin-ligase activity (Barro et al., 2007; Graff et al., 
2009). 
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The NSP1-mediated ability of RV to modulate the IFN response is conserved 
between strains infecting different species. However, it has been reported that 
targets within the induction and signalling pathways vary between strains.  
1.3.1 IRFs  
Recent studies have identified a host cell-specific interaction between RV 
NSP1 and IRF-3 using the yeast two-hybrid system (Barro et al., 2005). Expression of 
NSP1 from the bovine RV strains UK and NCDV in COS7 and 293T cells directed the 
proteasome-mediated degradation of IRF-3, however, such regulation was missing in 
in mouse embryonic fibroblast (MEFs) 3T3 cells (Sen et al., 2009). In contrast, 
expression of NSP1 encoded by rhesus (RRV), simian (SA11) and murine (EW) strains 
is capable of driving IRF-3 degradation in 3T3 cells (Sen et al., 2009) and Caco-2 cells 
(Barro et al., 2005). Interestingly, the human strains Ku, DS-1, AU-1 and Wa (Arnold 
et al., 2011; Barro et al., 2007) and porcine Osu (Graff et al., 2007; Sen et al., 2009) 
have been reported to have no effects on the levels of IRF-3 in 293T and MA104 cell 
lines. However, infection with these strains leads to a downregulation in IFN-β 
expression, suggesting the use of alternative strategies by the virus to down regulate 
IFN expression. It has also been shown that simian Sa-11 NSP1 expression can 
interfere directly with the accumulation of the activated (homodimerized) form of 
IRF-3 and its nuclear translocation in Caco-2 cell line (Barro et al., 2005, 2007). Given 
the role of IRF-3 in initiating IFN-β expression and IRF-7 as the “master regulator” of 
type I IFN, downregulation of IRF-7 would also interfere with the ability of the host 
to activate the IFN-dependent antiviral state. Consistent with this, RV NSP1 has also 
been shown to induce proteasome-mediated degradation of IRF-7 (Barro et al., 
2007).  
The adaptor proteins STING, MAVS, and TRIF contain a conserved motif, pLxIS 
(in which p represents a hydrophilic residue, x represents any residue, and S 
represents a phosphorylation site), that is phosphorylated by TBK1 or IKKε and 
mediates the recruitment of IRF-3 to the signalling complexes. Moreover, IRF-3 itself 
also contains a pLxIS motif that is crucial for phosphorylation-induced dimerization 
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and activation of IRF-3 (S. Liu et al., 2015). Mutation of the serine in the 
phosphorylation site within the pLxIS motif of STING, MAVS, and TRIF abolish the 
induction of type I IFNs in their respective signalling pathways (S. Liu et al., 2015). 
BLAST searches revealed that NSP1 isolates from different hosts contains a conserved 
pLxIS domain (B. Zhao et al., 2016). This domain falls in the last 17 amino acids 
residues located in the C-terminal of NSP1, which is essential for targeting IRF-3 
(Barro et al., 2005). Recent studies have identified that L486 and I488 are essential 
residues in the NSP1-mediated degradation of IRF-3 (B. Zhao et al., 2016). Similar 
results have been reported by Kobayashi’s group (Kanai et al., 2017), which used an 
entirely plasmid-based RV reverse genetic system to shown that the C-terminus 
region of NSP1 is responsible for the IRF-3 interaction.  
1.3.2 RIG-I, MDA5 and MAVS 
It has been shown that porcine (OSU) NSP1 interacts with RIG-I, inducing its 
degradation in a proteasome-independent way (Qin et al., 2011). With its position 
within the type I IFN induction pathway, downstream of viral detection and upstream 
of IκB and IRF-3 phosphorylation, MAVS has an essential role in establishing an early 
antiviral response. It has been reported that MAVS is also targeted by NSP1 leading 
to its proteasome-mediated degradation (Broquet et al., 2011; Kawai et al., 2005; 
Nandi et al., 2014) in a strain independent manner, which is independent of the IRF 
degradation. 
1.3.3 NF-κB 
NF-κB is a transcription factor that is known to play an important role in the 
induction of elements of the immune response. NF-κB also acts broadly to influence 
gene expression events that impact cell survival, differentiation, and proliferation 
(Hayden et al., 2012). RV NSP1 has a conserved C-terminal domain that mimics the 
IκB phosphodegron recognised by β-TrCP. NSP1 uses this sequence, defined 
phosphodegron-like (PDL) motif to interact with β-TrCP, driving its proteasome-
mediated degradation (Davis et al., 2017a; Morelli, Dennis, et al., 2015) resulting in 
an inactive form of NF-κB dimers that are unable to translocate to the nucleus and 
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activate IFN transcription. This mechanism is strain dependent, with porcine OSU, 
bovine NCDV and human D, DS-1, Ku, P, Wa strains able to induce the degradation of 
β-TrCP, while porcine Gottfried and YM, and human IAL28, ST3 and WI16, lack this 
mechanism (Di Fiore et al., 2015; Graff et al., 2009). In addition, certain RV strains 
show the ability to sequester NF-κB p65 subunit in viroplasms during infection or 
interfere with NF-κB nuclear accumulation (Holloway et al., 2009), potentially 
blocking NF-κB signalling pathways in a β-TrCP-independent manner.  
1.3.4 STAT1 and STAT2 
NSP1 from rhesus RV (RRV) and the porcine strain, SB1A can interfere with 
IFN signalling by blocking STAT1/2 nuclear localization (Holloway et al., 2009). NSP1 
antagonizes IFN mediated STAT1 Y701 phosphorylation, and the inactivated complex 













Figure 8. Modulation of type I IFN induction and signalling by rotavirus NSP1. 
RV NSP1 is able to modulate the induction of IFN by targeting members of the induction and 
signalling pathways and inducing their proteasome-mediate degradation. The ability of NSP1 to 
modulate the IFN response is conserved among species, however, the specific targets vary among 
strains. Moreover, in vitro experiments have underlined how the ability of NSP1 to induce the 
degradation of its targets depends on the cellular context. Overall, the human, bovine and murine 
strains are likely to preferentially target the IRFs (IRF-3,-5,-7 and 9). The porcine strains appears to 
target the helicase RIG-I and MDA-5 and β-TrCP which regulates the activation of NF-кB. Monkey 










NSP1 is the most variable protein expressed by RV, however, the kind of 
selective pressure the protein is subject to remains unknown. It has been shown that 
NSP1 is essential in subversion of immune responses, targeting members of IFN 
induction and signalling pathways. This role is well conserved among strains that 
infect different host species, but the specific targets of NSP1 vary. This may be a 
major contributor to the observed host range specificity for which the molecular 
mechanisms remain unattributed. In order to evaluate if NSP1 from different host 
species downregulates the induction and signalling of interferon by targeting 
different host proteins in this signalling pathway or if all NSP1s target a set of proteins 
which are the common targets irrespective of the host species: 
Objectives: 
1. Determine if NSP1 proteins, from strains of RV that infect different 
mammalian species, differentially interact with members of the IFN 
induction and IFN signalling pathways (RIG-I, MDA5, MAVS, IRF-3, IRF-7, 
TrCP, and TBK1) using the yeast-2-hybrid system (Y2H).  
2. Determine if NSP1 proteins derived from different RV strains show a 
strain-dependent expression level and stability. 
3. Determine if NSP1 proteins derived from RV strains which infect different 
mammalian species, can differentially antagonise type I and III IFN 
















Material and Methods 
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2 Material and methods  
2.1 Cell Culture 
2.1.1 Cell lines 
Unless otherwise stated, cells were cultured in GMEM-BHK21 (Thermo Fischer 
Scientific, #11710035) or DMEM (Thermo Fischer Scientific #41965-039)cell culture 
media  supplemented with 5% foetal bovine serum (FBS) (Thermo Fisher Scientific, 
#10270106), penicillin (100 U/mL) and streptomycin (100 μg/mL) (Sigma, #P4333). 
Table 3. List of cell lines used in this study 
Cell line Comments Culture medium Splitting ratio ACC Source 
BSC-1 African green monkey kidney 
cells 




MA104 African green monkey kidney 
cells 




Caco-2 Homo sapiens Colon Colorectal 
cells 





HEK293T Human embryonic kidney cells 
expressing large T-antigen of 
SV40 




HT-29 Homo sapiens Colon Colorectal 
cells 











Porcine kidney epithelial cells 
stably expressing CSFV Npro 
DMEM 1:4  Julian 
Seago 




MDBK-t/2 Madin Derby bovine kidney cells 
stably transfected with Mx-CAT 
DMEM + 
10μg/ml blasticidin 
1 in 10  Julian 
Seago 
BSRT-7/5 BHK-derived cell line stably 
expressing T7 RNA polymerase 
DMEM + 
10μg/ml/geneticin 
1:10  Julian 
Seago 
TS20 Balb3T3-derived cell line 
harbouring a temperature-
sensitive allele of the ubiquitin-
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2.1.2 Maintenance of cells in tissue culture 
Cells were maintained at 37°C with 5% CO2 in a humidified incubator in 75 cm2 
flasks using the appropriate media. When confluent, the cells were passaged as 
follows: cells were washed twice with Hank's Balanced Salt Solution (HBSS, Thermo 
Fisher Scientific, #14170070), incubated with 3 ml trypsin-EDTA (Sigma, #T3924) for 
5min at 37°C, or until they were no longer adherent, and then pelleted by 
centrifugation at 500 x g for 5min at RT. Cells were re-suspended in the appropriate 
medium and re-seeded at the required density (Table 3). All manipulations were 
performed under sterile conditions in a class II laminar flow cabinet using standard 
aseptic techniques. 
2.1.3 Maintenance of stable cells in tissue culture 
Blasticidin was purchased from Sigma (#15205) and used to maintain selection 
pressure on MDBK-t/2 cell lines. 
2.1.4 Transfection  
Relevant cell lines were grown to 80% confluency in 6-, 12- or 24-well plates. 
For each well 200 ng of DNA diluted at 15 ng/µl in Opti-MEM® (Gibco, #31985-062) 
was incubated with 1 µl of Lipofectamine2000® (Thermo Fisher, #11668030) - Opti-
MEM®mix (ratio 1:1) at RT for 20min. The mix was then added to the wells and 
incubated at 37°C for 4h, after which the media was removed and replaced with fresh 
complete GMEM media. Cells were then incubated overnight at 37°C/5% CO2. 
Alternatively, cells were transfected using TransIT®-LT1 transfection reagent 
(Mirus biolab, #Mir 2300) as follows: 50 μl of DMEM without FCS and 
penicillin/streptomycin was incubated with 1 μl of transfection reagent at RT for 
5min. Plasmids were added to the transfection mix and incubated at RT for 30min. 
During the incubation period, growth media was removed from the cells and they 
were washed with PBS before the addition of 300 μl of media without FCS and 
penicillin/streptomycin. The transformation mix was then added to the cells, 
followed by an incubation period for 4h at 37°C/5% CO2. 2 ml of complete media was 
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added, and cells were maintained overnight at 37°C in order to express exogenous 
proteins. 
2.2 Viruses 
2.2.1 Sendai virus 
Sendai Virus (SeV), Cantell Strain (ATCC VR-907 Parainfluenza 1), used for 
induction of IFN in HEK-293, Caco-2, HT-29, MA-104, BSC-1, PK-15 and MDBK cell 
lines (2.1.1) was purchased from Charles River, Wilmington MA, USA (#10100773) at 
a titre of 4000 HA tube titre/mL. 
2.2.2 Classical Swine fever Virus 
Classical Swine fever Virus (CSFV) strain Alfort 187 used to knock-down the 
expression of IRF-3 was available within the Molecular Virology group, having been 
originally provided by the EU reference laboratory, Hannover, Germany. The virus 
was stored at -80⁰C in 1 ml single use aliquot  
2.2.3 CSFV infection of PK-15 cell lines 
PK-15 cells were seeded in 6-well plates at 3 x 105 cells/ml with DMEM media. 
Once cells reached 80% confluency, media was removed and replaced with 750 µl of 
fresh DMEM without FCS and penicillin/streptomycin. 50 µl (200 HA) of CSFV was 
added to the cells and incubated for 1h at 37°C. Media was then removed and 
replaced with 3 ml of fresh DMEM. An incubation period of 48h at 37°C followed. 
2.2.4 Modified Vaccinia Ankara –T7 polymerase (MVA-T7) 
Modified vaccinia virus Ankara-T7 polymerase (MVA-T7) is an attenuated 
vaccinia virus strain encoding the bacteriophage T7 polymerase gene (Sutter et al., 
1995). The virus was used to promote higher levels of expression of RV NSP1 from 
the T7 promoter in the pcDNA3.1 derived construct. For T7 driven expression, cells 
were grown to 90% confluency in 6-well plates and infected with MVA-T7 1h prior to 
transfection. Briefly, growth media was removed, cells were washed with PBS and 
   
75 
 
250 µl of fresh GMEM without FCS and penicillin/streptomycin was added. 50 µl 
MVA-T7 was added directly to the growth medium and cells were incubated for 1h 
at 37°C. Supernatant was removed and replaced with complete media. Cells were 
transfected using TransIT®-LT1 transfection reagent (Mirus biolab, #Mir 2300) as 
described in 2.1.4. Cells were incubated at 37°C for 16h before cell lysates were 
prepared and protein expression checked by Western blot analysis as described in 
section 2.7. 
2.3 Cloning and plasmid preparation 
2.3.1 Polymerase chain reaction (PCR) 
DNA was amplified by PCR in 0.5 ml centrifuge tubes in a 100 µl reaction 
containing 10 ng of DNA template, 10 µl of 10X buffer, 200 µM dNTPs, 1.5 mM 
MgSO4, 0.3 pmol/µl of forward and reverse primers (Table 7) and 1U KOD polymerase 
(Merck Millipore, #71085-3) adjusted to the final volume with dH2O. 
Alternatively, PCR was carried out in a final volume of 50 µl containing 25 μl 
of Taq 2X master mix (Thermo Scientific, #K1081), 0.5 µM forward and reverse 
primers and dH2O to the final volume. In some cases, adjustments in thermal cycling 
parameters were necessary to improve amplification specificity and DNA yield. 
PCR was carried out under the following cycling condition:  
Table 4. Standard PCR thermal cycling conditions 
Stage Temperature and Time Number of cycles Step 
1 95°C for 1min 1 Initial denaturation 
2 94°C for 30sec 30 to 35 Denaturation 
3 55°C to 60°C for 30sec 
 
Annealing * 
4 72°C 60 sec/kb 
 
Elongation 
5 Go to step 2   
6 72°C for 5min 1 Final elongation 
7 rt hold  
* The annealing temperature was adjusted based on the Tm of the primers. 
   
76 
 
2.3.2 Agarose gel electrophoresis 
  DNA fragment size was determined by agarose gel electrophoresis 
using 0.8% - 1.2% (w/v) agarose gels (Invitrogen UltraPure™ Low Melting Point 
Agarose, #16520-100) dependent on the size of the products being resolved. Agarose 
was dissolved in 1X Tris-Acetate EDTA (TAE) (40 mM Tris, 20 mM acetic acid, and 
1mM EDTA, pH 8.0) (Severn Biotech, #20600110) or Tris-Borate EDTA (TBE) (0.9 M 
Tris-base, 0.9 M Boric acid, 0.02 M EDTA) (Ambion,#AM9863) and heated until 
dissolved. Melted agarose was cooled down and supplemented with 1 µg/ml 
ethidium bromide (ThermoFisher, #15585011). Gel loading buffer was added to DNA 
samples and run alongside a 1 kb ladder (Promega, #G5711 or New England BioLabs, 
#N3232L) in 1X TAE or 1X TBE buffer at 90 mA for a sufficient time to obtain a clear 
separation of the products.  
2.3.3 Gel purification of DNA 
DNA was visualized using UV trans-illuminator at 365 nm (UV-A range) and the 
bands of interest were excised. DNA was recovered using the Wizard® SV Gel and 
PCR Clean-Up System (Promega, #A9281) or QIAquick® gel extraction kit (Qiagen, 
#28704), according to the manufacturer’s instructions. 
2.3.4 Restriction enzyme digestion of DNA 
Analytic digestions were performed in 1 ml microcentrifuge tubes in a reaction 
volume of 5 µl. For each, 150 ng of DNA was digested with 1U of appropriate 
restriction enzyme, 0.5 µl of the corresponding 10X buffer and 0.5 µl of 10X Bovine 
Serum Albumin (BSA). Reactions were incubated for 2-3h at 37⁰C. 
Preparative digestions of 5-20 µg were performed in 1 ml micro-centrifuge 
tubes in a reaction volume of 30 µl, using 5-10 U of appropriate restriction enzyme, 
3 µl of the corresponding 10X buffer and 3 µl of 10X BSA. Reactions were incubated 
overnight at 37°C but time was adjusted for efficiency or to reduce star activity. DNA 
was purified as described in 2.3.3 
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2.3.5 Dephosphorylation of vector DNA 
The 5’-phoshate groups were removed from the digested DNA Vector using 
FastAP Alkaline Phosphatase (ThermoFisher scientific, #EF651) following the 
manufacturer’s protocol. Briefly, 1U of FastAP was added to purified DNA and 
incubated 10 min at 37 °C. FastAP was inactivated with an incubation for 5min at 
75°C. DNA was purified as described in 2.3.3. 
2.3.6 DNA ligation  
Ligations were performed in 1 ml microcentrifuge tubes in a reaction volume 
of 20 µl. 100 ng (~1 µl) of vector DNA was incubated with a 3:1 molar excess of insert 
DNA, 1 µl of 10X T4 DNA ligase buffer (New England BioLabs, #B0202S), 20U of T4 
DNA ligase (New England BioLabs,#M0202S) and dH2O to the final volume. For each 
ligation, a “vector only” control was performed using the same quantity of vector 
DNA, buffer and T4 DNA ligase excluding the insert DNA. Ligation reactions were 
performed at room temperature (RT) overnight. 
2.3.7 Transformation 
For each transfection 2 µl of ligation or control was added to 50 µl of 
chemically competent XL1-Blue MRF’ supercompetent E.coli in a 1 ml 
microcentrifuge tube. 0.7µl of β-mercaptoethanol was then added and incubated on 
ice for 40min. The mix was heat shocked at 42°C for 45sec and placed on ice for 2min. 
0.5 ml of Luria Broth (LB) was then added and the E.Coli were incubated at 37°C for 
1h with shaking (200rpm). Transformation of Subcloning Efficiency™ DH5α, One 
Shot® TOP10 Chemically Competent or Rubidium Chloride chemically competent 
E.coli was carried out as previously described, with the exception of the 
administration of β-mercaptoethanol. Following incubation, the transformed E.coli 
were plated onto selective LB agar plates (in-house) supplemented with either 
Kanamycin (50 µg/ml (w:v)) (Sigma Aldrich #0879) or Ampicillin (100 µg/ml (w:v)) ( 
Thermo Fisher, # 11593027) selective antibiotics and incubated at 37°C for 16h. 
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2.3.8 Small scale plasmid DNA preparation (mini prep) 
For each plasmid preparation, an individual bacterial colony was used to 
inoculate 5 ml LB medium containing the appropriate antibiotic before incubation for 
16h at 37°C with shaking (200rpm). Plasmid DNA was then purified using a QIAprep 
Miniprep Kit (QIAGEN, #27104) following the manufacturer’s protocol. Briefly, each 
overnight bacterial culture was pelleted by centrifugation at 17,900 x g for 15min at 
RT. Supernatant was discarded and the pellet re-suspended in 250 µl of buffer P1 in 
a 1 ml microcentrifuge tube. 250 µl of Lysis buffer P2 was then added. 350 µl of 
Neutralization buffer N3 was added, gently mixed and the sample was centrifuged at 
17,000 x g for 10min at RT. The supernatant was transferred to a QIAprep 2.0 spin 
column and centrifuged at 17,000 x g for 1min at RT. The flow-through was then 
discarded, 500 µl of Binding buffer PB was added and the column centrifuged at 
17,000 x g for 1 min at RT. The flow-through was discarded, 750 µl of Washing buffer 
PE was added and the column centrifuged at 17,000 x g for 1min at RT. The flow-
through was discarded and an additional centrifugation performed, before the 
column was transferred to a clean 1 ml microcentrifuge tube and the plasmid DNA 
eluted by the addition of 50 µl of DNase/RNase free dH2O and centrifugation for 1 
min at 17,000 x g, RT. 
2.3.9 Permanent bacterial stock 
One ml aliquot of the overnight culture generated in 2.3.7 was inoculated in 
5 ml of fresh LB media containing the appropriate antibiotic resistance and cells were 
incubated with shaking (200 rpm) at 37°C for 3h. 500 µl of 100% glycerol (VWR 
International, #24388.260) was added and the culture aliquoted in 1.5 ml cryogenic 
vials and stored at -80°C. 
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2.3.10 Bacterial strains used for the amplification of plasmid DNA 
Subcloning Efficiency™ DH5α™ E.coli (F- Φ80lacZΔM15 Δ (lacZYA-argF) U169 recA1 
endA1 hsdR17(rk-, mk+) phoA supE44 thi-1 gyrA96 relA1 λ- ) (ThermoFisher Scientific, 
#18265017) were used to amplify plasmid DNA. 
One Shot® TOP10 Chemically Competent E. coli F- mcrA Δ (mrr-hsdRMS-mcrBC) 
Φ80lacZΔM15 Δ lacX74 recA1 araD139 Δ (araleu)7697 galU galK rpsL (StrR) endA1 
nupG (ThermoFisher Scientific, #C404003) were used to amplify plasmid DNA. 
XL1-Blue MRF’ supercompetent E.coli (∆ (mcrA) 183∆ (mcrCB-hsdSMR-mrr)173 
endA1 supE44 thi-1 recA1 gyrA96 relA1 lac[F  ́proAB acIqZ∆M15 Tn10(Tet r) (Agilent, 
#200230) were used to amplify plasmid DNA. 
XL10-Gold Ultracompetent cells, XL10-Gold β-ME (Tetr∆(mcrA)183 ∆(mcrCB-
hsdSMR-mrr)173 endA1 supE44 thi-1 recA1 yrA96 elA1 lac Hte [F’ proABlacIqZ∆M15 
Tn10(Tetr) Amy Camr] 
Rubidium competent E.coli strain JM109 (endA1, recA1, gyrA96, thi, hsdR17 rk–, 
mk+), relA1, supE44, Δ( lac-proAB), [F´ traD36, proAB, laqIqZΔM15]), (in-house) were 
used to amplify plasmid DNA.  
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2.3.11 DNA sequencing 
DNA concentrations were determined by measuring the OD260 using a 
NanoDrop spectrophotometer (NanoDrop™ 2000/2000c). 100 ng of plasmid DNA 
was sequenced in-house using the BigDye® Terminator v3.1 Cycle Sequencing Kit 
(Thermo Fischer Scientific, #4337454). Briefly, for each reaction 200 ng of plasmid 
(1.5 µl) and 4.8 µL of dH20 were added to a 0.5 ml microcentrifuge tube and heated 
at 94°C for 4 min to denature DNA prior to placing on ice for 2 min. 1.9 µl of BigDye® 
10X buffer, 0.5 µl of sequencing mix, 1.5 µl of primer (at 3.4 pmol/µl) were then 
added before PCR was performed under the conditions reported in Table 5:  
Table 5. PCR protocols to amplify DNA sequences using BigDye® Terminator v3.1 Cycle Sequencing 
Kit. 
Stage Temperature and Time Number of Cycles Step 
1 95°C for 1min 1 Initial denaturation 
2 94°C for 45sec 25 denaturation 
3 50°C for 10sec 
 
annealing 
4 60°C for 4min 
 
elongation 
5 Go to step 2   
6 4°C hold  
 
Following PCR, 5 µl of EDTA (100 mM) was added to stop the amplifying 
reaction. 70 µl of 100% ethanol (v/v) was then added and the sample centrifuged at 
16,000 x g for 30min at 4°C, to precipitate the DNA. The supernatant was removed 
and 400 µl of 70% ethanol (v/v) was added before centrifugation at 16,000 x g for 
10min at 4°C. The supernatant was then discarded and the pellet air dried for 10min 
prior to storage at -20°C. The pellet was re-suspended in 20 µl Hi-DiTM Formamide 
and sequenced in-house using an ABI 3730 DNA analyser (Applied Biosystem). 
Sequence electropherograms were analyzed using Chromas Lite® software.  
2.3.12 Site-directed mutagenesis  
Site-direct mutagenesis was performed using QuikChange Lightning Site-
Directed Mutagenesis Kit (Agilent, # 210518) following the manufacturer’s protocol. 
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Briefly, PCR was performed in a 0.5 µl microcentrifuge tube in a 50 µl reaction 
containing 1 µl of DNA template (~150 ng), 5 µl of 10X reaction buffer, 2 µl of forward 
and reverse primers (150 ng each primer), 1 µl of dNTPs mix, 1.5 µl of quick solution 
reagents, 1 µl of quick change enzyme and the total volume was made up to 50 μl 
with dH2O. PCR amplification was set up under the conditions reported in Table 6. 
Table 6. PCR protocols to perform site-direct mutagenesis using the Quickchange® Lightening Site-
Directed Mutagenesis Kit 
Stage Temperature and time Number of cycles Step 
1 95°C for 2min 1 Initial denaturation 
2 95°C for 20sec 18 denaturation 
3 60°C for 10sec 
 
annealing 
4 68°C for 30sec/kb 
 
elongation 
5 Go to step 2   
6 68°C for 5min hold  
 
2 µl of β-mercaptoethanol were added to 45 µl of XL-Gold Ultracompetent 
cells and incubated for 5 minutes on ice. 2 μl of Dpn-I restriction endonuclease was 
added to the PCR reaction and incubated at 37oC for 5min. 2 μl of Dpn-I-treated DNA 
was added to the cells and incubated on ice for 30min. Cells were heat-shocked at 
42°C for 40sec and incubated on ice for 2min. 500 µl of SOC was added and bacteria 
were incubated for 1h at 37°C with shaking. After incubation, 100 µl of the bacteria 
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2.4 Yeast Two-Hybrid  
The Y-2-H technique is based on the observation that many eukaryotic 
transcriptional factors (TFs) are formed of a discrete and separable DNA-binding 
domain (BD) and a transcriptional-activation domain (TD) (Fields et al., 1989). The 
system utilizes the reconstitution of an active TF to assay for protein-protein 
interaction. The fusion of each protein to separate TF domains reconstitutes an active 
TF when test proteins interact. The expression of reporter genes, that contain an 
upstream element to which the DNA binding domain binds, can be monitored to 
detect the interactions. 
2.4.1 Yeast strains 
The Saccharomyces cerevisiae strain AH109 (Matchmaker Y-2-H System 3) 
was used (Clontech). AH109 yeast use 4 reporter genes under the control of distinct 
GAL4 upstream activating sequences; two auxotropic reporter genes –(ADE2, HIS3) 
that facilitate growth on selective media and two reporter genes (LacZ and MEL1) 
(Aho et al., 1997) that process chromogenic substrates to produce blue coloured 
colonies. 
2.4.2 Yeast media 
Yeast growth media and supplements, dropouts (DO), double dropouts (DDO) 
(#630317), triple dropouts (TDO) (#630319) and quadruple dropouts (QDP) 
(#630323) were sourced from Clontech. 
2.4.3 Small-scale LiAc yeast transformation 
An aliquot of -80°C Saccharomyces cerevisiae stock was streaked on a fresh 
YPDA agar plate (Clontech, #630465) and incubated at 30°C to allow yeast colonies 
to grow. A sterile inoculation loop was used to scrape a single colony, which was then 
resuspended in 200 ml of YPDA medium (Clontech, #630464). An incubation period 
of 18h at 30°C with shaking (250rpm) followed, after which the absorbance at 600 
nm (OD600) was confirmed to be above 1.5. 30 ml of the overnight culture was 
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transferred to a new flask containing 300 ml of YPD, giving an OD600 between 0.2-0.3. 
An incubation period of 3h at 30°C with shaking (250rpm) followed. The OD600 was 
checked to be between 0.4-0.6.  
Cells were placed in 50 ml tubes and centrifuged at 1000 x g for 5 min at RT. 
The supernatant was discarded and the pellet resuspended in a 50 ml of dH2O. The 
cells were centrifuged again at 1000 x g for 5 min at RT, the supernatant was 
discarded and the cells were resuspended in freshly prepared sterile 1X TE/ 1X LiAc.  
1 µl of the “bait” and “prey” plasmids were mixed together with 10 µl of 
carrier DNA. 100 µl of yeast competent cells were added to each tube and mixed well 
by vortexing. Each tube was inoculated with 600 µl of freshly prepared sterile 1X PEG/ 
1X TE/ 1X LiAc solution and vortexed for 10sec and incubated for 30min at 30°C with 
shaking (250rpm), after which 70 µl of DMSO was added and mixed gently. The cells 
were then heat-shocked by incubation for 15min at 42°C, followed by placement on 
ice for 2min. The cells were pelleted by centrifugation at 17,000 x g for 1min at RT. 
The supernatant was removed and the cells were resuspended in 500 µl of sterile 1X 
TE buffer. Finally, 150 – 200 µl of transformed cells were plated on the appropriate 
agar plate. Yeast -2-hybrid screening experiments were carried out with: 
A positive control co-transforming competent yeast cells with a “bait” plasmid 
pGBKT7-53 and a “prey” plasmid pGADT7-T. pGBKT7-53 encodes the Gal4 DNA-BD 
fused with murine p53 while pGADT7-T encodes the Gal4 AD fused with SV40 large 
T-antigen. Since p53 and large T-antigen are known to interact in a yeast two-hybrid 
(B. Li et al., 1993), mating yeast with pGBKT7-53 and pGADT7-T will result in cells 
containing both plasmids that can activate all four reporters and grow on DDO media 
(-Leu,-Trp) and QDO media (-Leu, -Trp, -Ade, -His). 
A negative control co-transforming competent yeast cells with a “bait” 
plasmid pGBKT7-Lam (which encodes the Gal4 BD fused with lamin) and a “prey” 
plasmid pGADT7-T. Yeast containing pGBKT7-Lam and pGADT7-T will grow on DDO 
media (-Leu,-Trp) but not on QDO media (-Leu, -Trp, -Ade, -His). 
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2.5 Mx/CAT assay 
2.5.1 Interferon induction in cell lines 
Cells were seeded in 6-well plates at 2 x 105 cells/well with 2 ml of DMEM and 
incubated for 18h at 37°C/5% CO2. At 80% confluence, media was removed, cells 
washed twice with PBS and 2 ml of fresh DMEM were added. Synthetic dsRNA (poly 
I:C; Sigma, #P0913) was added directly to the media and the cells were incubated for 
a further 18h at 37oC/5% CO2. Alternatively, poly I:C was transfected into cells using 
a TransIT-LT1 kit (Geneflow, #E7-004). Briefly, the required concentration of poly I:C 
was mixed with 7.5 µl of TransIT-LT1 reagent in 250 µl of media without FCS and 
penicillin/streptomycin and incubated for 30min at RT. The mix was then added to 
the cells, which were incubated for a further 18h at 37oC/5% CO2. 
SeV infection was performed by washing cells twice with 1X PBS and adding 
600 µl of DMEM without FCS and penicillin/streptomycin plus 50 µl (200 HA) of SeV, 
followed by a 2h incubation at 37oC/5% CO2. The media containing SeV was removed 
and 2 mL of fresh DMEM was added. Cells were incubated for a further 18h at 
37°C/5% CO2. Supernatant was removed and stored at -20˚C for quantification of IFN 
using the Mx/CAT assay. 
2.5.2 Mx/CAT reporter assay 
MDBK-t2 cells, in which the chloramphenicol acetyltransferase (CAT) gene is 
under the control of the human MxA promoter (Fray et al., 2001) were used to 
determine the presence of biologically active IFN. 
MDBK-t2 cells were seeded in 6-well plates at 2 x 105 cells/well in 2 ml of 
DMEM. At 80% confluence, media was removed and replaced with 800 µl fresh 
DMEM containing 1% FCS. 200 µl of sample cell culture supernatant generated in 
2.5.1 was added to the cells and mixed gently. A standard curve of recombinant 
bovine IFN-α (Novartis) was separately prepared in 1.5 ml microcentrifuge tubes at a 
dilution of 90, 30, 10, 3.3 , 1.1 , 0.31, 0.123 IU/ml  in GMEM containing 2% FCS. 200 
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µl of each dilution and 800 µl of complete DMEM were then added to duplicate wells 
of the MDBK-t2 cell plate. The cells were incubated for 24h at 37°C/5% CO2 to allow 
for induction of the MxA promoter and the expression of chloramphenicol 
acetyltransferase (CAT) enzyme in the reporter cell line. After 24h, supernatant was 
removed and cells washed twice with 1X PBS. After removal of the supernatant 1 ml 
of lysis buffer (Sigma, #11363727001) was then added to the cells and the plate was 
incubated for 20min at RT. Lysates were collected in glass vials and stored at -80°C 
before assaying for CAT levels by ELISA 
2.5.3 Chloramphenicol acetyltransferase (CAT) ELISA 
A CAT ELISA (Sigma, #11363727001) was used to indirectly measure IFN 
production (Fray et al., 2001). 200 µl of supernatant generated in 2.5.2 was added in 
to duplicate wells in the anti-CAT micro-plates, sealed and incubated for 1h at 37°C. 
Supernatants were removed and wells washed five times with 200 µl/well washing 
buffer provided with the kit. 200 µl per well of anti-CAT DIG were added to each well, 
the micro-plates were sealed and incubated for 1h at 37°C. Supernatants were 
removed and wells washed three times as previously described. 200 µl of anti-DIG 
POD was added to each well and the plates were sealed and incubated for 1h at 37°C. 
Supernatants were removed and wells washed as previously described. 200 µl of POD 
substrate was added to each well and plates were incubated a RT till until colour 
development. ELISA plates were read at an absorbance 405 nm (reference 
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2.6 NSP1 sequences 
NSP1 cDNAs derived from different RV species were cloned into a mammalian 
expression vector to investigate their functions. The sequences of NSP1s derived 
from RV isolated from human and pig were kindly provided by Professor Miren 
Ituriza-Gomara (University of Liverpool). Based on phylogenetic analysis (0), the 
relative nucleotide sequences were ordered from GeneArt gene synthesis (Thermo 
Fisher). 
2.6.1 Cloning of NSP1s in mammalian expression vector pcDNA 
PCR was performed in 0.5 microcentrifuge tubes in a final volume of 25 µl. 
Reactions contained 1 µl of template DNA (~300 ng/µl), 6.2 µl (2 µM) of each forward 
and reverse primer (Table 7) and 12.5 µl of master mix reaction (Promega, GoTaq® 
Long PCR, #4021). PCR was carried out using the cycling conditions reported in Table 
4. PCR products were gel purified using the GFX™ PCR DNA and Gel Band Purification 
Kit (Healthcare, #28-9034-70) as described in 2.3.3. Products were then ligated into 
the pcDNA3.1/V5-His-TOPO® plasmid (Invitrogen, K4800-01) under the following 
conditions: 1 µl of vector was mixed with 3 µl of purified PCR product and 1 µl of salt 
solution and incubated at RT for 30min. Competent cells were transformed as 
described in (2.3.7). Transformed rubidium competent E.coli were plated on agar 
plates supplemented with Ampicillin (100 µg/ml) and incubated at 37°C for 16h. 
2.6.2 In vitro transcription and translation 
In a 1.5 ml microcentrifuge tube, 1 μl (~300 ng) of plasmid was mixed with 40 
μl of TnT® Quick master mix (Promega, #L5061), 2 μl of [35S]methionine (EasyTag; 
Perkin Elmer) and a final volume of 50 μl was reached with nuclease-free water. The 
reaction was incubated at 30°C for 90min. 5μl of each TnT® reaction was added to 20 
μl of Lamelli lysis buffer and heated at 95°C for 5min. Samples were resolved by SDS-
PAGE as indicated in 2.7.1. 
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The SDS gel was then incubated in fixing solution (50% methanol, 10% glacial 
acetic acid, 40% water) with shaking for 30min. The fixing solution was removed and 
the gel was immersed in 10% glycerol for 5min to prevent cracking during drying. The 
gel was placed on Whatman 3MM filter paper (ThermoFisher, # 05-716-E), covered 
with plastic wrap and dried at 80°C for 60min, after which it was placed in an 
exposure cassette with CL-XPosure™ Film (Thermo Fisher, #34089) for 24h or until 
the desired proteins were detected. 
2.7 Protein analysis 
2.7.1 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
Gradient SDS-PAGE gels were used to separate proteins according to size. 
Cells were seeded in 6-well plates at a density of 2 x 105 cells/well with 2 ml of culture 
media and maintained at 37°C with 5% CO2. When confluent, 200 µl of Laemmli lysis 
buffer was added, lysates were collected and heated for 5 min at 95°C. 20 µl of each 
lysate was loaded on a 4-20% universal gel (NuSep, #NG21-420) and run at 150 V for 
60min. Protein sizes were determined by comparison to a full range molecular weight 
rainbow marker (Sigma, # RPN800E). 
2.7.2 Immunoblotting analysis  
Resolved protein bands were transferred onto a nitrocellulose membrane 
(Amersham™ Protran™, #10600016) in 1X Western blot buffer for 60min at 100 V 
(200 mA). Following transfer, membranes were first blocked in 5% milk solution (milk 
powder, 0.1% tween, dissolved in PBS) for 1h at RT with shaking (40 rpm) to prevent 
non-specific binding. Membranes were incubated with primary antibody diluted in 
milk solution (referred to table 2.13 dilution/concentration) overnight at 4°C with 
shaking (40 rpm). Membranes were then washed three times with milk solution, each 
time for 10min, prior to incubation with secondary antibody HRP conjugates (diluted 
in milk solution) for 1h at RT with shaking (40 rpm). Membranes were washed three 
times, each time for 10 min, in 1X PBS (0.1% TWEEN) and then washed once in 1X 
PBS. Residual solution was removed from membranes and 1 mL of pre-mixed 
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SuperSignal® West Pico 86 Chemiluminescent Substrate (Pierce, #34087) or 
ImmobilionTM Western chemiluminescent substrate (Millipore, #WBKLS0500) was 
added to each membrane and incubated for 5min at RT. Membranes were placed in 
an exposure cassette with CL-XPosure™ Film (Thermo Fisher, #34089) for 5sec to 
10min, then incubated in developing solution (AGFA, #HT536) for 2 min, briefly 
washed in water and finally incubated in fixing solution (AGFA, #2828q) for 2min. 
Autoradiography film were washed then rinsed with water, air dried and scanned 
using An EPSON Selection V600 scanner. 
2.8 Dual Luciferase reporter assays 
Luciferase promoter reporter assays were used to investigate the ability to 
plasmid-encoded NSP1 proteins to downregulate the promoter activity of type I and 
III IFN (5.2.1.1, 5.2.1.2), NF-κB (5.2.1.3) and Mx (5.2.1.4). A dual luciferase system 
relies on the detection of two different reporter genes, Renilla (Renilla reniformis) 
and firefly luciferase (Photinus pyralis), to evaluate regulated genes expression. One 
reporter is used as an internal control to which measurement of the other reporter 
is normalized. The experimental reporter is coupled to a regulated promoter to study 
the structural or physiological basis of regulated gene expression. Relative changes 
in the expression of reporter activity correlate to changes in the transcriptional 
activity of the coupled regulated promoter. To provide an internal control for 
transcriptional activity, the second reporter gene is constitutively expressed. Cells 
were co-transfected with respective luciferase reporters and NSP1 as described in 
2.1.4. In order to prevent detachment of HEK293 cells, wells were treated with 1X 
Poly-D-lysine (Sigma, #P6407-5MG) for 30min at RT prior to use. Depending on the 
promoter investigated, cells were treated with different stimuli (SeV, TNFα, IFNα) as 
stated. After induction, cells were washed in 1X PBS and lysed in 100 µl of passive 1X 
lysis buffer for 30min at RT. Supernatants were collected and luciferase values were 
obtained using the Dual-Luciferase® Reporter (DLRTM) Assay System (Promega, 
#E1910) and a spectrophotometer (Biotek, #Synergy 2). 30 µl of each lysate was 
added to a white sided, white flat bottom Greiner CELLSTAR® 96 well plate (Sigma, # 
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CLS3912) in triplicate. 40 µl of Luciferase Assay Buffer II was injected and firefly 
luciferase was automatically read for 8 seconds, then 40 µl of Stop & Glo® Buffer was 
added and Renilla luciferase values were automatically read. Values for firefly 
luciferase luminescence were then normalised to the expression of Renilla luciferase 
within the same sample. Values were converted into percentage expression of the 
positive control (stimulated cells containing empty vector only). 
2.9 Bionformatics 
ApE- A plasmid Editor (http://jorgensen.biology.utah.edu/wayned/ape/) was used to 
design primes. 
Vector NTI Advance™ 11.5.3 (LifeTechnologies) was used to align sequences and 
draw phylogenetic trees. 
ExPASy: SIB Bioinformatics Resource Portal was used to translate protein sequences 
(https://web.expasy.org/translate/). 
Basic Local Alignment Search Tool (BLAST) was used to align primary biological 
sequence information, such as the amino-acid sequences of proteins or the 
nucleotides of DNA sequences (https://blast.ncbi.nlm.nih.gov/Blast.cgi) 
Ensemble alignment tool was used to gain information about promoter sequences 
(http://www.ensembl.org/index.html) 
2.10 Statistical analysis  
Where required, t-test statistical analysis was performed with Graph Pad PRISM 7.00. 
2.11 Graphical presentation 
Dual luciferase reporter charts were generated using Graph Pad PRISM 7.00  
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2.12 List of primers 
Table 7 lists the main oligonucleotides used in this report. Oligonucleotide 
primers were synthesised by Sigma-Aldrich and stock solutions of 100 pmol/μl were 
made using RNase/DNase freedH2O (Sigma, #4502). 
Table 7. Primers used for this study. 
Primer name Sequence (5’to 3’) use 
βTrCPFwNed1 ACTATACATATGGACCCGGCCGAGGC To clone β-TrCP in pGADT7 (forward) 
βTrCPRevBamhI TGATATGGATCCTTATCTGGAGATGTAGGTGTA TGTTCGAGAAGG To clone β-TrCP in pGADT7 (reverse) 
3' DNA-AD Sequencing  AGATGGTGCACGATGCACAG To sequence of pGADT7 (reverse) 
3' DNA-BD Sequencing  ATCATAAATCATAAGAAATTCGCC Sequencing of pGBKT7 (reverse) 
pCDNA3.1_NSP1_Re TTATGCGGCCGCTGCAGG To clone NSP1s in pcDNA™3.1/V5-His-TOPO® 
(reverse) 
pCDNA3.1_NSP1_Fw CAGAGGAGGACCTGCATATG To clone NSP1s in pcDNA™3.1/V5-His-TOPO® 
(forward) 
T7 TAATACGACTCACTATAGGǴ To sequence NSP1s cloned in pcDNA™3.1/V5-
His (forward) 




BGH Reverse TAGAAGGCACAGTCGAGǴ 
 
To sequence NSP1s cloned in pcDNA™3.1/V5-





To sequence human NSP1 strain 18A annealing 





To sequence human NSP1 strain 1M0 





To sequence human NSP1 strain TC annealing 





To sequence porcine NSP1 strain G10P5 within 





To sequence porcine NSP1 strain A8 within the 





To sequence rhesus NSP1 strain RRV within 





To sequence bovine NSP1 strain UKtc within 
the sequence ( forward) 
TC_FW_HIStag_kpn1 TGGCTAGTTAAGCTTGGTACCATGCATCACCATCACCATCAC 
AAAAGTCTTGTGGAAGCCATG 












To clone HIS tag porcine NSP1 strain G10P5 in 
pcDNA3.1 (forward) 













To clone HA tag human NSP1 strain 18A, 1M0 
and TC in pcDNA3.1 (forward) 
G10P5_Fw_HAtag-kpn1 TGGCTAGTTAAGCTTGGTACCATGTACCCATACGACGTACCAGATTA
CGCTGCGACTTTTAAAGACGCTTGTTATC 








To clone HA tag bovine NSP1 strain UKtc in 
pcDNA3.1 (forward) 
NSP1s_Rev_not1 GCCCTTTTATGCGGCCGC To clone HIS and HA tag human 18A, 1M0 and 
TC strains , porcine G10P5 and A8 strains and 






To insert extra bases at the 5’-end of the 






To insert extra bases at the 5’-end of the 
porcine NSP1 G10P5 (reverse) 
E1a_Fw TCAAGCCTCAGACAGTGGTTC To sequence rhesus (RRV) NSP1 cloned in 
pEF/flag-_RRV_NSP1 
RRV_NSP1_inside CATGATTTAAATTTGGGGAG To sequence rhesus (RRV) NSP1 cloned in 
pEF/flag-_RRV_NSP1 
RRV_NSP1_ inside(2) TGAATTCACCTGGGATTCTCAAACTG To sequence rhesus (RRV) NSP1 cloned in 
pEF/flag-_RRV_NSP1 
hIRF3_EcoRI_Fw GCGCGCGAATTCATGGGAACCCCAAAGCC To clone the human IRF-3 in pGADT7 (Fw) 
















   
92 
 
2.13 Primary and secondary antibodies used in this study 
Table 8 lists the primary and secondary antibody used in this study. 
Table 8. Primary and secondary antibodies used in this study. 
Protein Primary antibody Secondary antibody 
   
IRF-3 Anti- IRF-3 rabbit polyclonal IgG, 1:3000 
(Santa Cruz , #9082) 
Goat-α-rabbit IgG-HRP Conjugate, 
1:5000 (Promega, # W401)  
 
γ -tubilin α-γ-tubulin mouse monoclonal Clone 
GTU-88 (IgG1) 1:5000 (Sigma, #T6557) 
Goat-α-mouse-HRP Conjugate, 1:5000 
(Promega, # W402B) 
 
NPRO α-DS14 rabbit 1:50 (IAH in-house)  
 
Alexa Flour 594 goat anti rabbit IgGI 1:500 
(Molecular probes, #A11011) 
HIS-tag Anti-HIS mouse monoclonal, 1:3000 (GE 
Healthcare, #27-4710-01) 
Goat-α-mouse-HRP Conjugate, 1:5000 
(Promega, # W402B) 
HIS-tag Anti-6X His tag® mouse monoclonal, 
1:3000 (Abcam, #ab18184) 
Goat-α-mouse-HRP Conjugate, 1:5000 
(Promega, # W402B) 
HA-tag Anti-HA Affinity Purified Antibody goat 
monoclonal, 1:3000 (QED Bioscience, 
#18849)  
Donkey Anti-Goat IgG (H+L), HRP 
Conjugate, 1:5000 (Promega, #V8051) 
MYC-tag Anti-MYC rabbit polyclonal IgG, 1:3000 
(Thermofisher, #PA1981) 
Goat-α-mouse-HRP Conjugate, 1:5000 
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2.14 Plasmids vectors 
Table 9 lists the plasmids used in this study. 
Table 9. Plasmids vectors used in this study. 
Plasmid Function Resistance Source 
pGADT7/bIRF-3 Expression of bovine IRF-3 prey protein fused 




Expression of monkey IRF-3 prey protein fused 
to the GAL4 AD domain protein 
A Michele Hardy 
pGADT7/hMAVS 
Expression of human MAVS prey protein fused 




pGADT7/hTBK1 Expression of human TBK1 prey protein fused 
to the GAL4 AD domain protein 
A Steve 
Goodbourn 
pGADT7/hRIG-I Expression of human RIG-I prey protein fused 
to the GAL4 AD domain protein 
A Steve 
Goodbourn 
pGADT7/hβTrCP Expression of human β-TrCP prey protein 
fused to the GAL4 AD domain protein 
A This study 
pGADT7/hMDA5 Expression of human βTrCP prey protein fused 





Plasmid containing the sequences encoding 




Plasmid containing the sequences encoding 





Plasmid containing the sequences encoding 
the human RV NSP1 (18A) 
A GeneART® 
pMAT16AAUNRP/NSP1-A8 Plasmid containing the sequences encoding 




Plasmid containing the sequences encoding 
the porcine RV NSP1 (G10P5) 
 GeneART® 
pGBKT7/hNSP1(1M0) 
Expression of the human RV NSP1 (strain 1M0) 
bait protein fused to the GAL4 BD protein 
K This study 
pGBKT7/hNSP1(TC) 
Expression of the human RV NSP1 (Tissue 
cultured adapted, TC) bait protein fused to the 
GAL4 BD protein 
K This study 
pGBKT7/hNSP1(18A) Expression of the human RV NSP1 (strain 18A) 
bait protein fused to the GAL4 BD protein 
K This study 
pGBKT7/pNSP1(A8) Expression of the porcine RV NSP1 (strain A8) 
bait protein fused to the GAL4 BD protein 
K This study 
pGBKT7/pNSP1(G10P5) 
Expression of the porcine RV NSP1 (strain 
G10P5) bait protein fused to the GAL4 BD 
protein 
K This study 
pGBKT7/RRV-NSP1 Expression of the rhesus RV NSP1 (strain RRV) 
bait protein fused to the GAL4 BD protein 
K Steve 
Goodbourn 
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pGBKT7/UKtc-NSP1 Expression of the bovine RV NSP1 (strain UKtc) 











Expression of the human RV NSP1 (strain 18A) 
in mammalian cell lines 
A This study 
pcDNA3.1/V5-His-TOPO-
human NSP1(1M0) 
Expression of the human RV NSP1 (strain 1M0) 
in mammalian cell lines 
A This study 
pcDNA3.1/V5-His-TOPO-
human NSP1(TC) 
Expression of the human RV NSP1 (strain TC) in 
mammalian cell lines 
A This study 
pcDNA3.1/V5-His-TOPO-
porcine NSP1(G10P5) 
Expression of the porcine RV NSP1 (strain 
G10P5) in mammalian cell lines 
A This study 
pcDNA3.1/V5-His-TOPO-
porcine NSP1(A8) 
Expression of the porcine RV NSP1 (strain A8) 
in mammalian cell lines 
A This study 
pcDNA3.1/V5-His-TOPO-
bovine NSP1 (UKtc) 
Expression of the bovine RV NSP1 (strain UKtc) 
in mammalian cell lines 
A This study 
pcDNA3.1/V5-His-TOPO-
human HA-NSP1(18A) 
Expression of the HA-tag human RV NSP1 
(strain 18A) in mammalian cell lines 
A This study 
pcDNA3.1/V5-His-TOPO-
human HA-NSP1(1M0) 
Expression of the HA-tag human RV NSP1 
(strain 1M0) in mammalian cell lines 
A This study 
pcDNA3.1/V5-His-TOPO-
human HA-NSP1(TC) 
Expression of the HA-tag human RV NSP1 
(strain TC) in mammalian cell lines 
A This study 
pcDNA3.1/V5-His-TOPO-
porcine HA-NSP1(G10P5) 
Expression of the HA-tag porcine RV NSP1 
(strain G10P5) in mammalian cell lines 
A This study 
pcDNA3.1/V5-His-TOPO-
porcine HA-NSP1(A8) 
Expression of the HA-tag porcine RV NSP1 
(strain A8) in mammalian cell lines 
A This study 
pcDNA3.1/V5-His-TOPO-
bovine HA-NSP1 (UKtc) 
Expression of the HA-tag bovine RV NSP1 
(strain UKtc) in mammalian cell lines 
A This study 
pcDNA3.1/V5-His-TOPO- 
rhesus HA-NSP1 (RRV) 
Expression of the HA-tag rhesus RV NSP1 
(strain RRV) in mammalian cell lines 
A This study 
pcDNA3.1/V5-His-TOPO-
human HIS-NSP1(18A) 
Expression of the HIS-tag human RV NSP1 
(strain 18A) in mammalian cell line 
A This study 
pcDNA3.1/V5-His-TOPO-
human HIS-NSP1(1M0) 
Expression of the HIS-tag human RV NSP1 
(strain 1M0) in mammalian cell lines 
A This study 
pcDNA3.1/V5-His-TOPO-
human HIS-NSP1(TC) 
Expression of the HIS-tag human RV NSP1 
(strain TC) in mammalian cell lines 
A This study 
pcDNA3.1/V5-His-TOPO-
porcine HIS-NSP1(G10P5) 
Expression of the HIS-tag porcine RV NSP1 
(strain G10P5) in mammalian cell lines 
A This study 
pcDNA3.1/V5-His-TOPO-
porcine HIS-NSP1(A8) 
Expression of the HIS-tag porcine RV NSP1 
(strain A8) in mammalian cell lines 
A This study 
pcDNA3.1/V5-His-TOPO-
bovine HIS-NSP1 (UKtc) 
Expression of the HIS-tag bovine RV NSP1 
(strain UKtc) in mammalian cell lines 
A This study 
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pGADT7/hIRF-3 Expression of human IRF-3 prey protein fused 
to the GAL4 AD domain protein 
A This study 
pGBKT7/pNSP1(G10P5) 
extra 
Expression of the porcine RV NSP1 (strain 
G10P5) with extra aa sequence at the 5’-end 
bait protein fused to the GAL4 BD 
K This study 
pEF-flag-hIRF3 






Expression of human IRF-3 prey protein fused 
to the GAL4 AD domain protein 
A This study 
pGL2/hIFNβ Luciferase reporter vector under the control of 




pRL Renilla Luciferase control reporter vector 






Expression of the Classical Swine Fever N-
terminal protease (Npro) in mammalian cell 
lines 
A Julian Seago 
pGL2/hIFNλ1 
Luciferase reporter vector under the control of 
the human IFN λ1 promoter. 
A Julian Seago 
pGL2/hIFNλ3 
Luciferase reporter vector under the control of 
the human IFN λ3 promoter. 
A Julian Seago 
pGL2/hIFNα Luciferase reporter vector under the control of 
the human IFNα4 promoter. 
A Julian Seago 
pGL2/pMx2 
Luciferase reporter vector under the control of 




Expression of the V protein encoded by 
rinderpest virus (RPV) Saudi/81 strain in 
mammalian cell lines 
A Michael Baron 
pMA-RQ/pigIRF-3 




Expression of porcine IRF-3 prey protein fused 
to the GAL4 AD domain protein 
A This study 
pMC159 
Expression of the MC159 protein encoded by 







Luciferase reporter vector under the control of 
the murine Mx1 promoter. 
A Georg Kochs 
P6kB-LUC-NF-κB 
Luciferase reporter vector under the control of 
the human NF-κB promoter. 
A Julian Seago 
pEGFP-C1-IRF-7 Plasmid containing the sequence encoding the 
human IRF-7 
K Julian Seago 
pEF-OSU_NSP1 
Expression of the porcine RV NSP1 (OSU) in 
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pc-CMV-P50 Expression of p50 (NF-κB subunit) in 
mammalian cell lines 
A Julian Seago 
pRC- Ikkα Expression of Ikkα in mammalian cell lines A Julian Seago 
pc-CMV-P65 Expression of p65 (NF-κB subunit) in 
mammalian cell lines 
A Julian Seago 




Plasmid containing the sequence encoding the 




Plasmid containing the sequence encoding the 




Plasmid containing the sequence encoding the 




Expression of recombinant NSP1 carrying the 
N-termini region of the human strain 18A and 
the C-termini region of the bovine strain UKct 




Expression of recombinant NSP1 carrying the 
N-termini region of the bovine strain UKct and 
the C-termini the human strain 18A region of 
in mammalian cell lines 
A GeneArt 















   
97 
 
2.15 Buffers, solutions and culture media 
Table 10 lists buffers, solutions and culture media used in this study 
Table 10. Buffers, solutions and culture media used in this study. 
Solutions Recipe Use 
LB media Tryptone (Oxoid,#LP0042) 4gr 
Yeast extract (Oxoid,#LP0021) 2gr 




LB Agar Tryptone (Oxoid,#LP0042) 4gr 
Yeast extract (Oxoid,#LP0021) 2gr 
Bacto Agar (Sigma,#A5306) 
Formulation for 400ml 
Culturing transformed bacterial 
cells 
S.O.C. 2% tryptone 
0.5% yeast extract 
10 mM NaCl 
2.5 mM KCl 
10 mM MgCl2 
10 mM MgSO4 
20 mM glucose 





20mM acetic acid 
1mM EDTA, pH 8.0 
DNA gel electrophoresis 
Tris-Borate EDTA 
(TBE) 
0.9 M Tris-base 
0.9 M Boric acid 
0.02 M EDTA 
DNA gel electrophoresis 
Loading buffer 10X 100 mg Orange G (Sigma,# O3756) 
Glycerol 15ml (Sigma,#G5516) 
Formulation for 50ml 
DNA gel electrophoresis: loading 
samples 
Laemelli buffer 4% SDS 
20% glycerol 
10% 2-mercaptoethanol 
0.004% bromphenol blue 




TRIS base (Sigma,#1503) 30gr 
Glycine (AnalaR Normapur,#101194M) 144gr 
SDS (Sigma,#L3771) 10gr 
Formulation for 1000ml 
To be used at 1X 
Protein manipulation: proteins 
resolution 
Transfer buffer 10X TRIS base (Sigma,#1503) 30gr 
Glycine (AnalaR Normapur,#101194M) 144gr 
Formulation for 1000ml 
To be used 1X: 100ml of 10X solution, 200ml 
isopropanol, 700ml H20 
Protein manipulation: transfer of 
resolved protein from the gel to 
membrane 
Washing buffer 0.1% Tween (Sigma,#P1379) in PBS Protein manipulation: washing 
western blot membrane 
Blocking buffer 5% skimmed milk powder in washing buffer Protein manipulation: prevention 
of unspecific bindings of the 
antibody 
Tris-EDTA (TE) 10X 10 mM Tris-HCl 
1 mM EDTA pH 8.0 
Yeast-two-hybrid assay 
40%PEG, LiAc, TE PEG50% 8ml 
LiAc 1M 1ml 
TE 10X 1ml 
Yeast-two-hybrid assay 
LiAc, TE TE 10X 1ml 
LiAc 1M 1ml 
8ml H2O 
Yeast-two-hybrid assay 











Result chapter 1 
 
Analysis of NSP1 interaction using a yeast-two-hybrid
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3 Strain-dependent interaction between IRF-3 and 
rotavirus NSP1 
Purpose 
This chapter describes experiments performed in order to identify host 
proteins involved in interferon induction which may interact with RV NSP1. A strain-
specific interaction was observed between a panel of NSP1 proteins from RV isolates 
and IRF-3 proteins from different mammalian species. These observations provide 
the foundations for the investigations in the following chapters. 
Introduction 
The role of NSP1 in modulating the host innate immune response suggests 
that the protein is required by the virus during first steps of its replication cycle 
(Desselberger, 2014). Successful replication of RV in its target cells is partially due to 
the ability of the virus to modulate the IFN induction through the expression of NSP1. 
It has been shown that NSP1 from the bovine strain UKtc is able to interact with IRF-
3, driving its proteasome-mediated degradation (Sen et al., 2009). By contrast, 
porcine NSP1 OSU is able inhibit NF-κB transcriptional activity targeting β-TrCP (Di 
Fiore et al., 2015). The ability of RV to downregulate the expression of IFN is 
conserved among different species, however, targets within the IFN pathways varies 
between strains (Arnold et al., 2011). In order to determine if NSP1s from different 
host species downregulate interferon induction by targeting different host proteins 
in this signalling pathway, or if all NSP1s target a set of proteins which are the 
common targets irrespective of the host species of origin, a yeast-2-hybrid (Y-2-H) 
assay was used. A panel of NSP1, encoded by RV isolated from different species 
(human, pigs, cattle and rhesus) were screened against host proteins involved in the 
induction of interferon. 
 
   
100 
 
3.1 Generation of reagents to identify interactions between NSP1 and 
members of the IFN -induction pathway using a Y-2-H assay   
3.1.1 Construction of “bait” plasmid pGBKT/NSP1 
The Y-2-H “bait” plasmid pGBKT7 containing the sequences encoding the 
bovine NSP1 (UKtc) (GU808570) and the rhesus NSP1 (RRV) (U08433.1) were a gift 
from Professor Steve Goodbourn (St. George’s, University of London). In order to 
include NSP1 derived from RV infecting human and pigs in the Y-2-H screening, 
plasmids encoding their sequences were ordered from GeneART/Thermo Fisher 
Scientific and sub-cloned into the “bait” yeast plasmid pGBKT7. 
Selection and cloning of NSP1 from human RV isolates 
Three NSP1 proteins encoded by human RV isolates were selected following 
the analysis of an alignment of thirteen different NSP1 amino acid sequences; the 
alignment included the NSP1 sequences of six human isolates belonging to the A2 
genotype (BID18A, BID1RU, BID1JK, BID156, BID1PP, BID2Q5) and seven human 
isolates belonging to the A1 genotype (BID1CH, BID2JS, BID225, BID1M0, BID2D5, 
BID2BM, WA) (Matthijnssens et al., 2008). 
 Based on alignment divergence, one within A1 genotype group (1M0 
(G12P[8], Ku048673)) and one representing the A2 genotype group (18A (G1P[8], 
MG181761)) were selected. The TC-tissue cultured adapted (G1P[8], JX406751.1) 
was included in the screening (Figure 9). GeneART/Thermo Fisher plasmids encoding 
the sequences for the human NSP1 were amplified, the insert corresponding to NSP1 
released and cloned into the MCS of the “bait” pGBKT7 plasmid using NdeI and 
BamHI restriction sites. Restriction digestion analysis and sequencing confirmed the 
presence of the NSP1 genes and regeneration of the ligation junctions. 
 
 




Figure 9. Phylogenetic tree derived from the amino acid alignment of NSP1 proteins from human 
rotavirus isolates. 
The amino acid sequences of thirteen NSP1 proteins were aligned and strains were selected based 
on divergence. Arrows indicate the three NSP1 proteins selected for use in Y-2-H analysis. 1M0 and 
Wa (referred as TC-adapted) belong to the Wa-like group, while 18A belongs to DS-1-like group. 
 
NSP1 isolates derived from rotavirus infecting pigs 
The amino acid sequences of four NSP1 proteins from porcine RV isolates 
were aligned and based on sequence divergence the A8 (KJ482247.1) and G10P5 
(AB972862.1) isolates were selected to perform Y-2-H analysis (Figure 10). Their 
respective nucleotide sequences were ordered from GeneART/Thermo Fisher. 
Plasmids encoding NSP1 sequences were amplified and inserted corresponding to 
NSP1 sub-cloned into the MCS of the “bait” plasmid pGBKT7 plasmid using NdeI and 
BamHI restrictions sites. Digestion analysis and sequencing confirmed the presence 
of the NSP1 genes in frame within the sequence of pGBKT7 yeast plasmid. 
 
Figure 10. Phylogenetic tree derived from the amino acid alignment of NSP1 proteins from 
porcine rotavirus isolates. 
The amino acid sequences of four NSP1 proteins were aligned and two strains were selected based 
on divergence. Arrows indicate the two porcine NSP1 that were chosen for use in Y-2-H analysis 
 
Analysis of the NSP1 amino acid sequence of the porcine G10P5 RV isolate 
revealed the absence of seven N- terminal amino acids present in the other porcine 
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RV isolate (A8) and all three human RV isolates (1M0, 18A and TC). In order to 
evaluate whether these seven amino acids could influence the interaction of G10P5 
NSP1 protein with “prey” proteins, the respective nucleotide sequence present in 
porcine A8 and human 1M0, 18A and TC NSP1 was inserted into the previously 
generated pGBKT7/G10P5 plasmid using a site-direct mutagenesis kit (Figure 11, 
Panel A). Sequence analysis confirmed the insertion of these additional nucleotides 
into the porcine NSP1 G10P5 open reading frame (ORF) (Figure 11, Panel B). This new 
“bait” plasmid was termed pGBKT7/G10P5extra and its encoded protein G10P5extra. 
 
 
Figure 11. Insertion of seven amino acids into the N-terminus of the porcine NSP1 G10P5. 
(A) Strategy used to insert seven amino acids using a Site-Directed Mutagenesis Kit. The Fw primer 
annealed within the yeast plasmid pGBKT7 (blue) and extended into the coding sequence of G10P5 
(green). The nucleotide sequence encoding the seven extra amino acids was inserted (red) 
immediately downstream of the translation initiation start codon. (B) Alignment of the NSP1 N-
terminal nucleotide sequences of porcine G10P5 and A8 RV isolates and the G10P5 isolate containing 
seven additional N-terminal amino acids (MKSLVEA) shown in yellow. The start codon (ATG) is 
highlighted in green. 
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3.1.2 Construction of “prey” pGADT7 plasmids encoding human β-TrCP, human IRF-3 
and porcine IRF-3 
A number of “prey” pGADT7 plasmids were kindly provided by Steve 
Goodbourn (St. George’s, University of London), including bovine-IRF-3 (bIRF-3), 
human IRF-7 (hIRF-7), human-MAVS (hMAVS), human-TBK1 (hTBK-1), human-RIG-I 
(hRIG-I) and human MDA5 (hMDA5). The “prey” plasmid pGADT7, encoding the 
sequence for green monkey (Cercopithecus aethiops) IRF-3 (mIRF-3), was a gift from 
Professor Michelle Hardy (Washington State University). 
Given the essential role of β-TrCP in the establishment of the host innate 
immune response, it is not surprising that some viruses have evolved strategies to 
counteract its activity (Bour et al., 2001; Mansur et al., 2013; Tang et al., 2003). β-
TrCP has been shown to be targeted for degradation by NSP1 proteins derived from 
the porcine OSU, the bovine NCDV and the human D, DS-1, Ku, P and Wa RV strains 
(Di Fiore et al., 2015; Graff et al., 2009). In order to determine if in a Y-2-H system β-
TrCP interacts with NSP1 proteins encoded by RV isolates from different species, its 
cDNA was amplified from pCNV5_ β-TrCP (Table 7) and cloned into the MCS of the 
yeast “prey” plasmid pGADT7. Restriction digestion analysis and sequencing 
confirmed the presence of the β-TrCP gene and regeneration of the ligation 
junctions. 
In order to include the human IRF-3 (hIRF-3) and the porcine IRF-3 (pIRF-3) in 
the panel of host proteins screened against RV NSP1, the nucleotide sequences of 
the 2 transcriptional factors were sub-cloned in to the yeast “prey” plasmid pGADT7. 
The sequence encoding hIRF-3 was amplified from pEF-flag-hIRF3 (Steve Goodbourn, 
St. George’s, University of London) (Table 7) and inserted into the MCS of pGADT7. 
Restriction digestion analysis and sequencing confirmed the presence of the hIRF-3 
gene and regeneration of the ligation junctions (Figure 12, Panel A). The nucleotide 
sequences encoding pIRF-3 (NM_213770.1) was ordered from GeneART/Thermo 
Fisher Scientific. The sequence ordered included the following silent substitutions: 
21G>A and 683G>A. These two silent mutations were inserted to remove BamHI 
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restrictions sites present in the original coding sequence. GeneART containing pIRF-
3 was PCR amplified, and inserted into the “prey” pGADT7 plasmid using NdeI and 
BamHI restriction sites. Restriction digestion analysis and sequencing confirmed the 




Figure 12. Construction of "prey" pGADT7 plasmids encoding human IRF-3 (hIRF-3) and porcine 
IRF-3 (pIRF-3). 
(A) Sequencing alignment of the hIRf-3 cloned in pGADT7 and the reference sequence. The ATG is 
represented in green. Underlined the EcoRI cloning site to insert the hIRF-3 cDNA in the MCS of 
pGADT7. (B) Sequencing analysis of the pIRF-3 cloned in pGADT7. The ATG is represented in green. 
Underlined the NdeI cloning site to insert the hIRF-3 cDNA in the MCS of pGADT7. Here shown the 
first 100 nucleotides. 
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3.2 Y-2-H interactions between components of the IFN induction pathway and 
RV NSP1 proteins. 
Before analysing putative interactions occurring between a panel of NSP1 (1 
3.1.1) and proteins involved in the host innate immune response (3.1.2), preliminary 
experiments were performed in order to check for auto-activation of the GAL4 
reporter promoter in the Y-2-H system. NSP1 “baits” were tested for self-activation 
when expressed alone or when co-transfected with the empty “prey” vector 
(pGADT7- expressing only the GAL4 activation domain). The reciprocal controls were 
performed to check for auto-activation by IFN components: “prey” plasmids were 
tested against the empty “bait” protein (pGBKT7- expressing only the GAL4 binding 
domain) and for self-activation when expressed alone. These experiments revealed 
that the porcine NSP1 A8 was able to self-activate the system, being able to grow on 
selective media when transfected alone or co-transfected in yeast with an empty 
“prey” plasmid (Figure 13, Panel A). The hIRF-7 was also shown to self-activate the 
system, generating yeast colonies on selective plates when co-transfected with an 
empty “bait” plasmid or transfected alone (Figure 13, Panel B). For this reason, IRF-7 
was excluded from further investigation involving the Y-2-H. Transformation of 
competent yeast with the porcine A8 was included in the Y-2-H screen as an 
additional positive control. 
 
 




Figure 13. Human IRF-7 and the porcine A8 NSP1 self-activate the Y-2-H system. 
Competent yeast were co-transformed as follows: (A) porcine NSP1 A8 together with an empty 
pGADT7 plasmid or alone, (B) human IRF-7 with an empty pGBKT7 plasmid or alone or (C) monkey 
IRF-3 with an empty pGBKT7 plasmid or alone and plated on DDO media. Once colonies had 
reached sufficient size (~5-7days), 5 were re-streaked from the original DDO media onto fresh QDO 
media (here reported). In the absence of an interaction between prey and bait proteins, yeast 
growth on selective quadruple dropout (QDO) media indicates the ability of a protein to self-
activate the Y-2-H system (A and B). The inability of the mIRF-3 (C) to grow on QDO in absence the 
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3.2.1 Y-2-H analysis between components of the IFN induction pathway and NSP1 
proteins from bovine (UKtc) and rhesus (RRV) RV isolates 
Once self-activating controls had been performed, the interactions occurring 
between NSP1 encoded by RV infecting cattle and monkeys and proteins involved in 
the IFN induction pathway were investigated. 
“Bait” plasmids expressing either rhesus (RRV) or bovine (UKtc) NSP1 were 
individually co-transformed into competent AH109 yeast cells with a “prey” plasmid 
expressing either bovine-IRF-3 (bIRF-3), monkey IRF-3 (mIRF-3), human-MAVS 
(hMAVS), human-TBK1 (hTBK1), human-RIG-I (hRIG-I), human β-TrCP (hβ-TrCP) or 
human MDA5 (hMDA5). Following transformation, the yeast were plated on the 
appropriate selective media: double drop-out ((DDO) -Leu,-Trp) to confirm the 
correct co-expression of both plasmids in a single yeast cell, and quadruple drop-out 
((QDO) -Leu, -Trp, -Ade, -His) to identify a putative interaction between encoded 
proteins. 
The results of this assay are shown in Figure 14. Competent yeast were 
successfully co-transformed with the “bait” and “prey“ plasmids (Figure 14, Panel A). 
The co-expression of bovine NSP1 UKtc with either bIRF-3 or mIRF-3 resulted in the 
growth of colonies on QDO media (Figure 14, Panel B), suggesting the proteins were 
interacting. No interaction was observed between bovine NSP1 and hMAVS, hTBK1, 
hRIG-I, hβ-TrCP or h-MDA5. Co-transformation of rhesus NSP1 RRV with any of the 
individual “prey” proteins did not result in growth on QDP plates (Figure 14, Panel B), 
suggesting no interactions occurred. 
The ability of yeast colonies to grow on QDO plates when co-transformed with 
a “bait” plasmid pGBKT7-53 and a “prey” plasmid pGADT7-T confirmed 
transformation was successful. Co-transformation of competent yeast with a “bait” 
plasmid pGBKT7-Lam and a “prey” plasmid pGADT7-T was used as negative control.  
 
 




Figure 14. Y-2-H screening between rhesus (RRV) or bovine (UKtc) NSP1 and proteins of the IFN 
induction pathway, (bIRF-3, mIRF-3, hMAVS, hTBK1, hRIG-I, hBTrCP or hMDA5). 
Aliquots of transformed yeast were plated on DDO (-Leu,-Trp) selective media. Once colonies had 
reached sufficient size (~5-7days), 5 colonies were re-streaked from the original DDO media onto 
fresh DDO media (-Leu,-Trp) (panel A) as well as QDO media (-Leu, -Trp, -Ade, -His) (panel B). The 
ability of yeast to grow on DDO selective media indicated that both the “bait” and the “prey” 
plasmids had been successfully co-transformed into a single yeast cell. The ability of yeast to grow 
on QDO plates indicated that the proteins encoded by the yeast-expression plasmids interacted. 
Co-transfection of vectors pGBKT7-53 with pGADT7-T and pGBKT7-Lam with pGADT7-T were used 
as positive and negative controls, respectively. Each single colony is representative of 5 colonies.  
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3.2.2 Y-2-H analysis between components of the IFN induction pathway and NSP1 
proteins from porcine RV isolates: G10P5 and A8 
Y-2-H analyses were then performed to determine if the NSP1 proteins from 
three porcine RV isolates (G10P5, G10P5extra and A8) interact with proteins involved 
in the interferon induction pathway. In order to do this, previously generated “bait” 
plasmids encoding the sequences for NSP1 G10P5, G10P5 and NSP1 A8 (0) were 
screened against “prey” plasmids expressing either bIRF-3, mIRF-3, hMAVS, hTBK1, 
hRIG-I, hβ-TrCP or hMDA5. Competent yeast cells were co-transformed with a “bait” 
and a “prey” plasmid expressing components of the IFN induction pathway as 
previously described (3.2.1). 
 Figure 15 shows the results of the Y-2-H assays between the two porcine RV 
isolates, G10P5 and A8 and components of the IFN induction pathway. The ability of 
yeast to grow on DDO plates (-Leu, -Trp), confirmed that cells were successfully 
transformed (Figure 15, Panels A). The co-expression of porcine NSP1 G10P5 with 
mIRF-3 resulted in growth on QDO media, indicating that a putative interaction 
occurred. Y-2-H analyses involving the “bait” porcine G10P5 NSP1 and “prey” human 
RIG-I, β-TrCP, MAVS, TBK1 and bIRF-3 proteins did not result in growth on QDO 
media, suggesting no interactions occurred. The growth of yeast colonies co-
expressing G10P5 and MDA5 suggested a possible interaction occurred, however 
these colonies took longer to growth on QDO media compared to the other positive 
interactions, suggesting a possible weaker interaction.  
Previous control experiments have shown the ability of the “bait” porcine A8 
NSP1 to self-activate the expression of the reporter genes in absence of a true 
interaction (false positive) (Figure 13, Panel A). Co-transformation of competent 
yeast with porcine A8 and any on the “prey” plasmid was used as a further positive 
control (Figure 13, Panel B). In order to increase the stringency levels of Y-2-H 
screening involving the porcine A8 and to further corroborate its ability to self-
activate the system, QDO media was administered with 3-Amino-1,2,4-triazole (3-
AT) (Figure 15, Panel C) .3-AT is a competitive inhibitor of the imidazole-
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glycerolphosphate dehydratase (HIS3) gene product (Durfee et al., 1993) and yeast 
are capable of growing only if the production of histidine overcomes its inhibitory 
effect. Higher level of gene expression can be achieved only under the transcription 
of a full transcriptional factor, thus, the inability of yeast to grow on media containing 
3-AT indicated that yeast contained only the DNA BD carried by pGBK7. 
To determine if the additional 7 amino acids present in the N-terminus of 
G10P5extra NSP1 (0) could alter the interaction profile of the G10P5 NSP1 protein, 
Y-2-H screening was carried out using porcine G10P5extra NSP1 and the previously 
used components of the IFN induction pathway. Figure 16 shows that the insertion 
of the extra amino acids at the N-terminus of G10P5 did not alter the proteins binding 
profile to the “prey” proteins, and the only observable interaction was with mIRF-3 
(Figure 15).  
 




Figure 15. Y-2-H screening between the porcine G10P5 or A8 NSP1 proteins and components of 
the IFN induction pathway (bIRF-3, mIRF-3, hRIG-I, hBTrCP, hMAVS, hTBK1 or hMDA5. 
Aliquots of transformed yeast were plated on DDO (-Leu,-Trp) selective media. Once colonies had 
reached sufficient size (~5-7days), 5 colonies were re-streaked from the original DDO media onto 
fresh DDO media (-Leu,-Trp) (panel A) as well as QDO media (-Leu, -Trp, -Ade, -His) (panel B). The 
ability of yeast to grow on DDO selective media indicated that both the “bait” and the “prey” 
plasmids had been successfully co-transformed into a single yeast cell. The ability of yeast to grow 
on QDO plates indicated that the proteins encoded by the yeast-expression plasmids interacted. 
(C) Yeast colonies re-streaked from QDO media onto QDO media supplemented with 60 mM or 100 
mM 3AT. Co-transfection of vectors pGBKT7-53 with pGADT7-T and pGBKT7-Lam with pGADT7-T 










Figure 16. Y-2-H screening between the porcine G10P5extra NSP1 protein and components of the 
IFN induction pathway (bIRF-3, mIRF-3, hRIG-I, hBTrCP, hMAVS, hTBK1 or hMDA5. 
Aliquots of transformed yeast were plated on DDO (-Leu,-Trp) selective media. Once colonies had 
reached sufficient size (~5-7days), 5 colonies were re-streaked from the original DDO media onto 
fresh DDO media (-Leu,-Trp) (panel A) as well as QDO media (-Leu, -Trp, -Ade, -His) (panel B). The 
ability of yeast to grow on DDO selective media indicated that both the “bait” and the “prey” 
plasmids had been successfully co-transformed into a single yeast cell. The ability of yeast to grow 
on QDO plates indicated that the proteins encoded by the yeast-expression plasmids interacted. 
Each single colony is representative of 5 colonies. The vectors pGBKT7-53 plus pGADT7-T and 
pGBKT7-Lam plus pGADT7-T were used as positive and negative controls, respectively. 
The porcine NSP1 G10P5extra was constructed by inserting the nucleotide sequence encoding for 
the seven amino acids (METKSLVEA) at the 5- end of the porcine NSP1 G10P5. This sequence is 
present in the porcine NSP1 A8 and in the human 1M0, TC and 18A used in this study. 
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3.2.3 Y-2-H analysis between hIRF-3 and NSP1 proteins from porcine (G10P5, A8), 
bovine (UKtc) and rhesus (RRV) RV isolates 
Having established that the bovine and monkey IRF-3 were cellular partners 
of NSP1 (3.2.1, 3.2.2), the next step was to evaluate whether the cross-species ability 
of RV to subvert host innate immunity was due to the ability of NSP1 to target IRF-3. 
The initial Y-2-H assays established that the NSP1 proteins encoded by RV 
infecting cattle and monkeys interacted with the monkey IRF-3 and/or the bovine 
IRF-3. To extend these observations, the ability of rhesus (RRV), bovine (UKtc) and 
porcine (G10P5, G10P5extra and A8) NSP1 proteins to interact with hIRF-3 and pIRF-
3 (3.1.2) was investigated. Yeast were successfully co-transformed with a plasmid 
encoding hIRF-3 and either porcine (G10P5, G10P5extra and A8) bovine (UKtc), or 
rhesus (RRV) NSP1 (Figure 17, panel A). The co-expression of hIRF-3 with the porcine 
NSP1s G10P5 and G10P5 extra and the bovine UKtc NSP1 resulted in growth on QDO 
plates. The ability of the porcine A8 to self-activate the Y-2-H reporter compromised 
the possibility to assess whether a real interaction with hIRF-3 was taking place. 
Nevertheless, the data implies an interaction between porcine (G10P5) or bovine 
(UKtc) NSP1s with hIRF-3. The growth on QDO of yeast co-transfected with the hIRF-
3 and G10P5extra agreed with previous results (3.2.2, Figure 16) showing that the 
extra amino acid sequence had no effect on the binding activity of NSP1. No 
interaction was observed between the rhesus NSP1 protein and hIRF-3, as judged by 
a lack of yeast growth on QDO. 
 
 




Figure 17. Y-2-H screening between porcine G10P5, G10P5extra, A8, rhesus RRV and bovine UKtc 
NSP1s and hIRF-3. 
Aliquots of transformed yeast were plated on DDO (-Leu,-Trp) selective media. Once colonies had 
reached sufficient size (~5-7days), 5 colonies were re-streaked from the original DDO media onto 
fresh DDO media (-Leu,-Trp) (panel A) as well as QDO media (-Leu, -Trp, -Ade, -His) (panel B). The 
ability of yeast to grow on DDO selective media indicated that both the “bait” and the “prey” 
plasmids had been successfully co-transformed into a single yeast cell. The ability of yeast to grow 
on QDO plates indicated that the proteins encoded by the yeast-expression plasmids interacted. 
Each single colony is representative of 5 colonies. The vectors pGBKT7-53 plus pGADT7-T and 
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3.2.4 Y-2-H analysis between pIRF-3 and NSP1 proteins from porcine (G10P5, A8), 
bovine (UKtc) and rhesus (RRV) RV isolates. 
Yeast were successfully co-transformed with a plasmid encoding pIRF-3 and 
either a porcine (G10P5, G10P5extra, or A8) bovine (UKtc), or rhesus (RRV) NSP1 
(Figure 18, panel A). The co-expression of pIRF-3 with the porcine G10P5 or the 
bovine UKtc resulted in growth on QDO plates, indicating potential interactions. No 
interaction was observed between the rhesus NSP1 protein and hIRF-3, as judged by 
a lack of yeast growth on QDO. The ability of the porcine A8 to self-activate the Y-2-
H reporter compromised the possibility to assess whether a real interaction with 









Figure 18. Y-2-H screening between porcine G10P5 and A8, rhesus RRV and bovine UKtc NSP1s 
and pIRF-3. 
Aliquots of transformed yeast were plated on DDO (-Leu,-Trp) selective media. Once colonies had 
reached sufficient size (~5-7days), 5 colonies were re-streaked from the original DDO media onto fresh 
DDO media (-Leu,-Trp) (panel A) as well as QDO media (-Leu, -Trp, -Ade, -His) (panel B). The ability of 
yeast to grow on DDO selective media indicated that both the “bait” and the “prey” plasmids had been 
successfully co-transformed into a single yeast cell. The ability of yeast to grow on QDO plates 
indicated that the proteins encoded by the yeast-expression plasmids interacted. Each single colony 
is representative of 5 colonies. The vectors pGBKT7-53 plus pGADT7-T and pGBKT7-Lam plus pGADT7-
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3.2.5 Y-2-H analysis between components of the IFN induction pathway and NSP1 
proteins from human RV isolates: 18A, 1M0 and TC 
Y-2-H analyses were performed to determine if the NSP1 proteins from three 
human RV isolates (1M0, 18A and TC) interacted with proteins involved in the 
interferon induction pathway. Previously generated “bait” plasmids encoding the 
human NSP1 (0) were screened against “prey” plasmids expressing components of 
the IFN induction pathway. The ability of yeast colonies to grow on DDO media 
confirmed the competent yeast cells had been successfully co-transformed with 
“bait” and “prey” (Figure 19, panel A). However, the inability of yeast colonies to 

















Figure 19. Y-2-H screening between human NSP1 (1M0, 18A and TC) and proteins of the IFN 
induction pathway, (bIRF-3, mIRF-3, hMAVS, hTBK1, hRIG-I, hBTrCP or hMDA5). 
Aliquots of transformed yeast were plated on DDO (-Leu,-Trp) selective media. Once colonies had 
reached sufficient size (~5-7days), 5 colonies were re-streaked from the original DDO media onto 
fresh DDO media (-Leu,-Trp) (panel A) as well as QDO media (-Leu, -Trp, -Ade, -His) (panel B). The 
ability of yeast to grow on DDO selective media indicated that both the “bait” and the “prey” 
plasmids had been successfully co-transformed into a single yeast cell. The ability of yeast to grow 
on QDO plates indicated that the proteins encoded by the yeast-expression plasmids interacted. 
Each single colony is representative of 5 colonies. The vectors pGBKT7-53 plus pGADT7-T and 
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Further Y-2-H assays were performed to establish if the above mentioned 
panel of IRF-3 proteins (hIRF-3, pIRF-3, bIRF-3 and mIRF-3) could interact with the 
NSP1 proteins encoded by the three human RV isolates, 1M0, 18AA and TC. 
Competent cells were co-transformed with a “bait” plasmid expressing a single 
human NSP1 protein and a “prey” plasmid expressing either the human, porcine, 
bovine or monkey IRF-3. The ability of yeast colonies to grow on DDO media 
confirmed the competent yeast cells had been successfully co-transformed with 
“bait” and “prey” plasmids (Figure 20, panel A). However, the inability of yeast 
colonies to grow on QDP plates (Figure 20, panel B), suggested that no strong 
interactions were occurring between the human NSP1 and IRF-3s. 
 
 




Figure 20. Y-2-H screening between human NSP1 (1M0, 18A or TC) and hIRF-3, pIRF-3, bIRF-3 and 
mIRF-3. 
Aliquots of transformed yeast were plated on DDO (-Leu,-Trp) selective media. Once colonies had 
reached sufficient size (~5-7days), 5 colonies were re-streaked from the original DDO media onto 
fresh DDO media (-Leu,-Trp) (panel A) as well as QDO media (-Leu, -Trp, -Ade, -His) (panel B). The 
ability of yeast to grow on DDO selective media indicated that both the “bait” and the “prey” 
plasmids had been successfully co-transformed into a single yeast cell. The ability of yeast to grow 
on QDO plates indicated that the proteins encoded by the yeast-expression plasmids interacted. 
Each single colony is representative of 5 colonies. The vectors pGBKT7-53 plus pGADT7-T and 




   
121 
 
The Y-2-H screen indicated that no strong interactions were occurring 
between the NSP1 proteins from different human RV isolates and human, porcine, 
bovine or monkey IRF-3. In order to investigate whether these NSP1 transiently or 
weakly interact with IRF-3, the assays were repeated at a lower-stringency. As 
previously described, yeast were co-transformed with plasmids encoding one of the 
human NSP1 proteins and either the human, porcine, bovine or monkey IRF-3, and 
then plated on DDO media. Once colonies of sufficient size had grown (~5-7 days), 
yeast were re-streaked on lower-stringency media deficient for three instead of the 
possible four amino acids; triple drop out (TDO), -Leu,-Try,-Ade (-L,-W,-A) or TDO -
Leu,-Try,-His (-L,-W,-H) (Figure 21). 
The growth of yeast colonies on TDO plates co-expressing the human NSP1 
1M0 or TC and the bIRF-3 (Figure 21 Panel A and B) suggested that a weak interaction 
did indeed occur. 1M0 also appeared to weakly interact with the hIRF-3 (Figure 21 
Panel A) and the pIRF-3 proteins, while TC interacted weakly with the mIRF-3 (Figure 
21 Panel B). The screening of the human 18A on plates with lower stringency did not 
result in growth of yeast colonies, suggesting that it does not interact with IRF-3 in 
the Y-2-H system. 
 
 




Figure 21. Y-2-H screening between human NSP1 (1M0, 18A or TC) and hIRF-3, pIRF-3, bIRF-3 and 
mIRF-3. 
Aliquots of transformed yeast were plated on DDO (-Leu,-Trp) selective media. Once colonies had 
reached sufficient size (~5-7days), 5 colonies were re-streaked from the original DDO media onto 
fresh TDO media, (A) “-L, -W, A” (-Leu,-Try, - Ade), (B) -L, -W, -H (-Leu, -Try, -His). The ability of yeast 
colonies to grow on TFO media indicated a weaker and/or a transient interaction was occurring. 
Each single colony is representative of 5 colonies. The vectors pGBKT7-53 plus pGADT7-T and 
pGBKT7-Lam plus pGADT7-T were used as positive and negative controls, respectively. 
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3.3 Summary of Y-2-H interactions 
Results obtained in this chapter have shown how NSP1 encoded by different 
RV is able to target IRF-3 in a strain-specific manner. Interactions with the IRF-3 
encoded by different mammal species varied not only in terms of the relationship 
occurring between the host and the virus representing the scenario of a possible 
homologous or heterologous infection, but even in terms of the potency of the 
interactions. Y-2-H assay revealed that strong or weak interactions were occurring on 
species-specificity fashion. 
Table 11 shows a summary of the interactions that occurred between the 
various NSP1 and IRF-3 proteins. The bovine-derived NSP1 (UKtc) showed a more 
promiscuous activity, being able to strongly interact with IRF-3 encoded by each of 
the mammalian species tested. By contrast, the rhesus RRV was not able to interact 
with any of the IRF-3 proteins in the Y-2-H system. The NSP1 G10P5, derived from RV 
infecting pigs, was able to bind to the homologous IRF-3 and the one encoded by 
monkeys. The G10P5extra, that carried the extra amino acid sequence at its N-
terminus, showed no differences in binding affinity compared to the parental G10P5 
NSP1. The other swine-derived NSP1, A8, self-activated the system, therefore an 
interaction with IRF-3 could not be assessed. Preliminary experiments involving the 
human-derived NSP1 reported no interactions with any IRF-3 occurred. However, 
lower stringency screening revealed that 1M0 weakly interacted with the human, 
bovine and porcine IRF-3, whereas TC NSP1 showed a weak interaction with only the 
monkey and bovine derived IRF-3 and 18A NSP1 did not interact with any of the IRF-
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Table 11.Summary of interactions occurring between NSP1 and IRF-3 using a Y-2-H assay. 
“Preys” Human IRF-3 Rhesus IRF-3 Bovine IRF-3 Porcine IRF-3  
“Baits”     Stringency levels 
Human NSP1 1M0 
x x x x QDO 
+ x + + TDO 
Human NSP1 TC 
x x x x QDO 
x + + x TDO 
Human NSP1 18A 
x x x x QDO 
x x x x TDO 
Porcine NSP1 G10P5 ++ ++ x ++ QDO 
Porcine NSP1 G10P5extra ++ ++ ++ ND QDO 
Porcine NSP1 A8 ND ND ND ND QDO 
Bovine NSP1 UKtc ++ ++ ++ ++ QDO 
Rhesus NSP1 RRV x x x x QDO 
Summary of interactions occurring between NSP1 proteins from virus infecting human, pigs, cattle 
and monkey and the IRF-3s encoded by the same species. Screening involving human NSP1 were 
further classified based on stringency levels: QDO (quadruple dropout) media  (-Leu, -Trp, -Ade, -His) 
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4 NSP1 shows strain-dependent expression level 
Purpose 
This chapter describes experiments performed in order to construct a panel 
of eukaryotic expression plasmids encoding the sequences for RV NSP1. A series of 
different experimental approaches confirmed an efficient expression of NSP1, 
however, a strain-specificity was observed. The employment of a series of tags 
together with the enhancement of transcription through Modified Vaccinia Ankara 
(MVA) infection allowed detection of NSP1, however contrasting results were 
obtained based on the strain origin. Overall data present in this chapter confirmed 
the ability to express a full length NSP1. This allowed the investigation of plasmid-
encoded NSP1 on the downregulation of host innate immunity discussed in the 
following chapter. 
Introduction 
Following infection of target host cells, NSP1 is one of the less abundant non-
structural proteins expressed by rotavirus (Johnson et al., 1989; Mitzel et al., 2003). 
Studies about the function and the role of the protein have been hampered by its 
poor expression level in infected cells: the protein is usually undetectable or barely 
detectable by metabolic labelling of rotavirus-infected cells, representing less than 
0.1% of the total protein, with a half-life of 45 min (Johnson et al., 1989; Mitzel et al., 
2003). The stability of NSP1 seems to be related to the presence of other rotavirus 
proteins and it appeared further reduced when expressed on its own due to an 
increase in susceptibility to proteasome-mediated degradation. By contrast, the 
simultaneous expression of either other viral proteins or viral mRNA appears to 
increase NSP1 stability (Brottier et al., 1992; Hua et al., 1994). Given the low 
expression of NSP1 and its short half-life, it was important to confirm its expression 
before investigating the downregulation of the host innate immunity. 
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4.1 Expression of NSP1 in mammalian cell lines 
Preliminary experiments were performed in order to characterize the 
expression levels and stability of plasmid-encoded NSP1 by Western blot analysis. In 
order to do this, NSP1 constructs were first prepared by sub-cloning the respective 
NSP1 ORFs from plasmids used for the Y-2-H assays into mammalian expressing 
plasmids. The NSP1 sequences from human (18A, 1M0,TC), pig (G10P5, A8), bovine 
(UKtc) and rhesus (RRV) rotavirus isolates were amplified from the respective “bait” 
pGBKT7 plasmids with GoTaq® Long PCR Master Mix and ”TA-cloned” into the 
mammalian expressing plasmid pcDNA3.1/V5-His-TOPO®. 
 Due to the lack of commercial antibodies against NSP1, and to optimize 
potential detection of an epitope tagged NSP1 two further approaches were used. A 
similar set of plasmids were constructed with either the HIS epitope tag or an HA 
epitope tag (YPYDVPDYA) inserted 5’ to the NSP1 ORFs. PCR amplification was carried 
out using the pcDNA3.1/NSP1 plasmids generated above as templates (3.1) and 
primers that included the HIS-tag or the HA-tag sequences (Table 7). PCR products 
were then “TA-cloned” into pcDNA3.1/V5-His-TOPO®. Sequencing analysis 
confirmed the HIS-tag or the HA-tag were in frame with the respective ORF of each 
NSP1. 
In preliminary experiments, HEK293 cells were transfected with plasmids 
encoding HIS-tagged or HA-tagged NSP1 proteins and at 16h post transfection whole 
cell lysates were prepared and analysed by Western blot. However, neither HIS- or 
HA-tagged NSP1 proteins could be detected with the respective antibodies. 
In the following experiments, a number of strategies were employed in an 
attempt to enhance the expression levels of plasmid-encoded NSP1 proteins. First, 
the BSRT-7/5 cell line was used; this is a BHK-derived cell line that constitutively 
expresses the bacteriophage T7 RNA polymerase (Buchholz et al., 1999), facilitating 
higher levels of protein expression from plasmids that contain the T7 promoter. 
Second, cells were infected with modified vaccinia virus Ankara (MVA-T7), an 
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attenuated vaccinia strain that also encodes the T7 polymerase (Sutter et al., 1995). 
Third, the proteasome inhibitor MG132 (12h treatment at 25 µM) was used to reduce 
proteasome-mediated degradation of NSP1, which has been reported to be the main 
route of degradation for the viral protein (Pina-Vazquez et al., 2007). 
BSRT-7/5 cells were seeded in 6-well plates at a density of 3 x 105 cells/well 
and grown until 90% confluent. Prior to transfection, cells were first infected with 
MVA-T7, then 3h later transfected with a plasmid encoding the HIS-tagged NSP1 
protein from either the porcine G10P5 or the bovine rotavirus UKtc isolate. Finally, 
the infected transfected cells were treated with MG132. At 16 h post MG132 
treatment, whole cell lysates were prepared and analysed by Western blot for the 
expression of HIS-tagged NSP1 proteins using a monoclonal anti-mouse HIS antibody 
(Figure 1, Panel A and B, lanes 4). Experimental controls included non-transfected 
and transfected cells that received no other treatment (Figure 22, Panel A and B, 
lanes 3 and 7), or were also either infected with MVA-T7 (Figure 22, Panel A and B, 
lanes 1 and 5) or treated with MG132 (Figure 22, Panel A and B, lanes 2 and 6).  
In the absence of MVA-T7 infection and/or MG132 treatment NSP1 protein 
could not be detected in the whole cell lysate samples prepared from transfected 
cells (Figure 22, Panels A and B, lanes 7). NSP1 levels were not detectable in samples 
prepared from transfected cells treated with MG132, suggesting proteasome 
inhibition does not influence NSP1 expression (Figure 22, Panels A and B, lanes 6). In 
contrast, infection of BSRT-7 cells with MVA-T7 resulted in the detection of HIS-
tagged NSP1 proteins (Figure 22, Panels A and B, lanes 5). However, NSP1 was 
undetectable if cells were treated with MG132 following MVA-T7 infection (Figure 
22, Panels A and B, lanes 4). Similar transfection and Western blot experiments were 
carried out using the other plasmids encoding HIS-tagged human (18A, 1M0, TC), 
porcine (A8) or rhesus (RRV) NSP1, however, even with MG132 treatment or MVA-
T7 infection, these proteins could not be observed by Western blot analysis (data not 
shown).  




Figure 22. Western blot analysis of HIS- NSP1 expression in BSRT-7/5 cells. 
To investigate plasmid-based expression of the HIS-tagged NSP1 protein from the (A) porcine 
G10P5 rotavirus isolate or (B) the bovine UKtc rotavirus isolate, BSRT-7/5 cells were subjected to 
different treatments in combination with transfection. Cells were infected with MVA-T7 prior to 
transfection and/or treated with MG132 as indicated. Whole cell lysates were prepared and 
analysed by Western Blot using an anti-HIS antibody. Blots were then re-probed for γ-tubulin as a 
loading control. The highest level of NSP1 expression was observed in transfected cells that had 
been infected with MVA-T7.  
The predicted molecular weight of the HIS-tagged NSP1 protein is ~54 kDa. The asterisk indicates a 
non-specific protein that is cross-reactive with the anti-HIS antibody. 
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Due to the inability to detect HIS-tagged NSP1 in the absence of MVA-T7 
infection and the high background observed when using the HIS antibody, the 
expression and detection of HA-tagged NSP1 proteins was next investigated. As 
before, BSRT-7/5 cells were first infected with MVA-T7, then 3h later transfected with 
a plasmid encoding the HA-tagged NSP1 protein from either the porcine G10P5 or 
the bovine UKtc rotavirus isolate. Finally, the infected transfected cells were treated 
with MG132. At 16 h post transfection, whole cell lysates were prepared and 
analysed by Western blot for the expression of HA-tagged NSP1 proteins using a 
mouse monoclonal anti- HA antibody. Experimental controls included non-
transfected and transfected cells that received no other treatment (Figure 23, Panels 
A and B, lanes 3 and 8) or were also either infected with MVA-T7 (Figure 23, Panels 
A and B, lanes 1 and 6) or treated with MG132 (Figure 23, Panels A and B, lanes 2 and 
7). An additional control consisted of non-transfected cells that were both infected 
with MVA-T7 and treated with MG132 (Figure 23, Panel A and B, lanes 4 and 5).  
In contrast to the results obtained using the His-tagged NSP1 constructs 
(Figure 22), the stability of HA-tagged NSP1 increased when cells were treated with 
the proteasome inhibitor MG132 and the expression levels of the viral protein were 
further enhanced in presence of the T7 RNA polymerase encoded by MVA-T7.  
 
 




Figure 23. Western blot analysis of HA-NSP1 expression in BSRT-7/5 cell lines. 
To investigate plasmid-based expression of the HA-tagged NSP1 protein from the (A) porcine G10P5 
rotavirus isolate or (B) the bovine UKtc rotavirus isolate, BSRT-7/5 cells were subjected to different 
treatments in combination with transfection. Cells were infected with MVA-T7 and/or treated with 
MG132 as indicated. Whole cell lysates were prepared and analysed by Western Blot using an anti-
HA antibody. Blots were then re-probed for γ-tubulin as a loading control. The highest level of NSP1 
expression was observed in transfected cells that had been infected with MVA-T7 and treated with 
the proteasome inhibitor MG132. 
The predicted molecular weight of the HA-tagged NSP1 proteins is ~54 kDa.  
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Additional transfections were carried out to investigate the respective 
expression levels of the HA-tagged NSP1 proteins from rhesus (RRV), porcine (A8) 
and human (1MO and 18A) rotavirus isolates (Figure 24). A high level of expression 
of the HA-tagged Rhesus (RRV) NSP1 protein was observed even when cells were not 
infected with MVA-T7 or treated with MG132 (Figure 24, Lane 1). Interestingly, both 
MVA-T7 infection and MG132 treatment led to a comparative reduction in NSP1 
protein levels (Figure 24, Lanes 6 and 7). The observed decrease in RRV protein levels 
in presence of MVA infection could be explained with the downregulation of gene 
expression by the Vaccinia Virus D10 Protein (Shors et al., 1999). This effect was only 
observed for the RRV strain, which has a comparatively divergent amino acid 
sequence to all the other NSP1 used in this study (data not shown). Following MVA-
T7 infection and MG132 treatment, expression of the HA-tagged porcine (A8) NSP1 
protein was observed by Western blot analysis (Figure 24, Lane 4). However, the 
expression of NSP1 proteins from human rotavirus isolates (18A, 1M0 and TC) was 
not detectable by Western blot, even after combined MVA-T7 infection and MG132 








Figure 24. Western blot analysis of HA-NSP1 expression in BSRT-7/5 cell lines. 
To investigate plasmid-based expression of the HA-tagged NSP1 protein from the rhesus RRV (1, 6 
and 7), the porcine A8 (4), or the human 18A (2) and 1M0 (3) rotavirus isolates, BSRT-7/5 cells were 
subjected to different treatments in combination with transfection. Cells were infected with MVA-
T7 and/or treated with MG132 as indicated. Whole cell lysates were prepared and analysed by 
Western Blot using an anti-HA antibody. Blots were then re-probed for γ-tubulin as a loading 
control. 
The predicted molecular weight of the HA-tagged NSP1 proteins is ~54 kDa. The asterisk indicates 
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In the above described experiments, an increase in the expression level of 
some NSP1 proteins was observed following inhibition of proteasome-mediated 
degradation by MG132 treatment. To determine if the lack of expression exhibited 
by the remaining NSP1 proteins was due to their ubiquitin-dependent proteasome-
mediated degradation, similar transfection experiments were performed using the 
TS20 cell line. TS20 is a Balb3T3-derived cell line in which ubiquitination is inhibited 
by restrictive temperature (Chowdary et al., 1994). 
TS20 cells were plated at a density of 0.3 x 106 cells/well in 6-well plates and 
transfected with plasmid DNA encoding HA-tagged NSP1 derived from human (18A, 
1M0, TC), porcine (G10P5, A8), bovine (UKtc) or rhesus (RRV) rotavirus isolates. 16 h 
post-transfection, cells were left untreated or treated with proteasome inhibitor 
(MG132, 25 µM) and incubated overnight at permissive (34°C) or non-permissive 
(39°C) temperature. Whole cell lysates were then prepared and analysed by Western 
blot for the HA epitope tag as an indication of NSP1 expression (Figure 25).  
The expression levels of plasmid-encoded NSP1 proteins in the TS20 cell line 
appeared to be higher compared to those reported in BSRT-7/5 (Figure 22, Figure 23 
and Figure 24). However, although bands corresponding to the predicted molecular 
weight (54 kDa) of the HA-tagged NSP1 proteins were observed, other bands of 
slightly smaller size were also present. These bands did not appear to be unspecific, 
as they were absent in lanes corresponding to the mock-transfected cells. In all cases, 
the growth of the transfected TS20 cells at the non-permissive temperature of 39°C 
led to a reduction in the expression levels of the putative NSP1 protein bands. 




Figure 25. Western blot analysis of HA-NSP1 expression in TS20 cell lines at permissive and non-
permissive temperatures. 
TS20 cells were transfected with plasmids encoding HA-tagged NSP1 proteins from human (1M0, 
18A or TC), porcine (G10P5 or A8), bovine (UKtc) or rhesus (RRV) rotavirus isolates. 16h post 
transfection, cells were left untreated or treated with the proteasome inhibitor MG132, (25 µM) 
and incubated for a further 16h at 34°C (permissive temperature) or 39°C (non-permissive 
temperature). Whole cell lysates were prepared and analysed by Western blot analysis using an 
anti-HA antibody. Blots were then re-probed for γ-tubulin as a loading control.  
The predicted molecular weight of the HA-tagged NSP1 proteins is ~54 kDa. “+/-“ indicates 
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4.2 Expression of NSP1 in cell-free system 
In order to determine if full length HA-tagged NSP1 proteins from human 
rotavirus isolates (1M0, 18A and TC) could be expressed by the corresponding 
plasmids, the TnT® quick system from Promega was used. This kit provides the 
necessary components for T7 promoter-mediated transcription and subsequent 
translation of 35S-radiolabelled proteins. Figure 26 shows an autoradiograph of the 
TnT® results in which bands corresponding to the expected molecular weight 
(~54kDa) were observed for each NSP1 protein. The employment of a TnT® system 
confirmed the ability to express full length NSP1 proteins derived from RV infecting 
humans.  
 
Figure 26. In vitro transcription/translation assay of human NSP1 18A, 1M0 and TC. 
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4.3 NSP1 shows expression levels based on the strain of origin 
Results obtained in this chapter suggest that RV NSP1 proteins are expressed 
from plasmids in a strain-specific manner. The level of protein expression varied not 
only between NSP1 isolates from different species (human, pigs, cattle and rhesus) 
but also between isolates infecting the same species.  
NSP1 is the least abundant RV non-structural protein and experiments 
involving the bovine strain UKtc have reported that it has an estimated half-life of 45 
min in infected cells (Mitzel et al., 2003). In BSC-1 cells infected with RRV strain, NSP1 
was not detected after 9 hpi and at 12 hpi the protein represented less than 0.1% of 
total protein synthesis (Johnson et al., 1989). Moreover, it has been shown that NSP1 
is much more susceptible to proteasome-mediate degradation if the viral protein is 
expressed on its own, without viral proteins or RNAs (Pina-Vazquez et al., 2007). 
Based on these reports, a number of strategies were employed in this in this study to 
enhance the expression levels and the stability of plasmid-encoded NSP1 proteins. 
Studies involving the bovine UKtc, porcine OSU and the rhesus RRV have used 
a specific polyclonal rabbit antiserum termed C19. The serum was raised against the 
oligopeptide NH2-CGTLTEEFELLISNSEDDNE-COOH, which includes the last 19 amino 
acids of the simian SA 11 NSP1 (previously referred to as the NS53 protein due to its 
molecular weight) (Hua et al., 1994). The C19 antibody has been used for a series of 
experiments to characterize NSP1 (Bagchi et al., 2010; Barro et al., 2007; Ding et al., 
2016; Kearney et al., 2004; Nandi et al., 2014; J. Patton et al., 2009; J. T. Patton, 1995) 
and the employment of specific antibody raised against conserved regions at either 
amino or carboxyl regions of NSP1 has been extensively used (Bagchi, Bhowmick, et 
al., 2013; Bagchi, Nandi, et al., 2013; Bhowmick et al., 2013; Graff et al., 2009; Kanai 
et al., 2017).  
The lack of an antibody for the detection of RV NSP1 required the addition of 
a series of an N-terminal epitope tag. Relatively short epitope tags such as FLAG, 
hemagglutinin (HA), histidine (His) and c-Myc, are used for the detection of fusion 
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proteins in vitro. Their short, linear recognition motifs rarely affect the properties of 
the heterologous protein of interest and are usually very specific for their respective 
primary antibodies. In some cases, the tags may not only ease protein purification 
but also help in protein expression, folding, and/or solubility (Structural Genomics et 
al., 2008). 
 Indeed tagged NSP1 derived from each of the rotavirus strains was detected, 
however, contrasting results in their expression levels were obtained. In BSRT7/5 cell 
lines, His-tagged and HA-tagged NSP1 encoded by RV isolates that infect animals 
appeared to have higher levels of expression compared to isolates that infect 
humans. Compared to the other strains, the rhesus-derived (RRV) NSP1 showed a 
higher level of expression, being detected even in the absence of transcription 
enhancer (MVA infection) or proteasome inhibitor treatment (MG132) (Figure 24, 
lane 3). Low levels of porcine-derived G10P5 and the bovine-derived (UKtc) NSP1 
were detected in untreated cells, however, administration of MG132 or MVA 
infection resulted in increased levels of NSP1 proteins. Synergic effects on the level 
of HA-tagged NSP1 expression were observed when MG132 treatment followed MVA 
infection (Figure 23, Panels A and B, lanes 5, 6 and 7). Treatment of cells with MG132 
appeared to increase the stability of the porcine HA-tagged NSP1 A8 (Figure 24, lane 
4). The attempts to detect the HA-tagged NSP1 from human rotavirus isolates (1M0, 
18A and TC) in transfected BSRT-7/5 were not successful (Figure 24, lanes 2 and 3). 
The simultaneous inability to detect the human-derived NSP1 suggested a common 
molecular mechanism related to low expression levels and/or stability of the human-
derived strains in the cell lines used; full-length plasmid-encoded proteins could only 
be detected using an in-vitro system (Figure 26).  
The His tag does not offer increased expression or solubility levels, due to its 
relatively small size (∼2.5 kDa) in comparison to NSP1 (54kDa) and it was hoped that 
N-terminal fusion would not interfere with the function and structure of the NSP1 
proteins. His6 tag may be attached to the target protein internally, or at either the N- 
or C-terminus, and it has been believed to date that most proteins are functional with 
the tag attached (Uhlen et al., 1992). However, there is an increase in reports 
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indicating this assumption may be wrong (Ledent et al., 1997; Majorek et al., 2014; 
Sabaty et al., 2013). The variation of the length and the position of the tag appear to 
affect the expression and production of protein (A. K. Mohanty et al., 2004). His tags 
may affect the oligomeric states of proteins as well as their function (Araujo et al., 
2000; Majorek et al., 2014; Panek et al., 2013). Significant reductions in the enzymatic 
activity of several different enzymes were observed upon the incorporation of a His-
tag (Araujo et al., 2000; Majorek et al., 2014; Panek et al., 2013). Booth and 
colleagues (Booth et al., 2018) reported the impact of an N-terminal polyhistidine tag 
on protein stability; they analysed the stability and the expression of various 
recombinant proteins when tagged or untagged at different pH and salt 
concentrations. In most cases (65%) the presence of the His tag decreased the 
thermal stability of the protein. When the His-tag epitope was inserted at the C-
terminus of PhoP of Salmonella enterica, the biochemical proprieties of the protein 
were affected, mostly likely as result of conformation changes (Perron-Savard et al., 
2005). Previous work carried out in the Molecular Virology group on the Npro protein 
of Classical Swine Fever Virus (CSFV) has shown that the His tag is not accessible to 
anti-His antibodies and that this is probably caused by folding of the epitope at the 
N-terminus (unpublished data). To exclude the possibility that the His tag was 
affecting expression or detection of NSP1, it was substituted for a HA-tag. 
Contrasting results were obtained when NSP1 was fused at its N-terminus 
with the HA-tag from the influenza virus A, which has been extensively used in 
various experimental contexts of cell biology and biochemistry to track proteins of 
interest within cells, to isolate them and to co-precipitate binding partners (Lapaque 
et al., 2009; Strunk et al., 2011; Zhang et al., 2002). The condition of cell-lines has 
been reported to influence the ability to detect HA-tagged proteins. Schembri and 
colleagues showed that HA-tagged protein levels were drastically reduced in cells 
which were undergoing apoptosis (Schembri et al., 2007). This was due to the 
Caspase-3 and/or Caspase-7 mediated cleavage of the epitope tags from their fused 
proteins. The presence of a N-terminal HA-tag may have influenced the solubility and 
the stability of NSP1, however, the luciferase assay results (5.2) suggest the NSP1 
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proteins were functional and numerous studies have used tagged NSP1 proteins for 
functional assays. 
Other epitopes, such as the Myc (EQKLISEEDL) or FLAG (DYKDDDDK) tags 
could have been used to detect NSP1. The Myc tag has been used to study the 
expression levels of bovine and swine NSP1 (Graff et al., 2007) and the FLAG tag has 
been adopted to characterise the functionality of NSP1 isolates from RV infecting 
human, pigs and monkeys (Di Fiore et al., 2015; Holloway et al., 2009; B. Zhao et al., 
2016). Recently, a Halo-Tag has been used to identify proteins interaction occurring 
between NSP1 and host proteins involved in the ubiquitin-proteasome pathway (Lutz 
et al., 2016). Other work employed a GFP-tag fused to NSP1 to increase the stability 
of porcine (OSU) and simian (SA11) NSP1, facilitating the analysis of the levels and 
localization of the viral protein (Qin et al., 2011). GFP-tag has been used also to study 
by fluorescence microscopy the stability of NSP1 in COS7 murine-derived cell lines. 
Since expression of the HA-tagged NSP1 proteins had been confirmed and HA-tagged 
NSP1 proteins have been used in other functional studies of NSP1, the use of other 
epitope or fluorescent tags was not investigated further (Ding et al., 2016). 
Cell-free protein synthesis (CFPS) allows generation of functional proteins 
independent of cell culture. CFPS systems derived from crude cell extracts have been 
used for decades as a research tool in fundamental and applied biology, having been 
used in 1961 to decipher the mechanism behind the genetic code (Nirenberg et al., 
1961). More recently, CFPS has shown remarkable utility as a protein synthesis 
technology (Katzen et al., 2005; Swartz, 2006) including the production of 
pharmaceutical proteins (Goerke et al., 2008; Swartz, 2006) and high-throughput 
production of protein libraries for protein evolution and structural genomics (Madin 
et al., 2000; Takai et al., 2010). This method is especially attractive for proteins that 
are difficult to synthesize in traditional cell culture due to problems associated with 
cellular toxicity, low expression or aggregation (Katzen et al., 2005; Katzen et al., 
2009). To produce proteins of interest, CFPS systems harness an ensemble of 
catalytic components necessary for energy generation and protein synthesis from 
crude lysates of microbial, plant, or animal cells. Crude lysates contain the necessary 
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elements for transcription, translation, protein folding and energy metabolism (e.g., 
ribosomes, aminoacyl-tRNA synthetases, translation initiation and elongation 
factors, ribosome release factors, nucleotide recycling enzymes, metabolic enzymes, 
chaperones, foldases, etc). Activated catalysts within the cell lysate act as a chemical 
factory to synthesize and fold desired protein products upon incubation with 
essential substrates, which include amino acids, nucleotides, DNA or mRNA template 
encoding the target protein, energy substrates, cofactors, and salts. After initiation 
of cell-free protein synthesis, production typically continues until one of the 
substrates (e.g., ATP, cysteine, etc.) is depleted or by product accumulation (e.g., 
inorganic phosphate) reaches an inhibitory concentration (Lewin, 1975).  
Rabbit reticulocyte lysates (RRL) has been a useful CFPS tool for the 
enhancement of viral transcription of bovine-isolated RV proteins (Vende et al., 
2000) or virion assembly of simian RV (Clapp et al., 1991). Due to its low expression, 
a TandT® system has been employed in previous studies to dissect the expression 
and stability of NSP1 derived from RV infecting monkeys (SA11), birds (Ch2) and mice 
(EDIM) (Pina-Vazquez et al., 2007). Studying involving comparative analysis between 
NSP1 derived from different strains employed cell lines stably expressing the viral 
protein. Transfection of HEK293 with plasmids encoding NSP1 derived from RV 
strains RRV (simian), EDT (murine) or Wa (human) resulted in higher level of 
expression (Ding et al., 2016).  
Transcriptional control is mediated by transcription factors, RNA polymerase 
and a series of cis-acting elements located in the DNA, such as promoters, enhancers, 
silencers and locus-control elements, organized in a modular structure and regulates 
the production of pre-mRNA molecules, which undergo several steps of processing 
before they become functional mRNAs. UTRs are known to play crucial roles in the 
post-transcriptional regulation of gene expression, including modulation of the 
transport of mRNAs out of the nucleus and of translation efficiency (van der Velden 
et al., 1999) , subcellular localization (Jansen, 2001) and stability (Bashirullah et al., 
2001). Regulation by UTRs is mediated in several ways and nucleotide patterns or 
motifs located in 5'-UTRs and 3'-UTRs can interact with specific RNA-binding proteins. 
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 The open reading frame of each segment of RV genome is flanked by 5’ and 
3’ untranslated regions (UTRs) that are variable in length. Although UTRs are not 
completely conserved among the different genome segments (and often differ in 
their length), terminal consensus sequences are common to all eleven genome 
segments; these consist of the 5’-terminal consensus 5’-GGC(A/U)7−3’ and the 3’-
terminal consensus 5’-U(G/U)3(A/G)CC-3’. Work by Patton et al has shown how an 
insertion of an extra A in the 3’-UTR region of NSP1 sub-optimally affected its in vitro 
gene replication and expression (J. T. Patton et al., 2001). The insertion of the extra 
A had a negative impact on the replication of gene 5 (which encodes NSP1), causing 
a significant decrease in the expression of the ORF of the chimeric RNA. However, 
the insertion appeared to have no effects on the biology of the viruses, since RV 
carrying the mutation replicated at higher titer compared to wt viruses. This 
suggested that in cell culture NSP1 contributed to viral replication cycle and that the 
UTRs are not required for genome packing. A work by Kearney et al has shown how 
the sequence 5’-TGACC-3’ in the 3’-UTR is specifically recognised by NSP3. One of the 
roles of NSP3 is to facilitate the transcription of viral (Deo et al., 2002; Poncet et al., 
1993; Poncet et al., 1994), thus mutation in the 3’-UTR region of NSP1 resulted in 
decreased binding affinity with NSP3 and subsequent lower efficiency in NSP1 
transcription (Kearney et al., 2004). Sequences analyses of the 3’-UTR regions of 
NSP1 considered in this study revealed the presence of the conserved domain 5’-
TGACC-3’, with the exception of the porcine strain A8, which sequences of the 3’-UTR 
appeared incomplete (Figure 27). The absence of the motif from plasmid-encoded 
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      18A    GATGTTGAATAATTTCAG------ AATGTGACC 
      1M0    GACGTTGAATAATGAAAT------ AATGTGACC 
       TC    GATGTTGAATAGTAAAAG------ AATGTGACC 
    G10P5    GATGTTGAATGAATATGG------ AATGTGACC 
       A8    GATGTTGAGTAGTTGAGA------  
     UKtc    GATGTTGAATAAATATGG------ AATGTGACC 
      RRV    GATGACGACTAATGATTG------ ACTGTGACC 
Figure 27. Alignment of the 3'-UTR region of NSP1 reveals the presence of the conserved 
domain5’-TGACC-3’. 
Sequences analysis of the alignment of the 3’-UTR regions of the NSP1 revealed the presence of 
the conserved motif 5’-TGACC-3’, here underlined. The stop codon is deciphered in red. The 
distance between the stop codons and the motif are representative and do not reflect real 
distances, which vary between strains. 
 
A variety of expression systems have been developed to overproduce proteins 
in mammalian cells. Viral vectors are particularly powerful tools because they have 
inbuilt mechanisms to subvert the cellular machinery in their favour. Modified 
vaccinia virus Ankara-T7 polymerase (MVA-T7) is an attenuated vaccinia virus strain 
encoding the bacteriophage T7 polymerase gene. Vaccinia virus (VACV), the 
prototype of the Poxviridae family, has been widely used as an expression vector 
(Mackett et al., 1992). In numerous strategies for expression of foreign genes using 
VACV, the gene of interest has been positioned downstream of VACV early or late 
promoters. However, the highest expression levels have been achieved when the 
gene encoding the RNA polymerase from the bacteriophage T7 was integrated into 
the VACV genome (MVA-T7) and the foreign gene of interest was under the control 
of a bacteriophage T7 promoter (Sutter et al., 1995).  
The cloning strategy in this study used pcDNA3.1-V5-HIS-TOPO®, a 
mammalian expressing vector containing a T7 promoter upstream of its MCS. Thus 
infection with MVA-T7 promoted higher levels of expression of NSP1. When MVA-T7 
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infection was used to increase expression of HIS-tagged NSP1, the viral protein was 
detected only in vaccinia-infected cells. 
 The MG132 treatment following infection resulted in the inability to detect 
protein levels. These results may have been due to the fact that  MG132 treatment 
has been reported to block the expression of viral intermediate and late genes 
(Satheshkumar et al., 2009). However, an increase in HA-tagged NSP1 (UKtc and 
G10P5 isolates) expression was observed when transfected cells were first infected 
with MVA-T7 and then treated with MG132. Although the constructs used in this 
study did not contain the 5’-UTR of NSP1, it has been shown that T7 polymerase-
driven expression of RV cDNAs can be strongly inhibited due to the presence of an 
inhibitory motif (IM) within the long 5’-UTR regions of 8 genome segments. IM was 
mapped to the 5’ terminal 6-nucleotide long pyrimidine-rich tract 5’-GGY(U/A)UY-
3’(De Lorenzo et al., 2016). 
MG132 has been used to increase the level of GFP-tagged NSP1 in HT29 (Sen 
et al., 2014) and has been employed to study proteasome-mediated degradation of 
NSP1 derived from bovine (B641) and porcine (OSU) RV strains. The use of the 
proteasome inhibitor resulted in a 2.5 fold increase in NSP1 compared to untreated 
cells. However, the expression of OSU NSP1 in untreated HEK293 was higher than 
B641 NSP1, even when expressed from the same construct (Graff et al., 2007), 
indicating a strain-dependent level of expression. Moreover, MG132 appeared to 
increase the level of GFP-tagged NSP1 in HT29 (Sen et al., 2014). Transient 
transfection with GFP-tagged NSP1 derived from RRV or EW (murine) resulted in poor 
expression levels compared to GFP-tagged UKtc. Treatment with MG132 resulted in 
higher expression levels of both GFP-tagged RRV and EW. In contrast, GFP-UKtc was 
stable and expressed to similar levels in the presence or absence of MG132 (Sen et 
al., 2009). Thus, in contrast to the unstable nature of RRV and EW NSP1s, UK NSP1 
does not appear to be susceptible to proteasome-mediated degradation in COS7 cells 
although it can efficiently degrade IRF-3 in these cells. Degradation of IRF-3 by GFP-
tagged NSP1 has also been reported (Sen et al., 2014). 
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The 26S proteasome catalyses the great majority (at least 80%) of the protein 
degradation in growing mammalian cells, including both the rapid degradation of 
misfolded and regulatory proteins and most of the slower breakdown of the bulk of 
cellular proteins (J. Zhao et al., 2015). Since the discoveries of the critical role of 
ubiquitin (Ub) in protein turnover (Hershko et al., 1980) and of the 26S complex in 
digesting ubiquitin conjugates (Hough et al., 1987), it has been generally assumed 
that rates of proteolysis by this pathway are regulated solely through protein 
ubiquitination. However, it is now clear that ubiquitination and even the association 
of an ubiquitylated protein with the proteasome do not necessarily lead to its 
degradation (Crosas et al., 2006). Thus, the proteasome is not simply a machine for 
efficient, automatic destruction of ubiquitin conjugates and ubiquitin recycling, but 
its properties also determine whether an ubiquitylated protein undergoes 
degradation or survives intact. In addition, the proteasome's degradative capacity 
and selectivity are not fixed, but are precisely regulated by multiple post-synthetic 
mechanisms. 
The TS20 cell lines harbour a thermo-sensitive E1 ubiquitin activating enzyme. 
Since ubiquitin conjugating enzymes E2 (UBE2) are incapable of using ubiquitin 
without an E1 enzyme, the TS20 cells are unable to support ubiquitin conjugation at 
the non-permissive temperature, resulting in an accumulation of proteins usually 
targeted for ubiquitin-dependent degradation through the proteasome. Western 
blot analyses of whole cell lysates prepared from transfected TS20 cell lines treated 
with MG132 suggested a marginal role for ubiquitin-driven proteasome-mediated 
degradation of NSP1 (Figure 25). These results are consistent with previously 
published data where the MG132 treatment has no significant impact on NSP1 
protein levels (Bhowmick et al., 2013). The Western blot analyses also revealed the 
presence of a ladder of proteins with molecular weights (>40kDa and <54kDa) smaller 
than that predicted for the tagged NSP1 proteins (54kDa). These could be 
degradation intermediates, but they did not increase following MG132 treatment. 
Furthermore, they are unlikely to be caused by the presence of internal start codons, 
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as the N-terminal HA-tag was detected and the predicted molecular weights for 
proteins generated from alternative start codons do not correlate. 
When BSC-1 cell lines were infected with vaccinia virus expressing rhesus RRV 
NSP1 (vNSP1), the protein was highly susceptible to proteasome-mediated 
degradation, since a 4-fold increase in the expression of NSP1 was observed after 
treatment with the proteasome inhibitor clasto-lactacystine-βlactone (CLL) and a 2.5-
fold increase following MG132 treatment (Pina-Vazquez et al., 2007). The 
susceptibility to proteasome degradation and half-life of NSP1 in cells expressing 
vNSP1 was affected by the simultaneous co-transfection with total RRV mRNAs. In 
the presence of total RRV mRNAs NSP1 was stabilised and became less susceptible 
to proteasome degradation, since identical amounts of NSP1 were obtained 
regardless of treatment with the proteasome inhibitor MG132. Moreover, the same 
work showed that the half-life of NSP1 was 90 min, and the protein showed an 
increased stability compared to previous results. These data are in contrast with the 
reported stability of NSP1, as determined by pulse-chain analysis of RV-infected cells 
(Johnson et al., 1989; Mitzel et al., 2003; Pedley et al., 1984).  
 Specifically, Mitzel et al investigated the mechanism of regulation of RV gene 
expression of two differentially expressed viral mRNA: NSP1 and VP6. These two 
genes were chosen as models for analysis of rotavirus gene regulation because: (1) 
both are expressed early in infection; (2) VP6 is expressed at higher levels than NSP1, 
approximately 25-fold molar excess; and (3) the mRNAs and ORFs are similar in size, 
thus minimizing potential variations in expression due to mRNA length. They 
concluded that the difference in amount of NSP1 was due to poor translation 
efficiency of the mRNA compared to VP6. Due to contrasting results observed in the 
stability and half-life were observed for NSP1, which appeared for VP6, indicate that 
pulse-chase analysis cannot be used alone to determine the intracellular stability of 
NSP1. 
Differences in the stability of NSP1 and its susceptibility to proteasome-
mediated degradation have been reported by Sen et al (Sen et al., 2009). When COS7 
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cell lines were transfected with GFP-tagged NSP1 from simian (RRV), bovine (UKtc) 
or murine (EW) RV and treated with PYR-41, an E1 ligase inhibitor that blocks the 
activation and subsequent transfer of polyubiquitin to the substrates (Yang et al., 
2007), an in increased levels of the murine and rhesus NSP1 were observed, but not 
for the bovine.  
COPII coated vesicles are responsible for sorting and trafficking cargo out of 
the ER and into the Golgi apparatus (Campbell et al., 1997). Multiple host and 
pathogen proteins contain the orthodox COPII sorting motif, composed of a 
transmembrane (TM) domain, a tyrosine residue and a spaced diacidic signal. Two 
such motifs were reported to present in Wa-NSP1, one within the N-terminal RING-
finger domain and the other at the very C-terminus (Ding et al., 2016). In their work 
they showed how the human isolate Wa was localised to the Golgi, however, the role 
of the COPII sequence was not proven. A further examination of NSP1 sequences 
revealed evolutionary conservation of these motifs. The Golgi is home to a multitude 
of glycosyltransferases (GTs), glycosidases, and nucleotide sugar transporters that 
function together to complete the synthesis of glycans from founding sugars 
covalently attached to protein or lipid in the endoplasmic reticulum (ER). Thus, 
glycoproteins, glycosphingolipids (GSLs), proteoglycans and 
glycophosphatidylinositol (GPI) anchors acquire their final sugar complement during 
passage through the Golgi (Stanley, 2011). Bioinformatics analyses have revealed the 
presence of putative glycosylation sites within NSP1 sequences (data not shown). 
However, no additional bands with molecular weights higher than that predicted for 
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5 NSP1 shows a strain-dependent ability to differentially 
target components of IFN induction and signalling 
pathways  
Purpose 
This chapter describes experiments performed in order to characterize the 
ability of RV NSP1 to modulate IFN expression. Strain-specificity of plasmid-encoded 
NSP1 to downregulate type I and type III IFN was observed due to the ability of the 
viral protein to differentially target host proteins within the IFN and NF-κB pathways. 
By contrast, the NSP1 proteins from all species investigated were able to inhibit the 
activation of Mx promoter following stimulation with type-I IFN. 
Introduction 
The ability of the host to sense incoming viral infection and answer rapidly and 
efficiently to the virus spread is crucial for life. The importance of innate immunity in 
controlling viral replication means that most viruses have evolved strategies to 
counteract IFN-mediated innate responses, including interference with components 
of the IFN induction and/or signalling pathways. Despite RV infection resulting in 
activation of the host innate immune response, wild type strains are capable of 
spreading from the site of infection to surrounding cells and tissues (Feng et al., 
2009). Infected cells have been shown to express very low levels of IFN transcription 
or secretion, suggesting that the virus encodes proteins that antagonize the IFN 
pathways. 
NSP1-defective strains replicates in cell culture to titers close to those of their 
wild-type counterparts, but they yield small- to minute-plaque phenotypes. This 
suggests NSP1 could play a role in modulating the host innate immune response. A 
series of luciferase reporter assays were used to evaluate the effects of plasmid-
encoded NSP1 derived from different mammalian species (human, pigs, cattle and 
monkey) on the induction and signalling of type I and type III IFN. 
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5.1 Cell lines evaluation  
In order to evaluate the ability of NSP1 to downregulate IFN expression in the 
context of a homologous or heterologous infection, a set of human, monkey, pig and 
cattle-derived cell lines were first checked for (1) endogenous expression of IRF-3 and 
(2) the ability to induce an IFN response.  
In order to check for endogenous IRF-3 expression in untreated cells, whole 
cell lysates obtained from human (HEK293, Caco-2 and HT29), monkey (BSC-1 and 
MA104), bovine (MDBK) and porcine (PK15) cell lines were prepared and analysed by 
Western blot using an antibody against IRF-3. As reported in Figure 28 Panel A, 
HEK293 Caco-2, HT-29, , BSC-1, MA104 MDBK and PK15 expressed IRF-3, with bands 
of expected migration size (47kDa) being observed. In order to confirm that the 
observed bands corresponded to IRF-3, PK15 cells were infected with Classical Swine 
Fever Virus (CSFV) and blotted for IRF-3 expression. CSFV is known to induce the 
degradation of IRF-3 through the expression of the viral protein Npro (Seago et al., 
2007). 48h post-infection CSFV infection resulted in the complete abrogation of the 
expression of IRF-3. Similar results were obtained when IRF-3 expression levels were 
evaluated in a cell line stably expressing the CSFV Npro protein (data not shown) 
(courtesy of Molecular virology group–The Pirbright Institute). 
 Differences in the observed migration profiles were observed between 
samples and this was likely due to species-specific differences in the size of IRF-3 
(human IRF-3 427 aa, monkey IRF-3 422 aa, bovine IRF-3 417 aa and pig IRF-3 423 
aa). The higher band observed in PK15-CSFV infected cells may beeen a 
phosphorylated form of IRF-3 re-localised to the nucleus following viral infection, as 
previously reported for bovine viral diarrhoea pestivirus (Hilton et al., 2006). 
Doublets observed for Caco-2 and HT29 could be due to polymorphisms of the IRF-3 
locus. 
Next, employing an MX/CAT reporter assay, the ability to induce IFN in Caco-
2, HT29, HEK293, MA104, BSC-1, PK15 and MDBK cell lines upon Sendai virus (SeV) 
infection was evaluated (Strahle et al., 2003). At 3h, 6h and 16hpi cell culture 
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supernatants were collected and analysed for IFN production using MDBK-t2 IFN-
reporter cells (2.5). The respective amount of IFN produced by each cell type was 
quantified using regression analysis following the preparation of a standard curve 
(2.5.2).  
As reported in Figure 28 Panel B the human HT29 and HEK293 cell lines 
produced IFN, however, expression profiles were different: HT29 reached the peak 
of induction at 16hpi, while in HEK293 the highest induction was observed during the 
first 3h of infection, with the following 13h showing a basal expression of IFN. The 
human Caco-2 appeared not to induce IFN upon SeV infection. African green monkey-
derived cell lines MA104 and BSC1 showed a similar profile, with the highest levels 
of IFN induction observed at 16hpi (  ̴30 IU/ml). Similarly, the highest levels of IFN 
expression for both bovine MDBK and porcine PK15 cell lines was observed at 16hpi 
(  ̴140 IU/ml). 




Figure 28. Analysis of different cell lines for IRF-3 expression and IFN induction following SeV 
infection. 
(A) Whole cell lysates prepared from HEK293, Caco-2, HT-29 (human), BSC-1, MA104 (monkey), 
MDBK (bovine) and PK15 (swine) were analysed by Western blot using an antibody against IRF-3. 
Bands appeared to be at the expected size-related migration (~47 kDa). Infection of PK cell lines 
with CSFV results in the complete degradation of IRF-3. Overall protein expression was confirmed 
by probing for γ-tubulin. (B) Media samples were collected from Caco-2, HT29, HEK293, MA104, 
BSC1, PK15 and MDBK cell lines 3h, 6h and 16 hpi with SeV and analysed for the presence of IFN 
using MDBK-t2 MX-CAT reporter cells. 
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5.2 NSP1-mediated antagonization of the host innate immunity:                     Dual-
luciferase reporter assay 
Once the expression of full length plasmid-encoded NSP1 variants had been 
confirmed (4.1, 4.2) and the ability of relevant cell lines to express IRF-3 and produce 
IFN was established (Figure 28), the next step was to evaluate the effect of NSP1 in 
modulating the host innate immune response. To do this a Dual-Luciferase® Reporter 
(DLR™) Assay System (Promega) was used. This system involves co-transfecting 
mammalian cells with a firefly luciferase reporter under the control of a promoter 
region of interest, a plasmid encoding constitutively expressed Renilla luciferase 
(referred to herein as Renilla plasmid) and a plasmid encoding a putative effector 
protein. The co-transfected cells are then stimulated to induce expression of the 
firefly luciferase reporter, the activity of which can be rapidly quantified in a 
luminometer. Renilla luciferase activity is then quantified and used to normalise 
firefly activity to account for differences in transfection efficiency. The ability of the 
effector protein to increase or reduce transcriptional activity is then assessed.  
In this study, firefly luciferase reporters containing the promoter regions of 
host factors involved in the establishment of host innate immunity (IFN-β, IFN-α IFN-
λ, NF-κB, Mx2) were used (2.14), and NSP1 plasmids prepared in (2.6), encoded the 
effector proteins that were investigated. Cells were treated with different stimuli 
(Sendai virus, TNFα, IFNα) depending on the nature of the region promoter and 
unstimulated cells provided background levels of luciferase. 
Human HEK293 cell lines, which can be induced to produce IFN (Figure 28) and 
are known to have high transfection efficiency, were initially used. In order to assess 
the optimal concentration of NSP1 plasmid that could be transfected before 
observing cytotoxicity, a range of concentrations was first tested. To do this, cells 
were co-transfected with 250 ng of IFN-β reporter plasmid, 25 ng of Renilla plasmid 
and either 250 ng, 500 ng or 1µg of empty pcDNA3.1 vector (negative control), a 
plasmid encoding NSP1 (1M0), or a plasmid encoding the CSFV Npro protein (positive 
control) (Seago et al., 2007) respectively. 24h later the cells were infected with 50 µl 
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SeV (4000HA/ml) for a further 16h to induce expression of the firefly luciferase 
reporter. Cells were then harvested and firefly luciferase activity values were 
determined (Figure 29); from herein firefly luciferase will be referred to as luciferase. 
Although SeV infection of cells transfected with different amounts of the empty 
vector all led to an increase in luciferase activity, a sequential decrease in activity was 
observed with increasing amounts of plasmid. The luciferase activity values obtained 
for the empty vector control were then compared to those determined for cells 
transfected with either NSP1 or Npro plasmid. Interestingly, luciferase activity was 
downregulated when 250 ng and 500 ng of NSP1 plasmid were used, but not using 1 
µg. Transfection of increasing amounts of Npro plasmid led to a reduction in luciferase 
activity in each assay, however the use of 250 ng produced the highest inhibition. 
Based on these results, subsequent dual-luciferase reporter assays were performed 
using 250 ng of NSP1 plasmid.  
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Figure 29. Evaluation of the optimal concentration of plasmid-encoded NSP1 to be transfected 
for dual-luciferase reporter assays. 
HEK-293 cells were co-transfected with 250 ng of a IFN-β reporter, 25 ng of Renilla luciferase 
plasmid and either (A) 250 ng, (B) 500 ng or (C) 1 μg of a plasmid encoding the human rotavirus 
NSP1 (1M0), a plasmid encoding the CSFV N-terminal protease (Npro) or an empty vector. 24 h later  
cells were infected with SeV, or mock infected for a further 16h, after which luciferase values were 
determined. Luminescence was normalised by comparing Renilla luciferase activity. Data are 
presented as the mean of three independent experiments (+/- SD). 
 
5.2.1.1 The effects of plasmid-encoded NSP1 on the promoter of Type I IFN 
5.2.1.1.1 IFN-β 
HEK293 cells were co-transfected with IFN-β reporter and Renilla plasmids 
and a plasmid expressing either a single human (1M0, 18A and TC), porcine (G10P5 
and A8), bovine (UKtc) or rhesus (RRV) NSP1 protein. A plasmid expressing CSFV Npro 
and empty pcDNA3.1 vector served as positive and negative controls, respectively. 
24h after co-transfection, cells were mock-infected or infected with SeV for 16h. Cells 
were harvested and respective luciferase activities were then determined (Figure 
30). Luciferase activity values for NSP1 were compared to those obtained for the 
empty vector control (designated as 100% luciferase activity). The expression of each 
NSP1 protein led to a reduction in luciferase activity, with the exception of the 
porcine A8. The human 1M0, 18A and TC, together with the porcine G10P5, were 
able to reduce the level of luciferase activity to ~50% (P<0.05 and <0.01), while the 
bovine UKtc and rhesus RRV decreased the activity to ~40% (P<0.01). CSFV Npro was 
able to knock down IFN-β promoter activity to ~40% (P<0.001). 




Figure 30. IFN-β downregulation by plasmid-encoded NSP1 in human HEK293 cell lines. 
HEK293 cells were co-transfected with plasmids encoding either human (1M0, 18A, TC) porcine 
(G10P5, A8), bovine (UKtc) or rhesus (RRV) NSP1 proteins along with an IFN-β reporter and Renilla 
luciferase plasmid. Controls included transfection with an empty vector (pcDNA3.1) and plasmid 
expressing CSFV NPRO. Cells were then infected with SeV, or mock infected for a further 16h, after 
which luciferase values were determined. Activation of the IFN-β promoter (expressed in percentage) 
was determined by normalising the luciferase activity to Renilla and comparing the signals in cells 
transfected with NSP1 and cells expressing an empty vector. Data are presented as the mean of four 
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IFN-β, the prototypical type I IFN, is induced by the combined actions of the 
transcription factors AP-1, IRF-3, IRF-7 and NF-κB (1.2.4). The binding sites for each 
set of transcription factors are localized in close proximity to each other and IFN-β 
expression requires the cooperative binding of all activators in a complex, the 
enhanceosome (Panne, 2008). In order to evaluate if the previously observed 
downregulation of IFN-β (Figure 30) was due to the ability of NSP1 to specifically 
target IRF-3, a PRD-III IFN-β reporter plasmid was used. This reporter plasmid 
expresses firefly luciferase under the control of only the IRF-3 binding sites (PRD-III) 
in the human IFN-β promoter. 
 HEK293 cells were co-transfected, infected with SeV, harvested as previously 
described (5.2.1.1.1) and luciferase activity was measured (Figure 31). Compared to 
the results showed in Figure 30, the human 1M0 and rhesus RRV NSP1 proteins 
mediated a further ~20% decrease in luciferase activity (P<0.001 and P<0.0001 
respectively). Both porcine NSP1 proteins, G10P5 (P<0.0001) and A8 (P<0.001), were 
able to reduce the activity a further ~30%, while the human 18A (P<0.001) and the 
bovine UKtc (P<0.0001) were able to reduce luciferase activity to ~50% and ~30% 
respectively (Figure 30). CSFV Npro was able to knock down PDRIII IFN-β promoter 
activity to ~20% (P<0.0001). 
 




Figure 31. IFN-β (Luc IRF-3/PDRII) downregulation by plasmid-encoded NSP1 in human HEK293 
cell line. 
HEK293 cells were co-transfected with plasmids encoding either human (1M0, 18A, TC) porcine 
(G10P5, A8), bovine (UKtc) or rhesus (RRV) NSP1 proteins along with a PDRIII IFN-β reporter (in which 
the promoter region is under the control of only IRF-3) and Renilla luciferase plasmid. Controls 
included transfection with an empty vector (pcDNA3.1) and plasmid expressing CSFV NPRO. Cells were 
then infected with SeV, or mock infected for a further 16h, after which luciferase values were 
determined. Activation of the IFN-β promoter (expressed in percentage) was determined by 
normalising the luciferase activity to Renilla and comparing the signals in cells transfected with NSP1 
and cells expressing an empty vector. Data are presented as the mean of four independent 
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In order to assess the ability of NSP1 to downregulate the IFN-β promoter 
reporter in other cell lines, transfections of HT29 and Caco-2 human cell lines were 
carried out. However, these were unsuccessful, yielding non detectable luciferase 
values. The PK15 porcine cell line was next evaluated. Cells were transfected as 
previously described, infected with SeV and luciferase activity was determined 
(Figure 5). Consistent with results obtained with Y-2-H screening in which NSP1 was 
able to interact with IRF-3 independently of its host origin, no differences were 
observed in luciferase activity in PK15, and all the NSP1 proteins were able to 
significantly inhibit the induction of IFN-β (P**P<0.01, ***P<0.001, ****P<0.0001). 
The only observed difference was related to the porcine G10P5 (P<0.001), which was 
able to reduce the expression by 80% of that observed for the empty vector control. 
In PK15 cell lines, CSFV Npro was able to completely knock down IFN-β promoter 










Figure 32. IFN-β downregulation by plasmid-encoded NSP1 in porcine PK15 cell lines. 
PK15 cells were co-transfected with plasmids encoding either human (1M0, 18A, TC) porcine (G10P5, 
A8), bovine (UKtc) or rhesus (RRV) NSP1 proteins along with an IFN-β reporter and Renilla luciferase 
plasmid. Controls included transfection with an empty vector (pcDNA3.1) and plasmid expressing CSFV 
NPRO. Cells were then infected with SeV, or mock infected for a further 16h, after which luciferase 
values were determined. Activation of the IFN-β promoter (expressed in percentage) was determined 
by normalising the luciferase activity to Renilla and comparing the signals in cells transfected with 
NSP1 and cells expressing an empty vector. Data are presented as the mean of four independent 
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Yeast-2-hybrid analyses (3.2.1) showed how bovine NSP1 UKtc was able to 
interact with IRF-3 encoded by human, pigs, cattle and monkeys. By contrast, the 
human 18A was not able to bind to any of the IRF-3 proteins, even in lower stringency 
conditions (3.2.5). Previous studies have shown how the C-terminus of NSP1 is 
important for the interaction of the viral protein with its targets (Barro et al., 2007; 
Graff et al., 2002; B. Zhao et al., 2016). In order to confirm that the C-terminus of 
NSP1, which has been reported to contain a putative IRF-3 interaction site (B. Zhao 
et al., 2016), was crucial in the binding ability of the viral protein to modulate the 
expression of IFN-β, two chimeric NSP1 were generated: 18A-UKtc (499aa), 
containing the N-terminus of the NSP1 protein from the human18A RV isolate and 
the C-terminus of the NSP1 protein from the bovine UKtc RV isolate, and UKtc-18A 
(487aa) containing the reciprocal terminus of either protein. A buffering area to swap 
domains was chosen based on a region of conserved amino acids, corresponding to 
the peptide sequence - L R Y F S K -. This sequence occurs between residues 640 to 
658 in 18A, but between 619 to 637 in UKtc. The sequences encoding the two 
chimeric NSP1 were ordered from GeneART® in the mammalian expression vector 
pCDNA3.1. 
Next, the effect of the swapped domains on the downregulation of IFN-β 
induction was evaluated using the DLR™ Assay System and HEK293 cells. Assays were 
performed alongside parental NSP1 proteins for comparison (Figure 33). Contrasting 
results were obtained on the effect of plasmid-encoded NSP1 on the downregulation 
of IFN-β. The human 18A either reduced luciferase activity to only ~80% or mediated 
no effect at all on, contrasting with the ~50% reduction previously reported (Figure 
30). The effect of the bovine UKtc appeared more remarkable, dropping from the 
previously observed reduction of ~60% to ~30%. Since the effect of Npro on luciferase 
activity was consistent and the expected luciferase activity was observed for the 
empty vector control, it is possible that this issue may have been due to the quality 
of NSP1 plasmid preparations. Due to unreproducible experiments, it was impossible 
to evaluate the effect of swapped-regions in chimeric NSP1 on the IFN 
downregulation. 





Figure 33. IFN-β downregulation by plasmid-encoded NSP1 in human HEK293 cell lines: swapped 
domains between the human 18A and the bovine UKtc. 
HEK293 cells were co-transfected with plasmids encoding either the human NSP1 18A, the bovine 
NSP1 UKtc, the recombinant 18AUKtc or the recombinant UKt18A along with IFN-β reporter and 
Renilla luciferase plasmid Controls included transfection with an empty vector (pcDNA3.1) and 
plasmid expressing CSFV NPRO. Cells were then infected with SeV, or mock infected for a further 
16h, after which luciferase values were determined. Activation of the IFN-β promoter (expressed 
in percentage) was determined by normalising the luciferase activity to Renilla and comparing the 
signals in cells transfected with NSP1 and cells expressing an empty vector. Data are presented as 
the mean of three independent experiments (+/- SD). 
The recombinant NSP1 18AUKtc of 499 aa in length has the N-terminus region (212 aa) from the 
human 18A and the C-terminus (287 aa) from the bovine UKtc. The recombinant UKtc18A of 487 
aa in length has the N-terminus (220 aa) from the bovine UKtc and the C-terminus (267 aa) from 








Recent studies have shown how NSP1 was able to induce the degradation of 
IRF-7 (Barro et al., 2007). In order to investigate if the presence of NSP1 results in the 
downregulation of IFN-α promoter activity, the expression of which is IRF-7 
dependent (Osterlund et al., 2007), a luciferase reporter assay was used in which the 
firefly luciferase was under the control of the human IFN-α4 promoter region. 
Preliminary experiments were performed in order to evaluate the induction of IFN-
α4 promoter; HEK293 cells were co-transfected with the IFN-α4 reporter and Renilla 
plasmids and either a plasmid encoding CSFV Npro or the empty pcDNA3.1 vector. 
Cells were then mock infected or infected with SeV. 
Infection of HEK293 cells with SeV seemed to poorly induce IFN-α4 
transcription, with no substantial differences occurring between stimulated and 
unstimulated cells (Figure 34). These results are consistent with data published by 
Osterlund, who investigated the ability of IRFs and NF-κB family members to activate 
type I and type III IFN promoters (Osterlund et al., 2007). 
 




Figure 34. IFN-α induction in human HEK293 cell lines. 
HEK293 were co-transfected with plasmid encoding either an empty vector (pCDNA3.1) or CSFV Npro 
along with an inducible firefly luciferase reporter under human IFN-α4 promoter region and a non-
inducible plasmid encoding Renilla. After 24h interferon response was induced infecting cells with SeV 
for 16h or mock infected. Cells were harvested and luciferase values were read. Activation of IFN-α4 
promoter was evaluated by normalising luciferase activity to Renilla comparing the signals in cells 
infected with SeV and mock infected. Data are presented as the mean of two independent 
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Having confirmed that SeV was not able to induce IFN-α4, the exogenous 
expression of IRF-7 was investigated. To facilitate this, HEK293 were co-transfected 
as previously described along with 50 ng, 100 ng or 200 ng of pEF-C1/EGFP-IRF7 
plasmid encoding human IRF-7. 8 h post-transfection, cells were infected with SeV or 
mock-infected and 18 h later cells were harvested and luciferase levels measured 
(Figure 35). The administration of exogenous IRF-7 clearly activated the IFN-α4 
promoter reporter in HEK293 cells, with a two fold increase in luciferase activity 
observed between 50 ng and 100 ng. However, when increased to 200 ng, no further 
increase was observed. No difference in luciferase activity profiles were observed 











Figure 35. IRF-7 mediated induction of IFN-α4 in human HEK293 cell lines. 
HEK293 were co-transfected with plasmid encoding either an empty vector (pCDNA3.1) or CSFV 
Npro along with a IFN-α4 reporter and Renilla plasmid and 50 ng, 100 ng or 200 ng of human IRF-7. 
Cells were allowed to express plasmid-encoded proteins for 8h and infected with SeV overnight or 
mock infected before being harvested and luciferase values read. Luminescence was normalised by 
comparing Renilla luciferase activity. Induction of the human IFN-α4 promoter was evaluated 
comparing the signals in cells stimulated to produce interferon with the ectopic expression IRF-7 
and those subsequently infected with SeV. Data are presented as the mean of two independent 
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Having confirmed exogenous IRF-7 activated the IFN-α4 promoter reporter, 
assays were carried out using 100 ng of IRF-7 and plasmids expressing human (1M0, 
18A and TC), porcine (G10P5 and A8), bovine (UKtc) and rhesus (RRV) NSP1. The 
rotavirus NSP1 proteins had no effects on induction of the IFN-α4 promoter reporter, 
with the exception of the bovine UKtc, with a reduction to ~60 % (P<0.05) (Figure 36). 
As previously reported, CSFV Npro is able to target IRF-7 (Fiebach et al., 2011; Gottipati 




Figure 36. IFN-α4 downregulation by plasmid-encoded NSP1 in human HEK293 cells. 
HEK293 cells were co-transfected with plasmids encoding either human (1M0, 18A, TC) porcine 
(G10P5, A8), bovine (UKtc) or rhesus (RRV) NSP1 proteins along with an IFN-α4 reporter and Renilla 
luciferase plasmid. Controls included transfection with an empty vector (pcDNA3.1) and plasmid 
expressing CSFV NPRO. Interferon response was induced transfecting cells with 100 ng of human IRF-7. 
16h post-transfection cells were harvested and luciferase values were read. Activation of IFN-α4 
promoter (expressed in percentage) was determined by normalising the luciferase activity to Renilla 
and comparing the signals in cells transfected with NSP1 and cells expressing an empty vector. Data 
are presented as the mean of three independent experiments (+/- SD) and analysed with Student T-
test *P<0.05. 
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5.2.1.2 The effects of plasmid-encoded NSP1s on the promoter of Type III IFN 
In vivo, RV infects predominantly mature enterocytes in the mid and top 
section of the villi of small intestine (Estes et al., 2007) being able to replicate and 
spread in these cells. Moreover, it has been shown that IFN-λ knocked-out mice are 
more susceptible to RV infection compared to the wild-type or IFN-β knock-out mice 
(Hernandez et al., 2015). Given the close relationship between IL-22 and IFN-λ and 
their concerted action on the defence of epithelial cells, and due to the high tropism 
of RV to a specific niche of cells, the ability of the virus to modulate IFN-λ promoter 
activity was investigated using an IFN-λ promoter reporter plasmid. 
 
5.2.1.2.1 IFN-λ1 
HEK293 were co-transfected with a reporter plasmid encoding firefly 
luciferase under the control of the human IFN-λ1 promoter, Renilla plasmid and a 
plasmid expressing either human (1M0, 18A and TC), porcine (G10P5 and A8), bovine 
(UKtc) or rhesus (RRV) NSP1. A plasmid expressing CSFV Npro and the empty pcDNA3.1 
vector served as positive and negative controls, respectively. Cells were mock 
infected or infected with SeV (Figure 37). All the NSP1 proteins derived from human 
RV isolates reduced luciferase activity to ~40% (1M0 P<0.01, 18A P<0.01 and TC 
P<0.001). The swine-derived G10P5 was able to reduce luciferase activity to ~30% 
(P<0.001), and rhesus RRV to ~20% (P<0.001). By contrast, the porcine A8 (P<0.05) 
and the bovine UKtc (P<0.01) decreased the IFN-λ1 expression to ~60%. CSFV Npro was 
able to knock down IFN-λ promoter activity to ~40% (P<0.001) 
 
  




Figure 37. IFN-λ1 downregulation by plasmid-encoded NSP1 in human HEK293 cell lines. 
HEK393 cells were co-transfected with plasmids encoding either human (1M0, 18A, TC) porcine 
(G10P5, A8), bovine (UKtc) or rhesus (RRV) NSP1 proteins along with an IFN-λ1 reporter and Renilla 
luciferase plasmid. Controls included transfection with an empty vector (pcDNA3.1) and plasmid 
expressing CSFV NPRO. Cells were then infected with SeV, or mock infected for a further 16h, after 
which luciferase values were determined. Activation of the IFN-λ1 promoter (expressed in percentage) 
was determined by normalising the luciferase activity to Renilla and comparing the signals in cells 
transfected with NSP1 and cells expressing an empty vector. Data are presented as the mean of four 
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The ability of NSP1 to inhibit IFN-λ1 promoter activity was investigated in other 
human cell lines, however transfections of HT-29 and Caco-2 human-derived cell lines 
were unsuccessful, yielding non detectable luminescence values. The PK15 porcine 
cell line was next evaluated. Cells were co-transfected as previously described, 
infected with SeV and firefly luciferase activity under the control of IFN-λ1 promoter 
was measured (Figure 38). The human-derived 18A and TC (P<0.05), as well as the 
porcine G10P5 and the rhesus RRV (P<0.01), were able to reduce luciferase activity 
to ~40%. 1M0 reduced luciferase activity to ~60% (P<0.05), while the bovine was less 
efficient (reduced to ~80%, P<0.01).The porcine A8 did not reduce luciferase activity, 
suggesting an inability to inhibit activation of the type III IFN promoter following SeV 
infection. Similarly to data observed for IFN-β (Figure 32), in PK 15 cell lines, CSFV 










Figure 38. IFN-λ1 downregulation by plasmid-encoded NSP1 in porcine PK15 cell lines. 
PK15 cells were co-transfected with plasmids encoding either human (1M0, 18A, TC) porcine 
(G10P5, A8), bovine (UKtc) or rhesus (RRV) NSP1 proteins along with an IFN-λ1 reporter and Renilla 
luciferase plasmid. Controls included transfection with an empty vector (pcDNA3.1) and plasmid 
expressing CSFV NPRO. Cells were then infected with SeV, or mock infected for a further 16h, after 
which luciferase values were determined. Activation of the IFN-λ1 promoter (expressed in 
percentage) was determined by normalising the luciferase activity to Renilla and comparing the 
signals in cells transfected with NSP1 and cells expressing an empty vector. Data are presented as 
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Next, the previously generated chimeric NSP1 plasmids (18AUKtc or UKtc18A) 
were used to assess the ability of the encoded proteins to inhibit activation of the 
IFN-λ promoter in HEK293 cells following SeV infection. Figure 39 shows that 
swapping domains between the human 18A and the bovine UKtc appeared not to 
compromise the functionality of the viral protein, which was still able to 
downregulate type III IFN promoter reporter activity. The chimeric 18AUKtc, which 
had the 18A N-terminus and the UKtc C-terminus, showed a luciferase activity profile 
similar to that of the parental UKtc NSP1 protein, being able to reduce expression to 
~50% (P<0.0001). By contrast, the UKtc18A, which had the UKtc N-terminus and the 
18A C-terminus, showed a profile similar to the parental strain 18A, with a 
downregulation to ~60% of the total expression (P<0.001). Taken together this data 
confirmed the pivotal role of the C-terminus region of NSP1. As previously shown 










Figure 39. IFN-λ1 downregulation by plasmid-encoded NSP1 in human HEK293 cell lines: swapped 
domains between the human 18A and the bovine UKtc. 
HEK293 cells were co-transfected with plasmids encoding either the human NSP1 18A, the bovine 
NSP1 UKtc, the recombinant 18AUKtc or the recombinant UKt18A along with IFN-λ1 reporter and 
Renilla luciferase plasmid Controls included transfection with an empty vector (pcDNA3.1) and 
plasmid expressing CSFV NPRO. Cells were then infected with SeV, or mock infected for a further 
16h, after which luciferase values were determined. Activation of the IFN-λ1 promoter (expressed 
in percentage) was determined by normalising the luciferase activity to Renilla and comparing the 
signals in cells transfected with NSP1 and cells expressing an empty vector. Data are presented as 
the mean of three independent experiments (+/- SD) and analysed with Student T-test **P<0.01, 
***P<0.001, ****P<0.0001. 
The recombinant NSP1 18AUKtc of 499 aa in length has the N-terminus region (212 aa) from the 
human 18A and the C-terminus (287 aa) from the bovine UKtc. The recombinant UKtc18A of 487 
aa in length has the N-terminus (220 aa) from the bovine UKtc and the C-terminus (267 aa) from 








Like type I IFNs, type III are strongly induced by double stranded (ds) RNA or 
viral infection, suggesting common regulatory factors. Recently, it has been 
demonstrated that the IFN-λ1 gene, similar to the gene encoding IFN-β, is regulated 
by virus-activated IRF-3 and IRF-7. In contrast, IFN-λ2 and IFN-λ3 gene expression is 
mainly controlled by IRF-7, similar to the activation of IFN-α (Osterlund et al., 2007). 
Both IFN-λ1 and IFN-λ3 are able to activate STAT1 signalling. Microarray analysis has 
shown a profile of similar gene inductions by both cytokines and many of them play 
a role in antiviral immunity (Dickensheets et al., 2013).  
In order to evaluate if RV can affect IFN-λ3 promoter activity through the 
expression of NSP1, a luciferase reporter was employed. The role of IRF-7 in the late 
induction of IFN-α has been previously discussed, and analogies in the promoter 
sequences with IFN-λ3 presume a similar activation profile. Due to this, preliminary 
experiments were performed in order to evaluate the inducibility of IFN-λ3 promoter 
using a plasmid encoding IRF-7. HEK293 cells were co-transfected as previously 
described for IFN-α4 (5.2.1.1.2) and 8h post-transfection, cells were mock-infected or 
infected with SeV. 18 hpi cells were harvested and luciferase activity determined 
(Figure 40). Indeed the exogenous expression of IRF-7 induced activation of IFN-λ3 
promoter, as reported for IFN-α4 (Figure 35), and as previously reported, the infection 
with SeV without the presence of IRF-7 was not able to induce the promoter activity. 
However, if SeV infection followed IRF-7 transfection, differences in the activation of 
IFN-λ3 promoter activity were observed compared to when cells were only 
transfected with IRF-7. These results differed from those obtained studying the 
inducibililty of IFN-α4 promoter, where the subsequent SeV infection of HEK293 cells 
transfected with IRF-7, had no impact on the induction of the promoter activity. 
 




Figure 40. IRF-7 mediated induction of IFN-λ3 in human HEK293 cell lines. 
HEK293 cells were co-transfected with an empty vector pcDNA3.1 along with an IFN-λ3 reporter, 
Renilla plasmid and 50 ng, 100 ng or 200 ng of human IRF-7. Cells were allowed to express plasmid-
encoded proteins for 8h and where required infected with SeV overnight or mock- infected. Cells were 
then harvested and luciferase values were read. Induction of the human IFN-λ3 promoter was 
evaluated by normalising the luciferase activity to Renilla and comparing the signals in cells stimulated 
to produce interferon with the exogenous expression of IRF-7 and those expressing IRF-7 and infected 
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 Given the two temporal differences in the activation of the IFN-λ3 promoter 
depending on the nature of the induction (IRF-7 acts as an ISG, mimicking a later 
phase of infection, while SeV induces IRF-3 activation, resembling an early stage of 
infection), the ability of NSP1 to downregulate the type III IFN promoter was 
evaluated in HEK293 cells only transfected with IRF-7, as well as in cells transfected 
with IRF-7 and then infected with SeV (Figure 41). The human NSP1 1M0, 18A and TC 
proteins, together with the porcine A8, appeared to have no significant effects on 
luciferase activity of following IRF-7 expression in the absence or presence of SeV 
infection. The porcine G10P5 and rhesus RRV exhibited a reduction in luciferase 
activity to approximately ~80% (P< 0.05 and P<0.01, respectively), however, when 
cells were infected with SeV, RRV showed a slight higher ability to know down its 
expression. The bovine UKtc was able to reduce luciferase activity to ~50% (P<0.01). 
Interestingly, Npro mediated a greater reduction in luciferase activity in cells which 
were subsequently infected with SeV, in comparison to those expressing only IRF-7 
(P<0.05). 
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HEK293 cells were co-transfected with plasmid encoding either human (1M0, 18A, TC) porcine (G10P5, 
A8), bovine (UKtc), rhesus (RRV) NSP1 proteins, and 50 ng of human IRF-7 along with an IFNλ3 reporter 
Renilla luciferase plasmid. Controls included transfection with an empty vector (pcDNA3.1) and 
plasmid expressing CSFV Npro. Where required, 24h post-transfection, cells were infected with SeV for 
16h, before being harvested and luciferase values were read. Activation of the IFNλ3 promoter 
(expressed in percentage) was determined by normalising the luciferase activity to Renilla and 
comparing the signals in cells transfected with NSP1 and cells expressing an empty vector. Data are 
presented as the mean of two independent experiments (+/- SD) and analysed with Student T-test 
*P<0.05, **P<0.01.  
 
Figure 41. IFN-λ3 downregulation by plasmid-encoded NSP1 in human HEK293 cell lines. 
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5.2.1.3 The effects of plasmid-encoded NSP1 on the activity of NF-κB 
Preliminary experiments were performed in order to evaluate the inducibility 
NF-κB promoter activity. To facilitate this, the luciferase reporter plasmid pKB6tkluc, 
containing 6 NF-kB multimeric responsive upstream of the firefly luciferase gene 
under the control of the Herpes Simplex thymidine kinase promoter, was used 
(Traenckner et al., 1995).  
HEK293 cells were co-transfected with pKB6tkluc, Renilla plasmid and either 
an empty vector (pcDNA3.1) or a plasmid encoding the sequence of Molluscum 
Contagiosum virus (MCV) MC159 protein as positive control (C. M. Randall et al., 
2012). 24h after co-transfection cells were administered with 5 ng/ml, 10 ng/ml or 
20 ng/ml of pig TNFα (gift from Chris Netherton, The Pirbright Institute) or infected 
with SeV for a further 18h to induce NF-κB transcription of or mock-treated. Cells 
were then harvested and luciferase activity was determined (Figure 42). The 
administration of TNFα clearly induced the transcriptional activity of NF-κB, with no 
substantial differences occurring between different dosages. SeV infection was able 
to activate the promoter activity, however, less potently compared to TNFα. TNFα-
mediated activation of NF-κB was abrogated by the expression of MCV MC159. Based 
on these results, TNFα at final concentration of 5 ng/ml was used in following 
experiments.  
 




Figure 42. NF-κB induction in human HEK293 cell lines. 
HEK293 were co-transfected with an empty vector (pcDNA3.1) or Molluscum Contagiosum Virus 
(MCV) MC159 along with an inducible firefly NF-κB reporter and a non-inducible Renilla plasmid. Cells 
were allowed to express plasmid-encoded protein for 24h and then treated with 5 ng/ml, 10 ng/ml or 
20 ng/ml of TNFα or infected with Sendai virus to induce NF-кB transcription activity. 18h post-
treatment cells were harvested and luciferase values were read. Data are provided as the means ± 
ranges of luciferase activity normalised to Renilla levels from one experiment with error bars 
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Once the inducibility of the NF-κB reporter had been established, HEK293 
were co-transfected with pKB6tkluc, Renilla plasmid and a plasmid expressing either 
human (1M0, 18A and TC), porcine (G10P5, A8 and OSU), bovine (UKtc) or rhesus 
(RRV) NSP1. The MCV-MC159 plasmid and empty vector (pcDNA3.1) were used as 
positive and negative controls, respectively. 24h after co-transfection cells were 
either treated with 5 ng/µl of TNFα for 16 h or mock-treated. Cells were harvested 
and luciferase values were then determined (Figure 43). The human 1M0 (P<0.0001), 
the bovine UKtc (P<0.0001), the rhesus RRV (P<0.0001) and the porcine OSU (P<0.01) 
were all able to downregulate NF-κB activity to ~40%. The other human-derived NSP1 
proteins (18A (P<0.0001)) and TC (P<0.0001)), together with the porcine A8 
(P<0.0001) reduced luciferase activity to ~60%, while porcine G10P5 (P<0.001) 
reduced it to ~80%. The bovine UKtc and MCV-MC159 were able to reduce the 
transcriptional activity of NF-κB to ~30% (P<0.0001). 




Figure 43. NF-kB downregulation by plasmid-encoded NSP1 in human HEK293 cell lines. 
HEK293 cells were co-transfected with plasmid encoding either human (1M0, 18A, TC) porcine 
(G10P5, A8, OSU), bovine (UKtc), rhesus (RRV) NSP1 along with an NF-κB reporter and Renilla 
plasmid. Controls included transfection with an empty vector (pcDNA3.1) and plasmid expressing 
MCV-MC159. Plasmid-encoded proteins were allowed to express for 24h and cells were exposed 
to 5 ng/ml of pig TNFα or mock induced. 16h post-induction cells were harvested and luciferase 
values were read. NF-κB transcriptional activity (expressed in percentage) was determined by 
normalising the luciferase activity to Renilla and comparing the signals in cells transfected with 
NSP1 and cells expressing an empty vector. Data are presented as the mean of four independent 
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The ability of NSP1 to downregulate NF-κB transcriptional activity was 
investigated in other human cell lines, however, transfections of HT-29 and Caco-2 
human-derived cell lines were unsuccessful, yielding non detectable luminescence 
values. The PK15 porcine cell line was next evaluated. Cells were transfected as 
previously described, treated with TNFα and luciferase activity was measured (Figure 
44). The bovine UKtc was able to reduce NF-κB activity to ~30% (P<0.0001), while the 
rhesus RRV to ~60% (P<0.0.1). Of the porcine NSP1 proteins, only OSU (P<0.01) was 
able to block NF-κB activity, reducing it to ~80%, while the other porcine, together 
with the human strains, did not significantly change luciferase activity. In PK15 cell 
lines, MCV-MC159 appeared to knock down NF-κB activity to ~60% (P<0.01). 
 




Figure 44. NF-kB downregulation by plasmid-encoded NSP1 in porcine PK15 cell lines. 
PK15 cells were co-transfected with plasmid encoding either human (1M0, 18A, TC) porcine 
(G10P5, A8, OSU), bovine (UKtc), rhesus (RRV) NSP1 along with an NF-κB reporter and Renilla 
plasmid. Controls included transfection with an empty vector (pcDNA3.1) and plasmid expressing 
MCV-MC159. Plasmid-encoded proteins were allowed to express for 24h and cells were exposed 
to 5 ng/ml of pig TNFα or mock induced. 16h post-induction cells were harvested and luciferase 
values were read. NF-κB transcriptional activity (expressed in percentage) was determined by 
normalising the luciferase activity to Renilla and comparing the signals in cells transfected with 
NSP1 and cells expressing an empty vector. Data are presented as the mean of four independent 
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Next, the previously generated chimeric NSP1 plasmids (18AUKtc or UKtc18A) 
were used to assess the ability of the encoded proteins to inhibit the NF-κB promoter 
activity in HEK293 cells following TNFα treatment. Figure 45 shows that swapping 
domains between the human 18A and the bovine UKtc appeared not to compromise 
the functionality of the viral protein, which were still able to downregulate NF-κB 
activity. The chimeric 18AUktc, containing the 18A N-terminus and the UKtc C-
terminus, showed a profile similar to that of the parental NSP1 UKtc protein, being 
able to reduce NF-κB activity to ~50% (P<0.0001). By contrast, the UKtc18A, which 
had the UKtc N-terminus and the 18A C-terminus, showed a profile similar to the 
parental strain 18A, showed a similar profile to the parental 18A, modulating the NF-
κB activity down to ~30% (P<0.001). Consistent with previous results (Figure 43), 
MCV-MC159 appeared to knock down NF-κB activity to ~40% (P<0.0001). 
 




Figure 45. NF-κB downregulation by plasmid-encoded NSP1 in human HEK293 cell lines: swapped 
domains between the human 18A and the bovine UKtc. 
HEK293 cells were co-transfected with plasmids encoding either the human NSP1 18A, the bovine 
NSP1 UKtc, the recombinant 18AUKtc or the recombinant UKt18A along with an NF-κB reporter 
and Renilla plasmid. Controls included transfection with an empty vector (pcDNA3.1) and plasmid 
expressing MCV-MC159. 24h post-transfection cells were treated with TNFα for 16h, before being 
harvested and luciferase values were read. Activation of the NF-κB transcriptional activity 
(expressed in percentage) was determined by normalising the luciferase activity to Renilla and 
comparing the signals in cells transfected with NSP1 and cells expressing an empty vector. Data are 
presented as the mean of two independent experiments (+/- SD) and analysed with Student T-test, 
***P<0.001, ****P<0.0001. 
The recombinant NSP1 18AUKtc of 499 aa in length has the N-terminus region (212 aa) from the 
human 18A and the C-terminus (287 aa) from the bovine UKtc. The recombinant UKtc18A of 487 
aa in length has the N-terminus (220 aa) from the bovine UKtc and the C-terminus (267 aa) from 
the human 18A. 
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5.2.1.3.1 Dissecting the NF-KB pathway 
Having identified the ability of NSP1 to downregulate the induction of IFN-λ 
(5.2.1.2) and having established that NSP1 is able to reduce TNFα-induced activation 
of the NF-κB promoter (5.2.1.3), which has been shown to be a responsible for a 
potent and sustained induction of type III IFN (Siegel et al., 2011; Thomson et al., 
2009), the ability of NSP1 to target components of the NF-κB canonical pathway was 
investigated. In order to evaluate the effect of NSP1 on specific components involved 
in the activation of NF-κB transcriptional activity, preliminary experiments were 
performed in order to establish the responsiveness of the NF-κB reporter to ectopic 
















In order to evaluate the inducibility of the NF-κB reporter in response to 
variation in concentration of IKKα, HEK293 cells were co-transfected with an empty 
vector (pcDNA3.1) along with pKB6tkluc, Renilla plasmid and 50 ng, 100 ng or 200 ng 
of a plasmid encoding the IKKα protein. 16h after co-transfection cells were 
harvested and luciferase activity values were determined (Figure 46). NF-κB 
canonical activation with 5 ng/ml of porcine TNFα was used as a positive control. The 
exogenous expression of 50 ng of IKKα appeared to marginally induce NF-κB 
transcriptional activity, however, when the amount was doubled to 100 ng, a 
negative effect was observed. Due to the lack of response of NF-κB to IKKα in a dose 
dependent manner, the effect of NSP1 on the IKKα-mediated activation of NF-κB was 









Figure 46. NF-κB promoter activity in response to exogenous expression of IKKα in human HEK293 
cell line. 
HEK293 cells were co-transfected with an empty vector pCDNA3.1, a NF-кB reporter and Renilla 
plasmid along with and 50 ng, 100 ng or 200 ng of IKKα. Equal amount of transfected DNA was reached 
with empty vector. Cells were allowed to express plasmid-encoded proteins 16h before being 
harvested and luciferase values were read. As positive control, cells were treated with 5 ng/ml of 
TNFα. Activation of the NF-кB transcriptional activity was determined by normalising the luciferase 
activity to Renilla and comparing the signals in cells transfected with IKKα and cells expressing an 
empty vector. Data are presented as the mean of one experiment (+/- SD). 
 
5.2.1.3.1.2 Iккβ 
Next the ability of exogenous IKKβ to induce NF-κB transcriptional activity was 
investigated. HEK293 cells were co-transfected as previously described (5.2.1.3.1.1) 
along with 50 ng, 100 ng or 200 ng of IKKβ. 16 h after co-transfection cells were 
harvested and luciferase values were determined (Figure 47). NF-κB canonical 
activation with 5 ng/ml of porcine TNFα was used as a positive control. Co-
transfection of 50 ng IKKβ was able to activate the transcriptional activity of NF-κB 
and a dosage-dependent increase was observed for increasing amounts of IKKβ. 
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Based on these results, the effect of NSP1 on the IKKβ-mediated activation of NF-κB 
was evaluated using 50 ng of IKKβ plasmid for co-transfections.  
 
 
Figure 47. NF-κB promoter activity in response to exogenous expression of IKKβ in human HEK293 
cell line. 
HEK293 cells were co-transfected with an empty vector pCDNA3.1, a NF-кB reporter and Renilla 
plasmid along with and 50 ng, 100 ng or 200 ng of IKKβ. Equal amount of transfected DNA was 
reached with empty vector. Cells were allowed to express plasmid-encoded proteins 16h before 
being harvested and luciferase values were read. As a postive control, cells were treated with 5 
ng/ml of TNFα. Activation of the NF-кB transcriptional activity was determined by normalising the 
luciferase activity to Renilla and comparing the signals in cells transfected with IKKα and cells 
expressing an empty vector. Data are presented as the mean of one experiment (+/- SD). 
 
HEK293 cells were co-transfected with pKB6tkluc, Renilla plasmid and a 
plasmid expressing human (1M0, 18A and TC), porcine (G10P5, A8 and OSU), bovine 
(UKtc) or rhesus (RRV) NSP1 or an empty (vector pcDNA3.1). 24h after co-
transfection cells were harvested and luciferase values were determined (Figure 48). 
The effect of NSP1 on the induction of NF-κB activity was evaluated by comparing 
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luciferase activity between cells expressing the viral protein and those expressing an 
empty vector. The human 1M0 (P<0.01) and TC (P<0.01), together with the porcine 
G10P5 (P<0.05) and the rhesus RRV (P<0.05) were able to knock down the IKKβ-
mediated transcriptional activity of NF-κB to ~50%. The bovine UKtc (P<0.001) and 
the porcine OSU (P<0.001) showed a more potent effect, being able to downregulate 
NF-κB to ~30%. Downregulation observed for the porcine A8 was not statistically 
significant. 
 
Figure 48. Effects of plasmids-encoded NSP1 on the Iккβ-mediated activation of NF-κB 
transcriptional activity in human HEK293 cell line. 
HEK293 cells were co-transfected with plasmids encoding either human (1M0, 18A, TC) porcine 
(G10P5, A8, OSU), bovine (UKtc) or rhesus (RRV) NSP1 proteins along with an NF-κB reporter and 
Renilla plasmid. Controls included transfection with an empty vector (pcDNA3.1). Activation of NF-
κB transcriptional activity was achieved transfecting cells with 50 ng of IKKβ. 16h post-transfection 
cells were harvested and luciferase values were read. Activation of the NF-кB (expressed in 
percentage) was determined by normalising the luciferase activity to Renilla and comparing the 
signals in cells transfected with NSP1 and cells expressing an empty vector. Data are presented as 
the mean of three independent experiments (+/- SD) and analysed with Student T-test *P<0.05, 
**P<0.01, ***P<0.001. 




In order to evaluate if NF-κB transcriptional activity could be triggered in 
HEK293 through the exogenous expression of β-TrCP, cells were co-transfected with 
250 ng of empty vector (pcDNA3.1) along with a reporter plasmid encoding firefly 
under the control of the human NF-κB promoter, Renilla plasmid and 50 ng, 100 ng 
or 200 ng of plasmid encoding the sequence for β-TrCP. 16h after co-transfection 
cells were treated with 5 ng/ml of TNFα to for a further 6h, 12h or 24h before being 
harvested and luciferase values determined (Figure 49). NF-κB canonical activation 
with 5 ng/ml of porcine TNFα was used as positive control. As previously shown 
(Figure 42) treatment of HEK293 cells with TNFα induced a strong response in NF-κB 
transcriptional activity at 6h post treatment. As expected, TNFα treatment led to a 
significant increase in luciferase activity (P<.0001), however, this was not improved 
by prior co-transfection of the β-TrCP plasmid. In fact, co-transfection of the β-TrCP 
and subsequent TNFα treatment for 6h and 12h led to relative luminescence values 
that were ~50% lower than those observed for TNFα treatment only. Co-transfection 
followed by TNFα treatment for 24h after led to further reductions in relative 
luminescence values when 100 ng and 200 ng of the β-TrCP plasmid were used. 









Figure 49. NF-κB promoter activity in response to exogenous expression of β-TrCP in human 
HEK293 cell lines. 
HEK293 cells were co-transfected with 250ng of an empty vector (pCDNA3.1), a NF-кB reporter and 
Renilla plasmid, along and 50 ng, 100 ng or 200 ng of β-TrCP. Equal amount of transfected DNA was 
reached with empty vector. Cells were allowed to express plasmid-encoded proteins for 24 h and 
then exposed to 5ng/ml of pig TNFα. 6h, 12h and 24h post-induction, cells were harvested and 
luciferase values were read. Activation of NF-кB activity was determined by normalising the 
luciferase activity to Renilla and comparing the signals in cells transfected with β-TrCP and treated 
with TNFα. Data are presented as the mean of one experiment (+/- SD). 
The activity of NF-κB needs to be strictly controlled and a negative feedback 
loop is in place. The exacerbating overexpression of one of the components involved 
in the NF-κB canonical induction pathway can result in NF-κB-mediated induction of 
IκB. Newly synthetized IκB moves to the nucleus, binds to NF-κB and translocates into 
the cytoplasm, thereby terminating NF-κB directed transcription (Fagerlund et al., 
2015). Based on that, the induction of NF-κB was investigated only in response to 
exogenous expression of β-TrCP, without TNFα treatment. Due to the fact that no 
difference was observed between cells transfected with 50 ng of β-TrCP and cells 
containing only media, <50 ng of β-TrCP plasmid was used for co-transfections. 
HEK293 cells were co-transfected with an empty vector (pcDNA3.1) along with a 
reporter plasmid encoding firefly under the control of the human NF-κB promoter, 
Renilla plasmid and 10 ng, 25 ng or 50 ng of β-TrCP plasmid. NF-κB canonical 
activation with 5 ng/ml of porcine TNFα was used as control. 16h after co-
transfection cells were harvested and luciferase values were determined (Figure 50). 
Indeed the overexpression of β-TrCP was able to induce the NF-κB promoter leading 
to a significant increase (P<0.001) in luciferase activity. No substantial differences 
observed between 10 ng and 25 ng. Consistent with previously presented data 
(Figure 49), 50 ng appeared to be the highest amount of β-TrCP plasmid that could 
be transfected before a comparative decrease in relative luminescence was 
observed. Based on this, the effect of NSP1 on the β-TrCP-mediated activation of NF-
κB was evaluated following co-transfection of 25 ng β-TrCP plasmid.  





Figure 50. NF-кB promoter activity in response to exogenous expression of β-TrCP in human 
HEK293 cell lines. 
HEK293 cells were co-transfected with an empty vector (pCDNA3.1), a NF-кB reporter and Renilla 
plasmid, along with 10 ng, 25 ng or 50 ng of for β-TrCP. Equal amount of transfected DNA was reached 
with empty vector. 16h post-transfection cells were harvested and luciferase values were read. As 
positive control, cells were treated with 5 ng/ml of TNFα. Activation of the NF-кB transcriptional 
activity was determined by normalising the luciferase activity to Renilla and comparing the signals in 
cells transfected with β-TrCP and cells expressing an empty vector. Data are presented as the mean 
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HEK293 cells were co-transfected with pKB6tkluc, Renilla plasmid and a 
plasmid expressing human (1M0, 18A and TC), porcine (G10P5, A8 and OSU), bovine 
(UKtc) or rhesus (RRV) NSP1 or an empty vector (pcDNA3.1). NF-κB transcription was 
activated by co-transfecting cells with 25 ng of β-TrCP or mock-transfected. 24h after 
co-transfection cells were harvested and luciferase values determined (Figure 51). 
The effect of NSP1 on the induction of NF-κB promoter activity was evaluated by 
comparing the relative luminescence between cells expressing the viral protein and 
those expressing an empty vector. The human 1M0 and TC (P<0.001), together with 
the porcine G10P5 (P<0.001) and OSU (P<0.0001), the bovine UKtc (P<0.01) and 
rhesus RRV (P<0.01) were all able to reduce luciferase activity to ~50%. The human 
18A was able to further reduce the transcriptional activity to ~40% (P<0.001). By 











Figure 51. Effects of plasmids-encoded NSP1 on the β-TrCP-mediated activation of NF-κB 
transcriptional activity in human HEK293 cell line. 
HEK293 cells were co-transfected with plasmids encoding either human (1M0, 18A, TC) porcine 
(G10P5, A8, OSU), bovine (UKtc) or rhesus (RRV) NSP1 proteins along with an NF-κB reporter and 
Renilla plasmid. Controls included transfection with an empty vector (pcDNA3.1). Activation of NF-κB 
transcriptional activity was achieved transfecting cells with25 ng of β-TrCP. 16h post-transfection cells 
were harvested and luciferase values were read. Activation of the NF-кB (expressed in percentage) 
was determined by normalising the luciferase activity to Renilla and comparing the signals in cells 
transfected with NSP1 and cells expressing an empty vector. Data are presented as the mean of three 









Given that p50–p65 is the most commonly detected NF-κB dimer, the ability 
of NSP1 to downregulate NF-κB transcriptional activity by targeting p50 or p65 was 
investigated. Preliminary experiments were performed to study inducibility of the 
NF-κB activity in response to increasing concentrations of p50 and p65. In order to 
do this HEK293 cells co-transfected with pKB6tkluc, Renilla plasmid and 50 ng, 100 
ng or 200 ng of plasmid encoding the sequence for p50. 16h after co-transfection 
cells were treated with 5 ng/ml of TNFα for 6h, 12h or 24h before being harvested 
and luciferase values determined (Figure 52). p50 was unable to induce NF-κB 
activity, as an increase in luciferase activity was only observed when cells were 
subsequently treated with TNFα. In addition, increasing the concentration of co-
transfected p50 appeared to have a negative feedback on NF-κB transcriptional 
activity following TNFα treatment. Based on results previously observed with β-TrCP 
(Figure 50), a reduced amount of p50 plasmid was co-transfected to induce the NF-
κB promoter, and subsequent TNFα treatment was not used. 
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Figure 52. NF-κB promoter activity in response to exogenous expression of p50 in human HEK293 
cell lines. 
HEK293 cells were co-transfected with 250ng of an empty vector (pCDNA3.1), NF-кB reporter and 
Renilla plasmid, along and 50 ng, 100 ng or 200 ng of p50. Equal amount of transfected DNA was 
reached with empty vector. Cells were allowed to express plasmid-encoded proteins for 24 h and then 
exposed to 5ng/ml of pig TNFα. 6h, 12h and 24h post-induction, cells were harvested and luciferase 
values were read. Activation of NF-кB activity was determined by normalising the luciferase activity 
to Renilla and comparing the signals in cells transfected with p50 and treated with TNFα. Data are 
presented as the mean of one experiment (+/- SD). 
 
Figure 53 shows that co-transfection of 10 ng of p50 plasmid, in the absence 
of subsequent TNFα treatment, mediated an increase in luciferase activity in HEK293 
cells (P<0.05). However, co-transfection of 25 ng and 50 ng of p50 plasmid both led 
to a decrease in luciferase activity. NF-κB canonical activation with 5 ng/ml of porcine 
TNFα, in the absence of co-transfection of the p50 plasmid, was used as control and 
led to the highest increase in luciferase activity (P<0.05). This data suggested that at 
lower concentration, p50 is potentially dimerising with itself or available p65, moving 
into the nucleus and initiate transcription (Tong et al., 2004). However, when 
expression of p50 exceeded critical threshold, a negative feedback loop of NF-κB was 
induced. Based on these results, the overexpression of p50 was excluded from 
further investigation. 




Figure 53. NF-кB promoter activity in response to exogenous expression of p50 in human HEK293 
cell lines. 
HEK293 cells were co-transfected with an empty vector pCDNA3.1, a NF-кB reporter and Renilla 
plasmid along with 10 ng, 25 ng or 50 ng of p50. Equal amount of transfected DNA was reached 
with empty vector. Cells were allowed to express plasmid-encoded proteins16h before being 
harvested and luciferase values were read. As positive control, cells were treated with 5 ng/ml of 
TNFα. Activation of the NF-кB transcriptional activity was determined by normalising the luciferase 
activity to Renilla and comparing the signals in cells transfected with p50 and cells expressing an 
empty vector. Data are presented as the mean of two experiments (+/- SD). 
 
5.2.1.3.1.5 p65 
p65 (known also as RelA) is the major transcriptional activating NF-κB subunit. 
In resting conditions, p65 nuclear signal is sequestered by IκB, however, upon 
phosphorylation and β-TrCP-mediated degradation of IκB, nuclear signal is exposed 
and p65 is able to translocate to the nucleus. In order to evaluate if RV NSP1 can 
target p65, preliminary experiments were performed in order to evaluate if NF-κB 
activity responded to a variation in the cellular concentration of p65. In order to do 
this HEK293 cells were co-transfected with an empty vector (pcDNA3.1) along with 
pKB6tkluc, Renilla plasmid and either 10 ng, 25 ng or 50 ng of plasmid encoding the 
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sequence for p65. 16h after co-transfection cells were harvested and luciferase 
values determined (Figure 54). NF-κB canonical activation with 5 ng/ml of porcine 
TNFα was used as control. The exogenous expression of p65 appeared to induce NF-
κB activity in dose-dependent manner. Based on this, the effect of NSP1 on the p65-
mediated activation of NF-κB was evaluated activating NF-κB promoter activity with 
the ectopic expression of 50 ng of p65. 
 
 
Figure 54. NF-κB promoter activity in response to exogenous expression of p65 in human HEK293 
cell lines. 
HEK293 cells were co-transfected with an empty vector pCDNA3.1, a NF-кB reporter and a Renilla 
plasmid along with 10 ng, 25 ng or 50 ng of p65. Equal amount of transfected DNA was reached 
with empty vector. Cells were allowed to express plasmid-encoded proteins16h before being 
harvested and luciferase values were read. As positive control, cells were treated with 5 ng/ml of 
TNFα. Activation of the NF-кB transcriptional activity was determined by normalising the luciferase 
activity to Renilla and comparing the signals in cells transfected with 65 and cells expressing an 
empty vector. Data are presented as the mean of two experiments (+/- SD). 
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HEK293 cells were co-transfected with pKB6tkluc, Renilla plasmid and a 
plasmid expressing either human (1M0, 18A and TC), porcine (G10P5, A8 and OSU), 
bovine (UKtc) and rhesus (RRV) NSP1 or empty vector (pcDNA3.1). NF-κB was 
activated with the exogenous expression of p65 or mock-transfected. 24h after co-
transfection cells were harvested and luciferase values determined (Figure 55). The 
bovine UKtc and the porcine OSU were able to reduce NF-κB activity to ~60% (P<0.01), 
while the rhesus RRV showed an effect of the 20% (P<0.01). The human strain 1M0, 
18A and TC and the porcine G10P5 and A8 appeared to have no effect on the p65-
mediated activation of NF-κB transcriptional activity. 
 
 
Figure 55. Effects of plasmids-encoded NSP1 on the p65-mediated activation of NF-кB 
transcriptional activity in human HEK293 cell lines. 
HEK293 cells were co-transfected with plasmids encoding either human (1M0, 18A, TC) porcine 
(G10P5, A8, OSU), bovine (UKtc) or rhesus (RRV) NSP1 proteins along with a plasmid expressing 
luciferase under the control of mice NF-кB promoter and a non-inducible plasmid expressing Renilla 
and a plasmid expressing p65. Controls included transfection with an empty vector (pcDNA3.1). 
24h post-transfection cells were harvested and luciferase values were read. Activation of the NF-
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кB transcriptional activity (expressed in percentage) was determined by normalising the luciferase 
activity to Renilla and comparing the signals in cells transfected with NSP1 and cells expressing an 
empty vector. Data are presented as the mean of three independent experiments (+/- SD) and 
analysed with Student T-test **P<0.01. 
 
5.2.1.4 NSP1-mediated antagonization of Mx promoter activity 
It has been shown that the NSP1 protein encoded by the rhesus RV isolate 
(RRV) is able to affect the expression of ISGs by blocking STAT/1/2 nuclear 
translocation (Holloway et al., 2014; Sen et al., 2014). In order to investigate the 
ability of other NSP1 proteins to block the ISG induction a luciferase reporter assay 
was used in which the promoter sequence of the pig Mx2 gene was inserted upstream 
of a firefly luciferase reporter plasmid. 
Preliminary experiments were performed to evaluate the inducibility of Mx2 
reporter upon IFN treatment. HEK293 cells were co-transfected with Mx2 reporter, 
Renilla plasmid and an empty vector (pcDNA3.1) or plasmid encoding Rinderpest 
virus (RPV) Saudi/81 V protein as positive control (Chinnakannan et al., 2013). 24h 
after co-transfection cells were treated with 500 U/µl, 1000 U/µl, or 2000 U/µl of pig 
IFN-α (Abcam, #ab209114) for a further 6h or 8h, or were infected with SeV for 16h. 
Cells were then harvested and luciferase values determined (Figure 56). Treatment 
of HEK293 with IFN-α to induce Mx2 transcription resulted in a small, but not 
significant increase inMx2 promoter activation at 6h post-treatment, however, no 
substantial difference was observed in response to increasing concentrations of IFN-
α. Activation of the Mx2 promoter was also observed 18h post-treatment, however, 
this was unspecific the induction was observed in treated (red and purple bars) and 
mock-treated samples (blue bars).  
 
 





Figure 56. Porcine Mx2 induction in human HEK293 cell lines. 
HEK293 cells were co-transfected with an empty vector (pcDNA3.1) or Rinderpest virus (Saudi/80) 
V protein along with Mx2 reporter and a Renilla plasmid. After 24h cells were exposed to 500 U/ml 
1000 U/ml or 2000 U/ml of pig IFNα or infected with SeV. 6h or 18h post-treatment cells were 
harvested and luciferase values were read. Mx2 relative promoter activity was evaluated comparing 
luciferase produced in cells treated with IFNα with those containing only media. Data are provided 
as the means ± ranges of luciferase activity normalised to Renilla levels from one experiment with 
error bars representing standard deviation. 
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Strong basal luciferase activity has previously been reported for the Mx2 
luciferase reporter in the absence of IFN stimulation by Jorns et al (Jorns et al., 2006). 
They reported that a selective induction was achieved when the reporter gene was 
under the control of a 2.300 Kb-fragment of the mouse Mx1 promoter (Hug et al., 
1988). Therefore,HEK293 cells were co-transfected with a reporter plasmid encoding 
firefly under the control of the mouse Mx1 promoter (pGL3-Mx1P-luc, gift from Prof 
Kocks – Virology Institute of Freiburg), Renilla plasmid and a plasmid expressing 
either human (1M0, 18A and TC), porcine (G10P5 and A8), bovine (UKtc) or rhesus 
(RRV) NSP1. The RPV Saudi/81 V plasmid and empty vector (pcDNA3.1) were used as 
controls. 24h after co-transfection cells were treated with 500 U/ml of pig IFNα for a 
further 16 h to induce the Mx1 promoter. Cells were then harvested and luciferase 
values determined (Figure 57). The human NSP1 1M0, 18A and TC (P<0.0001) and 
the rhesus RRV (P<0.0001) were all able to reduce luciferase activity to ~80%. The 
porcine G10P5 and A8 reduced luciferase activity to ~70% (P<0.0001), while the 
bovine reduced it to 50% (P<0.001). RPV-V appeared to completely abolish Mx1 
promoter activity (P<0.0001). 
 
 




Figure 57. Murine Mx1 downregulation by plasmid-encoded NSP1 in human HEK293 cell lines. 
HEK293 cells were co-transfected with plasmids encoding either human (1M0, 18A, TC) porcine 
(G10P5, A8), bovine (UKtc) or rhesus (RRV) NSP1 proteins along with a Mx1 reporter and a Renilla 
plasmid. Controls included transfection with an empty vector (pcDNA3.1) and plasmid expressing 
Rinderpest virus V protein (RPV-V). 24h post-transfection cells were treated with pig IFNα for 16h, 
before being harvested and luciferase values were read. Activation of the Mx1 promoter (expressed in 
percentage) was determined by normalising the luciferase activity to Renilla and comparing the signals 
in cells transfected with NSP1 and cells expressing an empty vector. Data are presented as the mean 
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The ability of NSP1 to downregulate transcriptional activity of the Mx1 
promoter was investigated in other human cell lines, however, transfections of HT-
29 and Caco-2 human-derived cell lines were unsuccessful, yielding non detectable 
luminescence values. The PK15 porcine cell line was next evaluated. Cells were co-
transfected as previously described, treated with IFN-α and luciferase activity under 
the control of Mx1 promoter was measured (Figure 58). The human NSP1 1M0 and 
TC were able to reduce luciferase activity to ~40% (P<0.01). Human 18A (P<0.001), 
together with the porcine G10P5 and A8 and the bovine UKtc (P<0.001) all reduced 
luciferase activity to ~30%, while the rhesus RRV reduced it to ~20% (P<0.001). 
Consistent with previous data (Figure 57), in PK15 cell lines, RPV-V appeared to knock 










Figure 58. Murine Mx1 downregulation by plasmid-encoded NSP1 in porcinePK15 cell lines. 
PK15 cells were co-transfected with plasmids encoding either human (1M0, 18A, TC) porcine (G10P5, 
A8), bovine (UKtc) or rhesus (RRV) NSP1 proteins along with a Mx1 reporter and a Renilla plasmid. 
Controls included transfection with an empty vector (pcDNA3.1) and plasmid expressing Rinderpest 
virus V protein (RPV-V). 24h post-transfection cells were treated with pig IFNα for 16h, before being 
harvested and luciferase values were read. Activation of the Mx1 promoter (expressed in percentage) 
was determined by normalising the luciferase activity to Renilla and comparing the signals in cells 
transfected with NSP1 and cells expressing an empty vector. Data are presented as the mean of three 
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5.3 Summary of the luciferase reporters  
Results obtained in this chapter have reported a strain-specific ability of RV 
NSP1 to target the induction of type I and type III IFNs and their signalling pathway 
(Table 12). With the exception of the porcine-derived A8, all the NSP1 considered in 
this study appeared to be able to modulate the induction of type I IFN, IFN-β but not 
IFN-α. More pronounced effect in the downregulation of type III IFN was observed 
among different strains. In contrast, a more potent and conservative ability to target 
the transcriptional activity of NF-κB and the induction of Mx1 was observed. 
 
Table 12. Summary of the luciferase reporters. 
Host origin HUMAN PORCINE BOVINE RHESUS 
NSP1 strains 1M0 18A TC G10P5 A8 UKtc RRV 
Reporter  
IFN-β ++ ++ ++ ++ NE ++ +++ 
IFN-α NE NE NE NE + ++ NE 
IFN-λ1 ++ ++ ++ +++ + ++ +++ 
IFN-λ3 + NE NE + NE ++ + 
NF-κB ++ ++ ++ + ++ +++ ++ 
Mx1 +++ +++ +++ +++ +++ ++ +++ 
Table indicating the effects of plasmid-encoded NSP1 on the reporter activity of type I IFN (IFN-β and 
IFN-α), type III IFN ( IFN-λ1 and IFN-λ3), NF-κB and Mx1 in human cell lines HEK293. “+” indicates 
potency of downregulation: “+++” >70%, “++” 40%-60%, “+” 70%-90%. “NE” no effects. 
  




NSP1 is the most variable RV protein, with an amino acid sequence much more 
variable even then outer capsid proteins VP7 and VP4 (Dunn et al., 1994). The 
functionality of NSP1 in downregulating the host innate immune response suggests 
that the viral protein is expressed during the early stages of RV replication soon after 
the infection. NSP1 expression throughout the course of infection is very low 
(Johnson et al., 1989; Pina-Vazquez et al., 2007) and the protein does not appear to 
be essential for RV replication in cell culture as mutants encoding a truncated version 
of the protein can still replicate, however, producing smaller virus plaques (Kanai et 
al., 2017; K. Taniguchi et al., 1996). The NSP1-mediated ability of RV to counteract 
the IFN response is conserved between strains infecting different species, however, 
targets within the induction and signalling pathways may vary (Arnold, 2016). NSP1 
from bovine (UKtc), rhesus (RRV) and murine (EW) have been shown to target IRF-3 
inducing its proteasome-mediated degradation (Barro et al., 2005; Sen et al., 2009). 
In contrast, the OSU-derived NSP1 has been reported to target the NF-kB pathway, 
inducing the degradation of β-TrCP (Di Fiore et al., 2015; Graff et al., 2009). 
To understand if NSP1 derived from different RV strains are capable of down-
regulating the induction of IFN in a host-specific manner,  the Y-2-H system was 
employed to assess potential strain-specific interactions (Fields et al., 1989), which 
has been used in the past to screen for potential partner of NSP1 (Graff et al., 
2002).Y-2-H interaction assays carried out between NSP1 proteins derived from 
human (18A, 1M0, TC), porcine (G10P5, A8), bovine (UKtc) and rhesus (RRV) RV 
strains did not identify interactions with human MAVS, TBK1, RIG-I MDA5 and β-TrCP 
proteins under high stringency conditions (Figure 14, Figure 15, Figure 19). In 
contrast with Y-2-H screening, co-IP experiments reported that NSP1 encoded by pig 
(OSU), cattle (UKtc), human (Wa), mice (EW) and rhesus (RRV) RV strains interacted 
with human MAVS, driving its degradation (Nandi et al., 2014). The same 
experimental approach was used to confirm an interaction between NSP1 derived 
from pig (OSU) and simian (SA-11) RV strains and RIG-I (Broquet et al., 2011; Qin et 
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al., 2011). The interaction between β-TrCP and human NSP1 Wa was also confirmed 
by co-IP (Ding et al., 2016) or pull-down (Lutz et al., 2016), however, not by Y-2-H.  
 
 Y-2-H analysis performed in this study showed a strain-specific interaction 
occurring between IRF-3 and NSP1 encoded by different species. Some NSP1 were 
able to interact with IRF-3 from disparate host species even under high stringency 
conditions, while other NSP1 showed no interaction with any of the TF (Figure 14, 
Figure 15, Figure 16, Figure 17, Figure 18 and Figure 19). By contrast, other NSP1/IRF-
3 interactions were detectable only under lower stringency conditions (Figure 20). 
The bovine UKtc showed a more promiscuous activity, being able to strongly interact 
with the IRF-3 encoded by human, pigs, cattle and monkeys. Swine NSP1 G10P5 was 
able to target both pig and monkey IRF-3, while no interactions were confirmed for 
swine NSP1 A8 due to its ability to self-activate the system (Figure 13). Lower 
stringency screening revealed how the human 1MO was weakly interacting with the 
human, bovine and monkey-derived IRF-3. The same stringency conditions revealed 
a weak or transient interaction between the human TC NSP1 and the monkey and 
cattle-derived IRF-3. The other human (18A) and the rhesus (RRV) NSP1 proteins 
showed no interactions, even under lower stringency conditions (Table 11). 
The adaptor proteins STING, MAVS, and TRIF contain a conserved motif, pLxIS 
(in which p represents the hydrophilic residue, x represents any residue, and S 
represents the phosphorylation site), that is phosphorylated by TBK1 or IKKε and 
mediates the recruitment of IRF-3 to the signalling complexes (S. Liu et al., 2015). 
Because the pLxIS motif plays a critical role in mediating the recruitment of IRF-3 in 
the cGAS-, RLR-, and TLR-signalling pathways, NSP1 employs this motif to sequester 
IRF-3 and induce its degradation (B. Zhao et al., 2016). A BLAST homology search 
revealed that RV NSP1 also contains a pLxIS motif within its C-terminal 17 residues 
(B. Zhao et al., 2016). Interestingly, of the NSP1 considered in this study, only rhesus 
NSP1 RRV contains a complete pLxIS motif (alignment not shown); however, it was 
not able to interact with any of the IRF-3 under the stringency conditions tested. 
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Y-2-H screening involving chimeric NSP1 suggested that both the amino and 
carboxyl termini regions of NSP1 cooperate for an optimal interaction with IRF-3. 
Those two regions carry respectively the putative RING domain (located in the N-
terminus) and the pLxIS motif (located in the C-terminus). Proper folding and 
structure of NSP1 are important for IRF-3 interaction and experiments involving 
mutations in the zinc-binding RING domain have reported a reduction of 30% in IRF-
3 binding ability (Graff et al., 2007). 
Luciferase reporters have shown the ability of all NSP1 to downregulate the 
IFN-β induction, targeting components that bind the PDR elements in the promoter 
region of type I IFN (Figure 30 and Figure 32). The bovine UKtc and the rhesus RRV 
mediated the highest reduction in IFN- β promoter activity. In contrast with Y-2-H 
assays, the use of a PDRIII firefly luciferase reporter (a functional reporter whose 
expression is dependent on an IRF-3 sensitive promoter element (Fitzgerald et al., 
2003), showed that all NSP1 were able to target IRF-3-mediated induction of the IFN-
β promoter (Figure 31). The ability of the porcine-derived NSP1 to downregulate a 
PDRIII-driven IFN-β expression was greater than the human, and similar to that of 
UKtc and RRV NSP1. Arnold and colleagues reported the ability of NSP1 to target IRF-
3 is a three-factor event, which depends on the viral strain, the host species and the 
experimental context (Arnold et al., 2009). 
Results obtained with wild-type and PDRIII driven IFN-β promoter reporters 
showed contrasting results with previously published data. Simian-derived NSP1s 
have been shown to downregulate IFN-β by targeting IRF-3. Work by Barro showed 
how the simian SA-11 RV strain was able to suppress the IFN induction in FRhL2 cell 
lines (monkey) and how this was achieved by targeting IRF-3 (Barro et al., 2007). In 
the same work, they generated a series of truncated simian NSP1 which were unable 
target IRF-3 and to inhibit the expression of IFN-β. The same simian strain, together 
with the rhesus RRV, the bovine NCDV and the porcine OSU, were used by Arnold to 
show how the downregulation of IFN-β was not strictly correlated with IRF-3 
degradation: all the strains were able to modulate type I IFN, however, only the 
simian, rhesus and bovine but not OSU were targeting IRF-3 (Arnold et al., 2011).  
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MA104 infection with OSU RV or exogenous expression of OSU NSP1 results 
in IRF-3 phosphorylation and nuclear translocation (Graff et al., 2009; Graff et al., 
2007). In contrast with its inability to induce IRF-3 degradation, OSU infection of 
MA104 did not induce IFN-β. Recombinant strain carrying OSU NSP1 showed how the 
IFN downregulation was due to NSP1 (Graff et al., 2009). Similar results were 
obtained in different cell lines of different host origin, excluding the cellular context 
as a potential factor. 
The interplayed role of strain/host/cells in the NSP1-IRF-3 degradation and 
subsequent modulation of IFN-β was further investigated by Greenberg’s group, 
trying to identify the role of IFN-β response in regulation of heterologous and 
homologous RV infections in mouse embryonic fibroblasts (MEFs) (Feng et al., 2009). 
The virus yields of bovine (UK and NCDV) and porcine (OSU) RV from wild-type MEFs 
were more than 2 log units lower than that from IFN-deficient MEFs, indicating the 
IFN sensitivity of these strains in wild-type MEFs. In contrast, the replication rates of 
rhesus RRV and homologous murine ETD and EHP strains were similar in both wild-
type and IFN-deficient MEFs. The growth of another simian strain, SA-11, was 
reduced 8- to 10-fold in wild-type compared to IFN-deficient MEFs. These 
experiments indicated that the heterologous bovine and porcine RV strains were 
highly sensitive to the antiviral effects of the murine IFN system, while the two 
homologous strains together with the rhesus RRV strain, replicate optimally despite 
the presence of an intact IFN signalling system. MEFs infected with the bovine UKtc 
strain, or with RV reassortants carrying UKtc gene 5 (encoding NSP1) induced a robust 
IFN-β response. In contrast, rhesus RRV, RRV-like reassortant for gene 5 and EDT 
strains significantly reduced IFN-β secretion in wild-type MEFs.  
Infection of MEFs with bovine UKtc and NCDV or porcine OSU resulted in 
stable levels of IRF-3. By contrast, during RRV or EDT infection, IRF-3 was susceptible 
to proteasome-mediated degradation or unable to move to the nucleus. The inability 
of UKtc to target IRF-3 in MEFs cells was maybe due to intrinsic characteristics of the 
strain and/or to extrinsic host factors. In support to this, Sen et al found that infection 
of COS7 cell lines (simian) with the bovine UKtc and NCDV strains resulted in IRF-3 
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degradation (Sen et al., 2009). However, porcine OSU was still unable to target IRF-3 
even in COS7. In the same cell lines, using a PDRIII reporter, they showed how rhesus 
RRV, murine EW and bovine UKtc NSP1 strongly inhibited PDRIII activity upon 
poly(I:C) transfection. Increasing concentrations of ectopic IRF-3 alleviated this effect 
in a dose dependent manner, confirming the hypothesis that in COS7 the NSP1 
inhibition of poly(I:C) response occurs primarily by degradation of IRF-3. Moreover, 
they were able to identify the ability of RRV, EW and UKtc NSP1 to downregulate 
PDRIII activity upon activation of the reporter with the activator TBK1, confirming 
that in COS7 those NSP1 were able to inhibit IRF-3 function following the activation 
of the IRF-3 C-terminal cluster of 5-phospho acceptors sites, maybe targeting 
phosphorylated/dimerized IRF-3.  
In has been shown that in non-permissive cell lines bovine UKtc RV infection 
and UKtc NSP1 expression are not able to induce degradation of IRF-3, leading to in 
a strong IFN-β response (Feng et al., 2009). Same effect was obtained when UKtc 
NSP1 was expressed in 3T3 murine cell lines. However when 3T3 were infected with 
UKtc RV, a significant reduction in PDRIII IFN-β reporter was observed. Same effects 
were observed for Rhesus RRV and murine EW RV infection (Sen et al., 2009). These 
founding suggest that NSP1 may encodes additional mechanisms to inhibit IRF-3 
function that are independent of IRF-3 degradation. 
Infection of Caco-2 and FRhL2 cell lines with the simian SA-11 RV strain 
resulted in co-immunoprecipitation of NSP1 with IRF-3. A function of time decrease 
in IRF-3 levels was observed such that by 9–12 hpi, IRF-3 levels were considerably 
lower than those levels present in mock-infected cells (Barro et al., 2005). In the same 
cellular context, using an IFN-β luciferase reporter, they showed how infection with 
the simian strain SA-11 resulted in a 4-fold decrease in the IFN-β induction compared 
to cells infected with a virus carrying a C-truncated NSP1. SA-11 infection resulted in 
accumulation of IRF-3 in the cytoplasm, while a mutant carrying a C-truncated NSP1 
was unable to prevent IRF-3 nuclear translocation. They also showed how the simian 
NSP1 targets the phosphorylated forms of IRF-3 dimers, as previously shown by Sen 
(Sen et al., 2009). The ability of bovine RV B641 and simian RV SA-11 to induce the 
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degradation of IRF-3 has been also reported in MA104 cell lines (Graff et al., 2007), 
and is consistent with previously published data (Barro et al., 2005). 
MA104 infected with B641 carrying a rearrangement in gene 5 (strain A5-16) 
resulted in IRF-3 being activated and stable during the course of infection (Graff et 
al., 2007). Same effect on IRF-3 was observed when MA104 were infected with 
porcine OSU RV. To exclude that the inability of NSP1 to target IRF-3 was due to its 
low expression levels, Graff investigated the effect of transient expression of NSP1. 
In KEH293 cell lines, exogenous expression of OSU NSP1 resulted in IRF-3 being 
stable, further confirming the inability of the swine-derived NSP1 to target IRF-3, 
independently of the cellular context. 
Y-2-H analyses have shown how the porcine G10P5 interacts with the 
homologous IRF-3, plus the one encoded by human and monkey (Figure 15, Figure 
17 and Figure 18). Analyses of the amino acid sequences of the porcine G10P5 and 
OSU (data not shown) revealed that the OSU carries only 1 out of 5 of the amino acid 
of the PDL motif necessary for the interaction with IRF-3 (B. Zhao et al., 2016). 
Interestingly, the RRV NSP1, which has a full PDL motif is not interacting with any of 
the IRF-3s screened against, and the bovine UKtc NSP1, which present only a partial 
motif (1 out of 5 amino acid), is interacting with all IRF-3s. These findings suggest that 
the interaction between NSP1 and IRF-3 cannot be addressed to a single motif, but 
are more likely to be a synergic event involving more than one viral protein region. 
GST pull-downs revealed that UKtc and OSU NSP1 interact with monkey derived IRF-
3, however, UKtc precipitated comparatively more IRF-3 (Graff et al., 2007). This 
could explain that the stability of IRF-3 in cells infected with OSU or transfected OSU 
NSP1 could be due to a weak or transient interaction between NSP1 and IRF-3 human 
or monkey cell lines. 
Tandem affinity purification coupled with high-resolution mass spectrometry 
has revealed a strain-specific interaction between NSP1 and IRF-3 or β-TrCP (Ding et 
al., 2016). NSP1s from rhesus (RRV) and murine (ETD) RV strains exclusively bind to 
human IRF-3 while those from the two human (Wa, ST3) strains bind to human β-
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TrCP.  As reported in this study, the UKtc NSP1 interacts with human IRF-3 (Figure 
17). Ding showed how UKtc interacted with both human IRF-3 and β-TrCP likely 
representing an evolutionarily intermediate viral protein. In this study, no interaction 
between RRV NSP1 and any of the IRF-3s tested was observed using the Y-2-H system 
(Figure 14, Figure 17 and Figure 18). In agreement with the Y-2-H data described 
herein (Figure 14, Figure 15, Figure 16 and Figure 19), Ding reported that MAVS did 
not interact with NSP1 (Ding et al., 2016). However, it has been previously shown 
using co-IP that the simian Sa-11 NSP1 interact with MAVS (Nandi et al., 2014) and 
that bovine A5-13 with TRAF2 (Bagchi, Bhowmick, et al., 2013). 
Type I IFN also plays a role in driving the generation of adaptive immune 
responses (Le Bon et al., 2006; Le Bon et al., 2002), a process during which dendritic 
cells (DCs) play a central role. Studies have shown that virus exposure stimulates DCs 
to upregulate the surface expression of costimulatory molecules (Brimnes et al., 
2003; C. B. Lopez et al., 2004) and that type I IFN is important for mediating this effect 
(Hidmark et al., 2006; Honda et al., 2003). Viruses that encode type I IFN antagonists 
may therefore induce suboptimal immune responses not only in the early phase of 
the infection but also in terms of long-term adaptive responses, as recently discussed 
for influenza virus and its type I IFN antagonist, non-structural protein 1 (NS1) 
(Fernandez-Sesma et al., 2006). 
 Infection of murine bone-morrow derived DCs (mDCs) with the rhesus RRV 
RV strain resulted in induction of type I IFN and a similar response was obtained when 
cells were exposed to triple-layered particles (TPLs) which contain all structural 
proteins thus being infectious (entry competent) (Douagi et al., 2007). 
Immunofluorescence and western blot analysis showed how IRF-3 levels were 
profoundly lost in mouse embryonic fibroblast (MEFs) and MA104 cells infected with 
RRV, as previously reported (Barro et al., 2007). RRV infection of mDCs resulted in 
viral growth, but  no cytopathic effect was observed, as previously reported (Narvaez 
et al., 2005). In contrast with the detection of new viral protein production, there 
was no measurable release of newly synthesized infectious viral particles, suggesting 
that viral replication cycle is aborted at a stage prior to viral assembly or release, 
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maybe due to the higher immune response of DCs compared to other cells (Hidmark 
et al., 2005). 
IRF-3 expression in RRV-infected mDCs revealed no detectable loss of IRF-3 
expression over the time of infection. However, bulk measurement of IRF-3 
degradation will mask a small fraction of cells which actually express NSP1 and 
degrade IRF-3. mDCs may restrict viral proteins, thus the effect of a viral-encoded 
protein antagonist of type I IFN induction in DCs can be less profound compared to 
other cell lines, as MEFs. The use of transgenic mice lacking a functional gene for IRF-
3 (IRF-3-/-) revealed an induction of IFN-β by other IRFs, such as IRF-7. 
 The secretion of type I IFN can be initiated by a cascade of events upon 
detection of PAMPs by TLR receptors: TLR8, through MyD88 and Iκκα/β leading to 
the activation of NF-κB, and TLR3 through TBK1 with the activation of IRFs (Thwaites 
et al., 2014). The use of MyD88−/−, and TLR3−/− mDCs showed no difference in IFN-β 
induction, suggesting that RRV infection induces type I IFN induction in a TLR-
independent manner, and cytosolic recognition events mediate type I IFN induction 
in response to RRV infection. TLR (7/8 and 9) have been reported to play a pivotal 
role in the induction of type I IFN in response to viral infection or synthetic ligands in 
plasmacytoid dendritic cells (pDCs) (Bao et al., 2013), maybe due to the constitutive 
expression of IRF-7 (Barchet et al., 2002), which is normally expressed at low levels 
in resting conditions, but enhanced upon IFNAR signalling in other cell lines (Huye et 
al., 2007). Infection of pDCs with RRC RV resulted in induction of type I IFN-α.  
As professional antigen-presenting cells (APCs), DCs effectively link the innate 
recognition of invading pathogens to the generation of adaptive immune responses 
(Osmola-Mankowska et al., 2015; Steinman et al., 2006). DCs initiate a maturation 
process and then induce the activation and differentiation of naïve T cells into 
functional subtypes for the elimination of the relevant pathogen (Y. Wang et al., 
2014). It has been shown that the infection of murine bone marrow-derived DCs 
(BMDCs) with porcine PRV RV does not result in cell death but leads to cell 
maturation, with enhanced expression of MHC II and costimulatory molecules (CD40, 
   
219 
 
CD80, CD86 and CD83) (Ye et al., 2017). Moreover, PRV infection resulted in 
increased levels of TRL2, 3, 4, 7 and 8, leading to a MyD88-independent (TLR3) and 
MyD88-dependent (TLR2) maturation of BMDCs. Analysis of secreted cytokines 
revealed a predominant production of IFN-ɣ, indicating that PRV infection of BMDCs 
preferentially promoted a Th1-type T cell response (Ye et al., 2017). 
In order to obtain an efficient and sustained IFN response, a quick inducible 
system needs to be in place. In the early phase of infection, the immune response is 
mostly IRF-3 mediated, with the IFN expressed at very low levels. Sensed incoming 
infections are detected by PRRs and through the activation of IRF-3, IFN-β and IFN-λ 
are secreted. The IFNs induction results in the activation a full set of ISGs, including 
IRF-7. IRF-7 transcription is then rapidly increased through the expression of IFN 
(Hwang et al., 2013; Sato et al., 1998; Sato et al., 2000). In late phase, IRF-3 and IRF-
7 cooperate with each other for the amplification of IFN gene induction, resulting in 
full procurement of all IFN family members, including IFN-α (Figure 7). Thus, the 
induction of IRF-7 in response to IFNs and its activation after viral infection provide a 
positive feedback for the production of IFNs. The ability of RV to spread from the site 
of infection to surrounding cells and tissues suggests the ability of the virus to 
antagonise not only the induction, but also the paracrine action of IFN, blocking the 
activation of the ISGs. 
 Work by Barro has shown how the simian-derived NSP1 targets not only IRF-
3, but IRF-5 and IRF-7, inducing their proteasome-mediated degradation (Barro et al., 
2007). Similar results were obtained by Arnold (Arnold, Barro, et al., 2013), which 
was able to identify a C-proximal IRF association domain (IAD), which mediates IRF 
dimerization, as the region required for NSP1 interaction. The IAD was mapped in 
IRF-3, IRF-5 and IRF-7, while IRF-9 contains an IAD-like domain, but not in IRF-1which 
was not targeted for degradation (Arnold, Barro, et al., 2013). Transient expression 
assays have shown how the simian NSP1 Sa-11 was able to induce the degradation 
of IRF-5 and IRF-7 through a proteasome dependent process, allowing NSP1 to block 
the IFN pathway at different stages of an immune response (Arnold, Barro, et al., 
2013). 
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As previously reported (Osterlund et al., 2007), the ectopic expression of IRF-
7 is able to induce the expression of IFN-α in HEK293 cell lines, which do not express 
the TF (Huye et al., 2007). Based on the sequence analogies present in the promoter 
regions of IFN genes, Osterlund classified them as either IFN-α type (IFN-α1, IFN-α4, 
and IFN-λ3) or IFN-β type (IFN-β and IFN-λ1) promoters. Analogies corresponded to 
common regulation: SeV was able to activate the transcription of IFN-β and IFN-λ1 
(IFN-β type), however, no effects on the transcription levels of IFN-α1, IFN-α4, and 
IFN-λ3 (IFN-α type) promoter were observed. By contrast, the exogenous expression 
of IRF-7 was able to increase the activity of all promoters (IFN-α1, IFN-α4, IFN-λ3, IFN-
β and IFN-λ1) without SeV infection. 
Cells that have been pre-treated with IFNs and which have induced ISGs, 
produce other  IFNs, mainly α subtype, leading to a super-stimulation of ISGs, a 
phenomenon that is called “IFN type I receptor mediated feed-forward” (Marie et al., 
1998). Despite the fact that the type I IFNs constitute a family of related cytokines 
that all recognize the same receptor, differences in action have been shown in vitro 
and in vivo (van Boxel-Dezaire et al., 2006). Although target cells are identical, the 
kinetics of the different type I IFNs varies, with the sub-class IFN-α being expressed 
later (Pulverer et al., 2010). 
The inability of RRV to modulate type I IFN in pDCs (Douagi et al., 2007) 
together with the observed inability of RRV NSP1 to modulate IFN-α-promoter 
reporter activity (Figure 36) suggest that the ability of NSP1 to induce the 
degradation of IRF-7 (Barro et al., 2007) could be strain dependent. The inability of 
NSP1 to target induction of IFN-α could explain why IFN-α treatment in new-born 
mice is sufficient to prevent biliary and hepatic  disease (Petersen et al., 1997), 
however, the administration of the virus through the tail vein did not reflect the real 
site of infection of RV. For this reason, IFN-mediated  antiviral effects in other cells 
lines rather than small intestine-derived cells should be carefully considered.  
The ability of NSP1 to target IRF-7 has been further investigated by Di Fiore, 
comparing the effect of some human RV strains to antagonise the IRF-7-mediated 
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IFN-α1 promoter activity (Di Fiore et al., 2015). In support of the data generated in 
this thesis, IRF-7 was able to strongly induce IFN-α1 promoter activity (Figure 35). In 
the presence of a Wa-like or DS-1 like human strain, IFN-α1 promoter activity was 
reduced from 20% to 40% depending on the strain. In comparison, porcine CRW-8 
RV was not able to target IRF-7. In contrast, the simian SA-11 strongly inhibited IRF-
7-mediated IFN-α1 gene expression and was also able to downregulate IκKϵ-
stimulated IFN-β Luc gene expression. IκKϵ is an activator of IRF-3 and acts 
downstream of virus-sensing innate immune activators including RIG-I and MDA5. 
Human and porcine derived NSP1 were not able to target IκKϵ. These findings show 
a degree of inhibition of IRF-7 signalling by NSP1 from some human rotaviruses. 
The epithelium is the main entry point of many viruses, such as hepatitis B 
virus, hepatitis C virus, human immunodeficiency virus, influenza virus, poliovirus and 
rotavirus (Bomsel et al., 2003). Previous studies have reported how a synergic 
cooperation of  IL-22 and IFN-λ receptors, both of which are highly expressed in 
intestinal epithelial cells (IECs), is required for an optimal activation of the 
transcriptional factor STAT1 and expression of interferon stimulated genes (ISGs) 
(Pott et al., 2011). Epithelium-rich organs such as the intestine, stomach, skin and 
lungs show a high expression of IFNLR-1 and respond to IFN-λ (Brand et al., 2005; 
Doyle et al., 2006; Ioannidis et al., 2012; Kotenko et al., 2003; Zahn et al., 2011). 
While type I and type III IFNs and their receptors are only distantly related 
(Kotenko et al., 2003), they show virtually identical signalling behaviour in that they 
activate the STAT1-STAT2 transcription factor signalling pathway, which leads to the 
formation of the ternary interferon-stimulated gene factor-3 (ISGF3) complex 
(consisting of STAT1, STAT2 and IRF-9) that controls transcription of more than 300 
interferon-stimulated genes (ISGs) acting in concert to restrict replication of viruses 
(Aaronson et al., 2002; Leonard, 2001; Villarino et al., 2017). Recent studies have 
investigated the role of type I and type III IFN in vivo in clearance of virus infection, 
and they have demonstrated a high degree of redundancy and suggested that type 
III can support type I activity, however, it cannot replace its functionality (Mordstein 
et al., 2010). 
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 Infection of STAT1-deficient mice with RRV RV results in higher viral shed 
compared to wild-type mice (Vancott et al., 2003) and IFNAR1-deficient mice exhibit 
no enhanced susceptibility to RV infection (Angel et al., 1999). Work by Pott showed 
a distinct and critical role of IFN-λ in the vaginal mucosal in preventing RV infection 
that cannot be compensated for by IFN-α/β (Pott et al., 2011). These findings are 
unique, compared to other respiratory viruses (Mordstein et al., 2010). The apparent 
discrepancy between the conclusions of the current and previous studies may be a 
result of the exceptional tissue tropism of RV, which replicates mostly, if not 
exclusively in epithelial cells of the small intestine (Boshuizen et al., 2003). Using 
knock out mice for IFN-β (IFNAR10/0) and IFN-λ (IL28Rα0/0) receptors, they showed 
how epithelial cells respond far more strongly to IFN-λ rather to type I IFN, maybe 
due to restricted receptor expression (Sommereyns et al., 2008), and treatment of 
mice with IFN-λ, but not IFN-β, repressed RV replication (Hernandez et al., 2015; 
Mahlakoiv et al., 2015).  
Moreover, while humans have three or four functional IFNL genes, mice have 
only two (Ifnl2 and Ifnl3), because the IFNL4 genomic region is absent in mice and 
mouse Ifnl1 is a pseudogene (Donnelly et al., 2010). Therefore, studies involving the 
IFN-λ murine model should be carefully considered since the lack of IFN-λ1 may lead 
to an under estimation of the overall effect of type III IFN (Hermant et al., 2014; 
Pulverer et al., 2010).  
IFN-λ and the IFN-λ receptor (IFN-λR) share homologies with IL-10 family 
cytokines and their receptors. In particular, the gene encoding the α-chain of the IL-
22 receptor (Il22ra1) is the closest relative of the gene encoding the IFN-λR1 chain 
(Ifnlr1) (Kotenko et al., 2003). The close relationship between IFN-λR and IL-22R is 
interesting because both receptors are preferentially expressed by epithelial cells 
(Sommereyns et al., 2008), indicating a designated role in controlling epithelial 
function in response to infections. Given the important role of type III IFN in curtailing 
early RV replication (Pott et al., 2011) and the close homology occurring between 
IFN-λ and IL-22, it is not surprising that the two evolutionarily related mucosal 
cytokines cooperate synergistically to activate the transcriptional factor STAT1 and 
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express ISGs, curtailing RV homologous replication (Hernandez et al., 2015). The 
ability of NSP1 to downregulate the IFN-λ to a greater extent than IFN-β could be 
explained with the high tropism of the virus. However, later in the infection, 
spreading from intestinal epithelium to the lamina propria, the virus needs to be able 
to downregulate IFN-β, which is highly expressed in connective tissue (Mahlakoiv et 
al., 2015). 
The induction of IFN-λ is a synergic and cooperative action of different 
transcriptional factors. The promoter region of IFN-λ presents a series of NF-κB 
(PDRII) and IRF-3 (PDRIII or ISRE) binding element sequences, which synergistically 
act to ensure a potent transcription. Sequences analyses have shown a more distal 
NF-κB binding site within the IFN-λ promoter region (-1137 to -1182 bp) (Thomson et 
al., 2009). Based on the presence of multiple NF-κB binding sites compared to IRF-3 
ones, it is not surprising that a full procurement of IFN-λ induction is more linked to 
the transcriptional activity of NF-κB rather than to IRF family members (Odendall et 
al., 2015).  
NF-κB is a critical regulator of the immediate early pathogen response which 
plays an important role in promoting inflammation, regulating cell proliferation and 
survival (Hayden et al., 2012). The inactive NF-κB complex is activated in response to 
a variety of stimuli, including viral and bacterial infection, exposure to pro-
inflammatory cytokines, mitogens and growth factors and stress-inducing agents. 
Some of the cell membrane sensors involved in NF-κB activation have been 
characterized in more depth, as in the case of dsRNA virus infection which are sensed 
by Toll-like receptors (TLRs) and trigger the recruitment of the death domain-
containing adaptor protein myeloid differentiation primary response gene 88 
(MyD88) (Iordanov et al., 2001). One of the best characterised NF-κB induction 
signalling pathways is the one triggered by the pro-inflammatory cytokine tumour 
necrosis factor-α (TNFα). TNF-induced activation of NF-κB mostly relies on 
phosphorylation, ubiquitination and subsequent degradation of inhibitor of kappa B 
(IkB) proteins. The inhibitor of kappa B kinase (IKK) complex, a multiprotein kinase 
complex containing IKKα and IKKβ, is responsible for the TNFα-induced 
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phosphorylation of IkB. Following recognition by an E3 ligase complex containing β-
TrCP, polyubiquitination and degradation of IkB releases free NF-κB dimers to 
translocate to the nucleus and induces expression of certain genes (Kanarek et al., 
2012) (Figure 59). 
 
Figure 59. Schematic representation of NF-KB canonical induction pathway. 
A wide range of soluble and membrane-bound extracellular ligands activate the NF-кB pathway, as 
members of TNFR, TLR, IL-1R. The engagement of TNFα with its receptors initiates a cascade of events 
which end with the transcriptional activation of NF-кB. Under resting conditions, NF-кB dimers are 
bound to inhibitory IκB proteins, which sequester inactive NF-кB complexes in the cytoplasm. 
Stimulus-induced degradation of IκB proteins is initiated through phosphorylation by the IκB kinase 
(IKK) complex, which consists of two catalytically active kinases, IKKα and IKKβ, and the regulatory 
subunit IKKγ (NEMO). Phosphorylated IκB proteins are targeted for ubiquitination and proteasome-
mediated degradation by β-TrCP, which thus releases the bound NF-κB dimers so they can translocate 
to the nucleus, activating transcription. 
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The high tropism of RV, with the ability to downregulate IFN-λ induction and 
the ability of NSP1 to target β-TrCP (Davis et al., 2017a; Graff et al., 2009), together 
with a strong dependence of IFN-λ on NF-κB, prompted the investigation of the effect 
of NSP1 on the transcriptional activity of NF-κB (5.2.1.3). Previously works have 
reported that β-TrCP is preferentially targeted by human and porcine RV (Di Fiore et 
al., 2015; Graff et al., 2009) and that NF-κB transcriptional activity was targeted by 
NSP1 of bovine and monkey origin in the presence of a potent inducer such as TNFα 
(Graff et al., 2009). The ability to trigger NF-κB reporter with the ectopic expression 
of Ikkβ reported in this thesis (5.2.1.3.1) is consistent with previously published data 
(Gates et al., 2016; Israel, 2010; C. M. Randall et al., 2012). The presence of 
phosphorylated Ikk complex during the course of OSU and NCDV infection indicated 
that the kinase activity was not disrupted by either viruses with the downregulation 
of NF-κB happening at some point downstream of kinase phosphorylation 
(5.2.1.3.1.2). 
β-transducing repeat-containing protein (β-TrCP, encoded by BTRC) is the 
core substrate recognition component of the Skp1-Cul1-F-box (SCF)β-TrCP E3 ubiquitin 
ligase complex, which plays essential roles in a variety of biological processes, 
including apoptosis, cell cycle, carcinogenesis and innate immunity (Low et al., 2014). 
Modification of eukaryotic proteins with ubiquitin (Ub) prior to proteasome 
degradation requires an E1 activating enzyme, E2 conjugating enzyme, and an E3 
ligase that transfers Ub from E2 to the target substrate (Takayama et al., 2017). E3 
ligases fall into two major classes of proteins that contain either a catalytic HECT 
domain or a RING domain. Typical RING domains consist of cysteine and histidine 
residues spaced in a C3HC4 pattern that coordinately bind two zinc ions. The pattern 
of cysteine and histidine residues in the zinc finger motif of NSP1 is similar, but not 
identical, to RING finger domains in cellular E3 ubiquitin ligases (Graff et al., 2007). 
The RING domain variant of NSP1 could address a potential E3 ubiquitin ligase activity 
to the viral protein, attaching ubiquitin chains to host proteins to drive their 
proteasome-mediate degradation.  
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An associated inhibitor of κB protein (IκB) regulates NF-κB activation. IκB 
contains a degron motif (DSGΦxS, Φ, hydrophobic residue) (PD) that undergoes 
phosphorylation following pathogen recognition or other proinflammatory signals 
(Fortmann et al., 2015). Signals from PRRs or other receptors activate the IκB kinase 
(IKK) complex, which phosphorylates IκBs on a pair of serine residues within the 
degron motif DSGΦxS (Kanarek et al., 2012) . SCFβ-TrCP recognizes this phosphodegron 
through its β-TrCP (Ghosh et al., 1998). In association with the E2 ubiquitin-
conjugating enzyme UBCH5, SCFβ-TrCP polyubiquitinates phosphorylated IκB driving its 
proteasome-mediated degradation, releasing dimeric NF-κB to translocate to the 
nucleus, where it binds κB sites in the promoter and enhancer regions of target 
genes. The SCFβ-TrCP E3 ligase complex mediates proteasome-dependent degradation 
of several proteins with roles in regulating cell proliferation, including IκBα, NF-κB 
subunits p100 and p105, cyclin dependent kinases, and β-catenin, among others 
(Frescas et al., 2008). Aside from the IκB family, SCFβ-TrCP mediates the degradation 
of other proteins involved in NF-κB activation, as IFN-α receptor 1 (IFNAR1) (Kumar 
et al., 2004) and IL-1R-associated kinase 1 (IRAK1) (Cui et al., 2012) and of a number 
of cell cycle and pro-apoptotic regulatory factors (Frescas et al., 2008). NSP1-
mediated degradation of β-TrCP is expected to arrest the turnover of these proteins, 
which should have manifold implications for RV replication. 
Sequences analyses have revealed the presence of a similar sequence 
(DSGΦS) in several human proteins (IκBα, IκBβ, β-catenin, NRF2, YAP) (Diehl et al., 
2013) which turnover is mediated by the ubiquitin-proteasome system. The same 
motif is present in a number of unrelated virus proteins which mimic the PDL motif 
to sequester β-TrCP and thereby inhibit NF-κB activity, as Epstein-Barr virus (EBV) 
LMP1 (Tang et al., 2003), human immunodeficiency virus type 1 (HIV-1) Vpu (Bour et 
al., 2001) and vaccinia virus (VACV) A49 (Mansur et al., 2013). NSP1 proteins of most 
human and porcine RV strains conserve a C-terminal phosphodegron-like (PDL) motif, 
DSGΦS (Di Fiore et al., 2015). The PDL motif, present in most of the human (both Wa 
and DS-1 derived) and porcine strains but missing in cattle and murine proteins, is 
employed by NSP1 to sequester β-TrCP, as shown by co-IP experiments (Davis et al., 
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2017a, 2017b; Morelli, Dennis, et al., 2015). Deletion of this motif or mutation of its 
serine residues disrupts the ability of viral proteins to interact with its target (Di Fiore 
et al., 2015). Point mutation within the PD β-TrCP-binding pocket protects the 
protein from NSP1-mediated turnover (Morelli, Dennis, et al., 2015). Morelli 
proposed that the site of polyubiquitination on cellular targets of SCFβ-TrCP is a lysine 
located 9 to 14 residues N-terminal to the PDL motif. A conserved lysine (K465) is 
common in most of the human strains, but missing in NSP1 derived from virus 
infecting cattle and monkeys (Morelli, Dennis, et al., 2015). The functional role of this 
lysine is confirmed by the fact that NSP1 derived from pigs (Gottfried-U08431) and 
monkey (SA-11f-AF290881) strains, which are lacking a complete PDL or a conserved 
lysine in 465 position, lack the ability to target β-TrCP. Of the strains considered in 
this study, only the human 1M0, 18A and TC together with the porcine OSU NSP1 had 
a complete PDL motif and a conserved upstream lysine in position 465. Same lysine 
is present in the porcine A8, which carries a partial PDL motif. The other porcine 
G10P5 together with bovine UKtc and rhesus RRV are missing the lysine and a 
complete PDL (alignment not shown). However, all of them are capable to modulate 
NF-κB activity (Figure 43). 
The interaction between β-TrCP and NSP1 requires in first instance the 
phosphorylation of RV protein at least in one of the serine present in the PDL (Davis 
et al., 2017b). It is possible to speculate that the lack of interaction observed with the 
porcine G10P5 and A8, the bovine UKtc and rhesus RRV was due to the absence of a 
complete PDL motif of NSP1. However, the presence of a full PDL in human-derived 
NSP1 did not result in interaction with β-TrCP in the Y-2-H system. However, 
luciferase reporter experiments showed that NSP1 had effects on the β-TrCP-
mediated activation of NF-kB transcriptional activity (Figure 51). The ectopic 
expression of β-TrCP to induce NF-κB transcriptional activity has been proved as a 
reliable way to identify the point at which NSP1 is targeting the NF-κB pathway 
(Frescas et al., 2008; Muerkoster et al., 2005). This could be the result of interactions 
which were not detectable using a Y-2-H assay, or the stringency conditions used 
(Figure 14, Figure 15, Figure 16 and Figure 19). Co-IP experiments showed how the 
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NCDV or OSU derived NSP1 were interacting with β-TrCP (Di Fiore et al., 2015) and 
β-TrCP was not detected in either NCDV or OSU infected cells, however, its 
expression was stabilized when cells were treated with the proteasome inhibitor 
MG132. 
The interaction between β-TrCP with NSP1 reported by Morelli did not result 
in its degradation for all different isolates (Morelli, Dennis, et al., 2015), suggesting 
that some strains may target NF-κB through a mechanism independent to β-TrCP 
degradation. The employment of alternative ways to modulate the IFN response 
could be a common mechanism between different RV strains, as reported for bovine 
UK NSP1, which mediates the degradation of IRF-3 in a host-cell-specific manner but 
can also block IRF-3 transcriptional activity without inducing its degradation (Sen et 
al., 2009). Furthermore EBV LMP1 (Tang et al., 2003), HIV-1 Vpu (Bour et al., 2001) 
and VACV A49 (Mansur et al., 2013) all interact with β-TrCP to block NF-κB activation, 
without inducing β-TrCP turnover. 
Despite significant sequence variability occurring between different RV strains 
(Dunn et al., 1994), all full-length RVA NSP1 proteins are thought to utilize an N-
terminal RING domain to interact with a cellular E2 ubiquitin-conjugating enzyme and 
a C-terminal sequence element to provide binding specificity for a host innate 
immune target (Graff et al., 2007). Formation of such a complex is predicted to 
induce polyubiquitination of the target, followed by its degradation by the 
proteasome. NSP1 may conserve its architecture across strains, with one of two C-
terminal motifs (PDL or pLxIS) mediating target specificity. In this study, when 
domains were swapped between the human 18A and the bovine UKtc NSP1, data 
showed how the C-terminus was responsible for the ability of the viral protein to 
interact with their targets and downregulate NF-κB response (Figure 45).  
Chimeric NSP1 in which the PDL motif of the simian Sa-4f NSP1, which 
specifically targets IRFs (Arnold et al., 2011), was replaced  with the PDL of OSU NSP1 
showed that the recombinant NSP1 was still able to downregulate NF-κB, however 
less potently than the OSU, indicating that regions outside the C-terminal PDL motif 
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likely contribute to NF-κB antagonism by OSU NSP1 and are not fully captured by 
SA11-4F NSP1 (Morelli, Dennis, et al., 2015). Work by Di Fiore showed how truncation 
and point mutations in the PDL motif hampered the ability of NSP1 to target β-TrCP 
and inhibit NF-κB-driven reporter gene expression (Di Fiore et al., 2015). This finding 
suggests that the PDL motif, when paired with an intact RING domain, is sufficient to 
target SCFβ-TrCP, and that SA11-4F and OSU NSP1 proteins conserve an architecture 
and mechanism similar enough to permit this transfer of functionality. This data 
supports results generated in this work, where swapping domains did not alter the 
functionality of NSP1 (Figure 39, Figure 45). The interplaying role of the RING domain 
and PDL motif in orchestrating recognition and degradation of NSP1 targets has been 
further investigated by Ding, identifying a COPII signal domain within the N-terminal 
RING-finger domain and the other at the very C-terminus (Ding et al., 2016). COPII 
coated vesicles are responsible for sorting and trafficking cargo out of the ER and into 
the Golgi apparatus (Campbell et al., 1997), and their presence on NSP1 suggest that 
the interaction NSP1/CUL3/β-TrCP results in Golgi re-localization, where 
proteasome-mediated degradation takes place. Cullin-RING ubiquitin ligases (CRLs) 
comprise the largest known category of ubiquitin ligases. CRLs regulate an extensive 
number of dynamic cellular processes, including multiple aspects of the cell cycle, 
transcription, signal transduction, and development (Bosu et al., 2008). 
Proteomic analyses revealed how NSP1 of simian, murine, bovine and human 
origin were interacting with proteins belonging to the CRL complexes, including 
Cullins 1–7, the shared E3 ligase subunit Rbx1 and other CRL-associated components 
and regulatory factors (Ding et al., 2016). Cul3 has been observed to interact with 
porcine OSU-NSP1 (Pichlmair et al., 2012)  and more recently with NSP1s from 
several human and animal RV strains (Lutz et al., 2016). Proteomics analyses were 
confirmed by co-IP experiments and by expression of NSP1 or in the context of viral 
infection. Ding also showed that NSP1 precipitated with E2 ubiquitin-conjugating 
enzyme.  
 Fluorescence microscopy experiments have shown how during viral infection 
NSP1 is localised in proximity of the Golgi (Ding et al., 2016). Mutants lacking the 
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RING domain are unable to localize to the Golgi and they have lost their binding 
ability toward β-TrCP. Point mutations which partially restored the RING domain 
conferred to NSP1 the ability to bind again to β-TrCP and colocalize to the Golgi, 
however, binding affinity and NF-κB downregulation were less potent than the wild 
type NSP1 carrying a full RING domain. The fact that some strains (RRV) show an 
interaction between NSP1 and CUL3   and localization to the Golgi, but not β-TrCP 
degradation support the hypothesis that the specific functionality of NSP1 is strain 
specific, and within the tri-complex NSP1/CUL3/β-TrCP NSP1 acts more as an adaptor 
protein which mediated CUL3-β-TrCP interaction at the Golgi, rather being an E3 
ligase. Therefore, it appears that Wa-NSP1 does not function as an E3 ligase on its 
own but instead usurps the host CRL to degrade β-TrCP. The use of lactacystin as an 
irreversible inhibitor (Bogyo et al., 1997) confirmed that β-TrCP was degraded 
through the ubiquitin–proteasome pathway.  
The ability of some RV strains to target IRF-3 for degradation is independent 
of CUL3 (Bosu et al., 2008; Davis et al., 2017b), highlighting a major difference of 
NSP1 dependence on host control during RV evolution and emphasizing the 
versatility of various RV strains in identifying substrates. 
The interaction occurring between NSP1 and CUL3 has been further 
investigated by Lutz et al, however, their work showed contrasting results with Ding 
(Ding et al., 2016). The interaction between the two proteins was confirmed, 
however knocking down of CUL3 resulted in degradation of β-TrCP and IRF-3, 
suggesting that CUL3 played only a marginal role in the degradation (Lutz et al., 
2016). However, it is possible that a certain level of degradation was observed since 
knock down cells may still express sufficient CUL3 complex to interact with NSP1, or 
the viral protein could use other components of the CRL complex, such as CUL1. CUL3 
has been reported to be important for RV infection (Silva-Ayala et al., 2013) and its 
interaction with NSP1 raises the possibility that RV employs the NSP1-CUL3 
interaction to mediate degradation of other host proteins involved in immunity. 
Contrasting results showed by the two different groups might be due to the 
differences in methodology, including the use of stable cell lines by Ding, versus 
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transient transfection by Lutz. The use of siRNA to silence selective Cullins revealed 
a strain-specific ability of NSP1 to induce β-TrCP degradation (Ding et al., 2016; Lutz 
et al., 2016). In support of the data generated in this thesis, they showed how the 
bovine UKtc NSP1 was able to strongly induce β-TrCP degradation.  
The role of the PDL motif has been further investigated with point mutations 
that disrupt the N-termini domain, showing how mutation in the putative RING 
domain affected not only IRF-3 binding ability of NSP1 (Arnold et al., 2011) but also 
failed to block NF-κB activation. However, it is not established whether disruption of 
the RING domain may have perturbed the overall structure of NSP1 and affected 
functions other than its putative E3 ubiquitin ligase activity.  
The interaction of β-TrCP with Iκβ requires phosphorylation of two serine 
residues in the Iκβ motif (Fortmann et al., 2015). Since NSP1 employs a PDL motif to 
interact with β-TrCP mimicking Iκβ, it is possible that before the interaction its serine 
residues within the motif need to be phosphorylated. Indeed, phosphorylation of 
NSP1 is strictly required before interaction with CUL3 or β-TrCP takes place (Davis et 
al., 2017b). The phosphorylation is strain independent, however, is occurring in NSP1 
derived from RV infecting different animals (Davis et al., 2017b). In contrast with Iκβ 
which is phosphorylated by Iκκβ subunits (Israel, 2010), NSP1 carries recognition 
motifs for the constitutively expressed casein kinase II (CKII) (Davis et al., 2017a).  
Consistent with previously published data, although the RING domain and PDL 
motif cooperate together, their functionalities are not strictly correlated for β-TrCP 
interaction (Ding et al., 2016). NSP1 RING mutants which carried an intact PDL motif 
that could be phosphorylated, retained their ability to interact with β-TrCP, however, 
interaction was not followed by β-TrCP degradation. This finding suggests that β-TrCP 
may not be the only mechanism employed by RV to downregulate NF-κB activity.  
Alternatively, NSP1 could physically sequester β-TrCP prior to allocation with CUL3 
to prevent Iκβ degradation. The employment of a constitutively expressed kinase, 
such as CKII, for NSP1 phosphorylation would facilitate NSP1 to be primed for 
interaction with β-TrCP immediately after expression. In contrast, Iκβ 
   
232 
 
phosphorylation relies on upstream phosphorylation events. It has been shown that 
early in OSU infection phosphorylated levels of Iκβ increase, even in presence of β-
TrCP, suggesting that NSP1 may block NF-κB activation by sequestering β-TrCP. In 
support to this hypothesis, IκBα was detected in lysates from NCDV and OSU infected 
cells throughout a ten hour time-point experiment (Graff et al., 2009). Although IκBα 
was present at each time point, degradation of the NF-κB inhibitor was still observed 
in the early stages of infection, when viral-encoded proteins levels were low and not 
sufficient to block NF-κB activity.  
In support to the hypothesis that the presence of a PDL motif is not strictly 
correlated with the ability of NSP1 to downregulate NF-κB activity thought the 
degradation of β-TrCP, Graff showed, using a luciferase reporter, how the OSU NSP1 
was able to downregulate NF-κB activity in MA104 cells treated with polyI:C (Graff et 
al., 2009). In contrast, the NSP1 encoded by NCVD lacked this ability. Differences 
observed were not due to different expression levels of the two viral proteins, which 
showed a similar profile. Results of the bovine NCDV strain are in contrast with data 
generated in this work, since the bovine UKtc NSP1 was potently able to 
downregulate NF-κB activity (Figure 43). The two NSP1 encoded by RV infecting cattle 
are remarkably similar in their amino acid sequences, and they are 100% identical in 
the PDL motif (alignment not shown) which has been shown to be responsible for 
mediating the interaction (Davis et al., 2017a, 2017b). One of the possible reason 
could be the employment of two different cell lines, Ma104 by Graff, HEK293 in this 
work. Since NSP1 expression levels are very low during early stages of infection, it is 
possible that RV use this mechanism to reduce the level of active NF-κB without a 
long-term interaction between NSP1 and β-TrCP. Later in infection, when NSP1 levels 
have risen, a more long-term interaction may occur. 
The ability of human and porcine strains to preferentially target NF-κB rather 
than IRFs to modulate the host immunity had been further investigated by Coulson’s 
lab (Di Fiore et al., 2015). They selected a panel of human and porcine RV isolates 
and compared their respective activates to simian ones. CRW-8 swine RV shares 96% 
nucleotide sequence to the OSU, and clusters closely with the A8 used in this study. 
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They also considered a human WA-like (as 1M0 and TC) and a DS-1 like (like 18A) RV 
isolate. Consistent with previous results (Arnold et al., 2011; Graff et al., 2009), IκBα 
levels were stable during the course of the CRW-8, WA-like and a DS-1 like RV 
infection, indicating a block in the NF-κB pathway. In contrast, simian infection (SA-
11) showed a decrease in IκBα levels (Di Fiore et al., 2015). An opposite trend was 
observed when IRF-3 levels were analysed, with the simian strain being able to target 
IRF-3 and human and porcine not, as previously reported (Barro et al., 2005, 2007; 
Graff et al., 2002). 
TRAF6 induces canonical NF-κB pathway activation upstream of TBK1 and IκK. 
The ability to induce NF-κB activation through the ectopic expression of TRAF6, 
further supported the evidence that NSP1 of human and porcine origin were 
responsible for the stabilization of IκB observed during infection (Di Fiore et al., 
2015). The ability to induce NF-κB transcriptional activity with the ectopic expression 
of members involved in its regulation allowed a further species-specific dissection of 
the pathway. The human, porcine, bovine and rhesus NSP1 appeared to target NF-κB 
between the phosphorylation of IKβ-α by IKKβ and its attachment with a 
polyubiquitin chain by β-TrCP (Figure 48, Figure 51). However, the bovine UKtc 
appeared to have an effect downstream in the pathway, acting on p65 NF-κB subunit 
(Figure 55). The inability of rhesus RRV to target downstream of p65 (Figure 55) was 
consistent with published data, in which infection of murine MEFs with the simian RV 
resulted in nuclear translocation of p65 (Douagi et al., 2007). Similar results were 
obtained for human RV strains, however, information of the different genotypes 
were not indicated, with the two strains defined as human RV1 and human RV2 
(Hakim et al., 2018). 
Treatment of MA104 and HT29 cells with TNFα results in increased levels of 
phosphorylated p65 which is able to translocate to the nucleus. However, RRV and 
Wa infection of cells previously exposed to TNFα resulted in phosphorylation of p65 
that was unable to translocate to the nucleus (Holloway et al., 2009). The mechanism 
through which RV prevents nuclear accumulation of p65 is unknown. Since p65 is 
activated and its levels remain constant thought the course of infection, it is possible 
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that RV sequesters p65 to the cytoplasm or interferes with its mode of translocation. 
Consistent with the inability of NF-κB to translocate to the nucleus, RRV and Wa 
infection of MA104 cells previously treated with TNFα, showed a substantial 
decrease (9 fold reduction) in NF-κB transcriptional activity (Holloway et al., 2009). 
The inability of RRV to prevent nuclear translocation of p65 supports findings of this 
thesis, where NSP1 appeared to have marginal effects on the p65-mediated 
activation of NF-κB activity (Figure 55), suggesting that the viral protein is acting 
between β-TrCP degradation and p50/p65 release. 
The production of cytokines in RV-infected cells  depend on the relative timing 
of cell  response to infection and potency of RV disruption of gene expression, both 
of which may vary between cell types. Contrasting results have been obtained in 
mouse embryonic fibroblast (MEFs), where RRV infection resulted in nuclear 
translocation of NF-κB (Douagi et al., 2007). It is possible that NF-κB is activated in 
MEFs before RRV can inhibit its nuclear accumulation, or that RRV does not inhibit 
the nuclear accumulation of NF-κB in cells of mouse origin. 
The NF-κB transcription factor family in mammals consists of five proteins, 
p65 (RelA), RelB, c-Rel, p105/p50 (NF-κB1), and p100/52 (NF-κB2) that associate with 
each other to form distinct transcriptionally active homo- and heterodimeric 
complexes. The p50/65 heterodimer clearly represents the most abundant of Rel 
dimers, being found in almost all cell types. NF-κB p50 subunit mostly form dimers 
with p65 and it can form homodimers that act as repressor when they bound to the 
promoter, since they lack a trans-activator domain (Plaksin et al., 1993). 
MA104 cells infected with NCSV and A5-15 RV strains revealed high levels of 
active p50 (Graff et al., 2009). Analysis of the expression levels of the two subunits in 
RV infected cells revealed that viral infection with OSU or NCDV did not result in 
degradation of p50/p65. In contrast with their stability, the two subunits showed 
different activation profiles upon infection, with p50 activated and p65 inactivated. 
The latter was not able to translocate to the nucleus and accumulated in OSU and 
NCDV-encoded viroplasms (Graff et al., 2009).  
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Work by Hakim et al showed how TNF-α treatment of SA-11 RV infected Caco-
2 cell lines resulted in the production of IL32, IL8, CXCL11 and CCL20 which potently 
inhibited rotavirus replication (Hakim et al., 2018). Thus, the ability of NSP1 to 
modulate NF-κB transcriptional activity, prevents the secretion of cytokines with 
potent antiviral effect.  
Incoming viral infections trigger a cascade of events which in the end result in 
the production of type I IFN (α and β) and type III IFN (λ). IFN bind to their specific 
receptors and signalling thought the JAK/STAT pathway recruit IRF-9, forming the 
heterotrimeric complex Interferon-stimulated gene factor 3 (ISGF3). The ISGF3 
transcriptional factor enters the nucleus and binds to the IFN stimulated response 
element (ISRE) to activate the transcription of interferon stimulated genes (IGGs) (R. 
E. Randall et al., 2008). Of the many ISGs, one of the most studied and characterized 
is Mx. 
RV infection of intestinal hemapoietic cells compartment induces significant 
secretion of type I IFN (Ramig, 2004). However, the virus is able to spread from the 
site of infection to bystander cells, despite exogenous stimulation of the STAT 
pathway. It has been shown that IFN-α and IFN-γ signalling is required for the 
resolution of viral replication and extra-intestinal pathology in mice infected with 
certain RV strains but not others (Feng et al., 2008; Vancott et al., 2003). In MA104 
cell lines, RRV and Wa infection resulted in 50% decrease of ISGs expression upon 
stimulation with IFN-α or IFN-γ, and 8hpi a further 20% decrease was observed 
(Holloway et al., 2009). Interestingly, when the same experimental approach was 
performed in Caco-2 cell lines, while the human Wa retained its capacity, RRV lost its 
ability to block ISGs during the course of infection (Holloway et al., 2009). Despite 
differences in antagonising ISGs production later in the infection, both RRV, Wa and 
UKtc blocked their transcription preventing STAT nuclear translocation when cells 
were treated with IFN-α or IFN-γ (Holloway et al., 2009).  
The activation of STAT follows its phosphorylation at tyrosine Y701 by JAK 
(Villarino et al., 2017). Work by Sen has shown how RRV, EW, OSU and UKtc RV were 
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capable of inhibiting Y701 phosphorylation and how this was independent of the 
NSP1 RING domain (Holloway et al., 2014; Sen et al., 2014). Work by Holloway also 
suggested that the ability of blocking nuclear translocation of STAT was conserved 
among different strains of RV infecting human and pigs (Holloway et al., 2014). In 
contrast with previous findings, the authors suggested that the inhibition of ISG 
expression is due to the inability of STAT to translocate to the nucleus, rather than 
prevention of its phosphorylation. Some viruses inhibit STAT nuclear translocation by 
interfering with the importin machinery, as reported for Ebola VP24  (Reid et al., 
2006), however expression of RV proteins appeared not to compromise nuclear 
localization of MPα5 and IMPβ1 (Holloway et al., 2014). It is possible that RV employs 
a novel uncharacterised mechanism to prevent ISG expression.  
 Upon Activation, STAT associate with IRF-9 forming the ISGF3 heterotrimeric 
complex. It has been reported that NSP1 can induce degradation of IRF-9 (Arnold, 
Barro, et al., 2013) however, the authors describe how a truncated form of NSP1 was 
unable to degrade IRF-9, but still prevented STAT delocalization to the nucleus. In 
support of this, it has been reported that activated STAT is able to translocate to the 
nucleus without IRF-9 (Banninger et al., 2004). 
The varied ways in which NSP1 modulates the induction of different IFNs (type 
I and type III), by targeting different pathway components (IRF-3 and NF-κB) in a 
strain-dependent manner most likely contributes to the differences observed in 
homologous and heterologous infections. Rhesus RRV infection of type I and type II 
IFN-deficient suckling mice resulted in a prolonged infection in multiple extra-
intestinal organs (liver, bile duct, and pancreas), supporting the essential role of 
STAT-dependent IFN signalling response to control systematic replication. However, 
infection  of type I and type II IFN-deficient suckling mice with other heterologous 
strains, such as simian SA, bovine NCDV or porcine OSU, or homologous infection 
with murine EW triggered a robust type I and II IFN induction  and resulted in mild or 
absent effects, with the infection contained in the intestinal lumen (Feng et al., 2008). 
Different homologous murine strains have shown variable responses to the absence 
of IFN signalling, such as EC, that despite showing a similar pathogenicity to EW, is 
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able to spread from the site of infection to surrounding organs (Broome et al., 1993). 
A possible explanation could be that the NSP1 encoded by the two different RV 
strains could differentially target IRF-3 or NF-κB.  
Mouse biliary tract is high susceptible to rhesus RRV infection (Feng et al., 
2008) but not to bovine UKtc. Reassortments between RRV and UKtc have been able 
to identify in vivo that the high infectivity of RRV was facilitated by VP4, which  
provided an enhanced viral entry capacity, and NSP1 which was able to strongly 
suppress the host immune response compared to the parental strain (Feng et al., 
2011). Only reassortants that carried VP4 and NSP1 of RRV origin were able to grow 
to a titer similar to the parental virus. These results support previously generated 
data that showed NSP1 derived from UKtc and RRV were able to degrade IRF-3 with 
different efficiencies in MEFs (Feng et al., 2009; Sen et al., 2009). Understanding the 
impact of each viral protein in modulation of host innate immunity could be 
beneficial for development of a better vaccine since UKtc and RRV strains have been 
used as heterologous backbone strains for human RV vaccine (Flores et al., 1993; 
Midthun et al., 1985). However, infection of mice with the homologous EW, the 
heterologous UKtc or reassortants EWxUKtc revealed that an efficient infection and 
replication of EW was due to a constellation of murine genes expressing VP3, NSP2 
and NSP3 along with VP4 and NSP1 (Feng et al., 2013). 
Bulk measurement of the IFN response cannot reveal hierarchical, temporal 
and spatial response to virus infection. A single cell approach facilitates detailed 
dissection of the differences occurring in infected and bystander cells. This approach 
has been used to show how the homologous murine RV infection resulted in an 
induction of IRFs and NF-κB transcripts early in the infection (Sen et al., 2012). In 
contrast, rhesus RRV appeared to be able to block secretion of type I IFN early in 
infection. Interestingly, the activation of the NF-κB pathway was further reduced in 
bystander cells compared to the site of infection, with increased levels of Iκβα, in 
comparison with IRF-3 levels. These findings further corroborate the hypothesis that 
the ability of RV to successfully infect its host is related to its ability to modulate type 
III rather than type I IFN, as previously discussed (Hernandez et al., 2015; Pott et al., 
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2011). However, work by Lin et al has shown that RV sensitivity to IFN treatment is 
strain dependent and varies between hosts, and both type I and type III IFN 
cooperate synergistically for an optimal protection of the gastro-intestinal tract (J. D. 
Lin et al., 2016).  
The successful infection of the host requires virus dissemination from the site 
of infection to surrounding cells and tissues. This is translated in its capacity to mask 
its presence, prevent and/or downregulate immune response and keep the cells alive 
for sufficient time to support its replication. Antagonism of specific mediators of the 
apoptotic response is a survival mechanism adopted by many viruses (Best, 2008). 
For example, RSV selectively targets NF-κB (Bitko et al., 2007), whilst poliovirus 
(Autret et al., 2008), influenza A virus (Ehrhardt et al., 2007) and dengue virus (Lee et 
al., 2005) have all been shown to target phosphoinositide 3-kinase (PI3K)/Akt,. The 
activation of PI3K/Akt has been shown to support viral replication during acute 
infection inhibiting apoptosis (Diehl et al., 2013).  
During early stages of infection, RV creates a favourable environment for its 
replication by preventing apoptosis within infected cells. It has been reported that 
NSP1, through is RING domain, interacts with PI3K/Akt activating pro-survival 
pathways (Bagchi et al., 2010; Bagchi, Nandi, et al., 2013) and induces the 
proteasome-mediated degradation of p53 to prevent cell-cycle arrest (Bhowmick et 
al., 2013). In addition, degradation of β-TrCP prevents the secretion of a number of 
cell cycle and pro-apoptotic regulatory factors (Frescas et al., 2008). Later in the 
infection, when virus progeny have reached a lytic threshold, the level of NSP1 
decreases, leading to the inactivation of PI3K/Akt and the restoration of p53 levels, 
and subsequent initiation of pro-apoptotic signals. 
 
The high tropism of RV for mature enterocytes of the small intestine, means 
that upon infection the virus mainly faces a type III IFN-mediated host immune 
response. In early stages of infection, NSP1 levels and stability are not sufficient to 
inhibit the transcriptional activity of NF-κB and IRF-3, leading to the induction of IFNs, 
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which are secreted in an autocrine and a paracrine manner to other epithelial cells, 
inducing the transcription of ISG. ISG are able to boost the activity of NF-κB and IRF-
3, and together with the activation of IRF-7, procure the expression of other IFNs 
family members, as INF-α and IFN-λ3.  
In advanced stages of infection, with the expression of all RV-encoded 
proteins, NSP1 stability is increased, and the viral protein is able to target both NF-
κB and IRF-3, resulting in modulation of the IFN expression. The block of NF-κB also 
leads to a reduction of pro-apoptotic signals and together with the binding to p53 
and Akt, results in a favourable environment for viral growth. The subsequent 
decrease in NSP1 levels, reduces Akt activation and allows p53 to activate pro-
apoptotic pathways, resulting in cell death and virus release. Released virions can 
then infect bystander cells. The ability of NSP1 to modulate the JAK/STAT pathways 
help facilitate the spread. It has been shown that RV is able to systematically infect 
susceptible animals, spreading from the site of infection to surrounding tissues 
(Adeyi et al., 2010; Crawford et al., 2017). Crossing the barrier of epithelial cells, the 
virus needs to spread across the lamina propria tissue. In contrast with epithelial 
cells, lamina propria cells are more susceptible to INF-β rather than INF-λ. Thus, to 
cross this barrier, RV needs to be able to downregulate type I IFN expression rather 
than type III (Figure 60). 
 
The ability to modulate the host innate immune response appears conserved 
among different RV strains, with viruses isolated from different hosts being to 
downregulate the IFN response (5.2). Through the expression of NSP1, RV is able to 
modulate both the induction and signalling of IFN; by targeting PPRs and IRFs NSP1 
blocks the production and secretion of cytokines and by targeting the JACK/STAT 
pathway NSP1 affects their signalling action. Here we have reported that the NSP1 
encoded from different species (human, pigs, cattle and monkeys) are able to 
downregulate IFN-λ induction (5.2.1.2) targeting NF-κB (5.2.1.3). Epithelial cells 
mainly express type III IFN, however, due to similitudes in the promoter regions of 
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type III and type I IFN, viral infection results in a partial secretion of INF-β too. Thus, 
the ability of some NSP1 to be able to strongly downregulate both IFN-λ and INF-β 
could reflect the ability of some RV strains to establish a successful infection earlier 
compared to others.  
Together with the inhibition of IFN-λ, a conserved ability to interfere with the 
JAK/STAT pathway was observed (5.2.1.4). However, in contrast with the IFN 
induction pathway, we were not able to identify specific host proteins of the 
signalling pathway targeted by NSP1. Indeed the downregulation of ISG offers an 
advantageous scenario for the virus, preventing the boosting of IFN induction in 
infected cells and the activation of bystander cells, offering an easier target to infect. 
Interestingly, NSP1 appears to only marginally affect IFN-α (5.2.1.1.2) and IFN-λ3 
(5.2.1.2.2) induction. The expression of these two IFNs dos not take place directly 
upon viral infection through the activation of NF-κB or IRF-3, but they require IRF-7 
expression (Figure 35, Figure 40). A possible scenario could be that by the time IFN-
α and IFN-λ3 are activated, viral progeny has reached cell lyses threshold, and the 
block on IFN induction in infected cells in not required anymore. In contrast, the 
potential paracrine action of IFN-α and IFN-λ3 is compensated by the ability of NSP1 
to target the JAK/STAT pathway.  
In order to better define the observed host range restriction further 
comparative analysis are required. However, based on the finding of this work, it 
appears that successful infection of different host may not be solely dependent on 
the ability of RV to target different host proteins, but more related to the capacity of 
NSP1 to strongly interact early in the infection with its target (IRF-3, β-TrCP), 
preventing their activation and blocking or delaying the establishment of the antiviral 
state. 




Figure 60. Putative mechanism of action NSP1 during RV  infection 
Schematic representation of NSP1 mediated downregulation of the IFN induction and signalling.  
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7 Future work 
Viruses constitute a fascinating example of simple complexity. 
RV encodes only 12 proteins, of which six are non-structural (Desselberger, 
2014). With such a limited repertoire of functional tools, the virus is able to set up a 
complex cascade of events to establish a successful infection. Masking its presence, 
downregulating the immune response, controlling cellular trafficking, requesting 
translational machinery for its own advantage and using host components to 
assemble mature virions constitute only a few examples of the strategies pursued by 
the virus using a limited number of self-encoded proteins (Crawford et al., 2017). In 
such scenario, it is likely that virus-encoded proteins are multi-functional, thus other 
functions of NSP1 remain to be determined. 
Y-2-H screening revealed strain-dependent interactions between NSP1 
derived from RV infecting different species and IRF-3 (Table 11). Those interactions 
may reflect possible scenario of a homologous or heterologous infection, with 
differences in potency of the interaction been reported. Some NSP1s showed a 
strong interaction with their targets, by contrast, others were able to target IRF-3 
only under lower stringency conditions (Figure 20 and Figure 21). The Y-2-H system 
is one of the most popular, preferred, cost effective and scalable in vivo genetic 
approaches for screening protein-protein interactions (Aho et al., 1997). One of the 
possible, and maybe most significant, drawbacks of this technique is that relies on 
transcription: in order to assess a positive interaction the two proteins need to be 
able to initiate transcription, but only when they are in close association with each 
other (Causier et al., 2002). The employment of chimeras, with the fusion of the 
proteins to yeast DNA-BD and DNA-AD domain always pose a possible risk of altering 
the actual symmetrical arrangement of the bait or prey and, therefore, modifying its 
functionalities. This might also result in limited activity or in the inaccessibility to 
binding sites. Moreover, it needs to take into account that some protein interactions 
depend on post-translational modifications, such as glycosylation, formation of di-
sulfide bonds, and phosphorylation, and these may not occur, or occur unsuitably, in 
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yeast. In addition, the “bait” and the “protein” may not interact directly, but part of 
a larger complex of interacting proteins. In this case, the activation of the reporter 
genes does not reflect a direct interaction. Thus false positive and false negative 
interactions can occur. Since the employment of other techniques has shown that 
NSP1 interacts with RIG-I, β-TrCP and STAT1, Y-2-H interactions could be further 
investigated using alternative systems, such as pull-down or co-IP assays. Since lower 
stringency conditions in Y-2-H revealed a strain-specific ability of human NSP1 to 
interact with IRF-3 (Figure 21), same conditions could be used to screen for transient 
or weak interactions with MAVS and β-TrCP, which have been previously reported to 
interact with NSP1 (Di Fiore et al., 2015; Nandi et al., 2014). Moreover, since chimeric 
NSP1 were still able to downregulate type I, type III induction and NF-κB activity 
(Figure 33, Figure 39 and Figure 45), their ability to interact with IRf-3s could be 
further investigated. 
NSP1 showed a strain-dependent level of expression from transfected 
plasmids. A possible explanation for the differences observed for the various reporter 
assays could be due not to strain-specific ability of NSP1 to differentially target the 
induction of the relative promoter regions, but simply the result of differential levels 
of expression of NSP1 proteins. The employment of cell lines stably expressing NSP1 
will help to decipher the relative strain-specific ability to modulate immune response. 
Indeed a better understanding of the comparative expressions of different NSP1 in 
different mammalian cell lines is needed. NSP1 is the most variable protein encoded 
by RV (Dunn et al., 1994), however sequences analysis have identified  highly 
conserved residues or domains (Bremont et al., 1993; Hua et al., 1994; Mitchell et 
al., 1990; Okada et al., 1999) which can be used for the production of specific 
antibodies against NSP1. Western Blot analysis couple with TandT (4.2) would better 
define the strain-specific half-live of NSP1 and its levels of expression during the 
course of infection. 
The ability of NSP1 to target IRF-3 and NF-κB to downregulate the induction 
of type I and III IFN appears to be related to its ability to interact through specific 
NSP1 domains (Davis et al., 2017a; Di Fiore et al., 2015; Ding et al., 2016; Graff et al., 
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2007; Kanai et al., 2017; Lutz et al., 2016; Morelli, Dennis, et al., 2015; B. Zhao et al., 
2016). A RING domain in the N-termini region and a PDL or pLxIS motif in the 
carboxyl-termini are reported to coordinate NSP1 function. Contrasting results were 
obtained on the role of these motifs in inducing degradation of their targets. Since 
chimeric NSP1 were still functional, the generation of NSP1 containing targeted 
mutations in these motifs would be able to better define their role in IFN 
downregulation. Upon infection, IRF-3 proteins dimerise, trans-phosphorylate and 
subsequently translocating to the nucleus. Since NSP1 has been shown to have a 
strain-specific ability to interact with IRF-3 and downregulate IFN-β  (Table 11, Figure 
30, Figure 31, Figure 32) (which is mostly IRF-3 driven) production, it would be 
interesting to determine if NSP1 targets IRF-3 monomers or activated dimers. It has 
been proposed that an alternative way of NSP1 to affect β-TrCP is not driving its 
proteasome-mediated degradation, but sitting in its PD motif, preventing recognition 
with IκBβα (Ding et al., 2016). Similarly, NSP1 could prevent IRF-3 monomers 
interaction, occupying their respective docking sites. The use of chimeric NSP1 and 
investigation in IRF-3 phosphorylated levels would better characterize NSP1 ability. 
Modulation of NF-κB transcriptional activity has cast a new light on the ability 
of NSP1 (Figure 43 and Figure 44). Luciferase reporters suggested that the activity of 
NSP1 in the downregulation of NF-κB activity appears located upstream of p65/p50 
(Figure 55) nuclear translocation and downstream of β-TrCP (Figure 51). However, 
differences between strains were observed. To further elucidate possible steps 
targeted by NSP1, a series of alternative approaches can be used to detect NF-κB 
activation, such as band-shifts. The ability of NSP1 to target β-TrCP resulting in stable 
IκBβα levels could be investigated by measuring the levels of phosphorylated IκBβα 
or its degradation by Western blot analysis. Confocal microscopy analysis have 
revealed contrasting results regarding nuclear translocation of p65 in the nucleus 
(Graff et al., 2009; Holloway et al., 2009). Nuclear fraction Western Blot analysis will 
help to better elucidate the effect of NSP1 on the release of IκBβα and NF-κB 
subunits. The presence of NSP1 appears to not affect the activation of the IKK 
complex (Figure 48) (Graff et al., 2009). However, the employment of an IKKβ Kinase 
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Assay would be beneficial to better understand if the viral protein employs another 
system to block the NF-κB pathway. 
Mx CAT assay has provided a versatile and powerful tool to assess the IFN 
induction (Fray et al., 2001), and the assay does allow a classification of the type of 
IFN induced (Kugel et al., 2011) . As reported, the dual role of IFN-β and IFN-λ in 
clearance and control of RV infection has shown contrasting results and further 
analysis are required. SeV infection has been able to trigger both type I and III IFN 
(Figure 30 and Figure 37). Since the IFN-λ produced in response to infection is acid 
labile (Kugel et al., 2011), the employment of a MX CAT assay of acid-treated 
supernatant collected from cells infected with SeV would allow to understand which 
type if IFN is blocked in presence of NSP1. The employment of a luciferase reporter 
under the control of the Mx1 promoter identified a conserved ability of NSP1 isolates 
from RV infecting different species to block the IFN signalling targeting the JAK/STAT 
pathway (Figure 57 and Figure 58). A series of studies have reported how different 
RV strains are capable of blocking the ISGs induction targeting different steps of the 
JACK/STAT pathway, as at level of STAT phosphorylation (Sen et al., 2014), or 
preventing its nuclear translocation (Holloway et al., 2014). Since RF-9 has a crucial 
role in formation of the ISGF3 complex, would be interesting investigated the strain-
specific ability of NSP1 to target IRF-9. The ectopic expression of components of the 
NF-κB pathways has allowed a better understanding of which stages of the NF-κB 
induction could be targeted by NSP1 (5.2.1.3.1). A similar approach could be 
employed to narrow the window of action of NSP1 in the JAK/STAT pathway. 
To conclude, a better understanding of the downregulation of the host 
immune response could come from infectious studies using full RV viruses rather 
than plasmid-encoded proteins. A fully functional reverse-genetic system is in place, 
allowing the study of RV replication, pathogenicity and downregulation of the 
immune response by NSP1 related to a different gene constellation.  
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8 List of abbreviations 
+RNA positive-sense RNA 
aa amino acid  
BD dna-binding domain 
BLAST basic local alignment search tool  
BSA bovine serum albumin  
BVT Bluetongue virus 
CARD cysteine-aspartic protease (caspase)-recruiting domain 
CAT chloramphenicol acetyltransferase 
cDCs classical dendritic cells 
CFP cell-free protein synthesis  
complementary DNA cDNA 
CSFV Classical Sswine Fever Virus 
CTD c-terminal domain 
CTD carboxy-terminal domain 
DDO double drop-out  
distilled water dH2O 
DLP double layered particle 
DLR dual-luciferase reporter  
DMEM dulbecco’s modified eagle medium  
DNA deoxyribonucleic acid 
dNTPs deoxynucleotide triphosphates  
dsRNA double-stranded RNA 
e1F4E eukaryotic initiation factor 4e 
EDTA ethylenediaminetetraacetic acid  
ELISA enzyme-linked immunosorbent assay 
ELISA enzyme-linked immunosorbent assay 
ENS enteric nervous system 
GFP green fluorescent protein 
GPI glycophosphatidylinositol 
GSLs glycosphingolipids  
GTs glycosyltransferases  
h hour 
HA haemagglutinin  
HIV Human Immunodeficiency Virus 
hpi hours post infection 




IFNAR ifn α/β receptors 
IFNLR ifn λ receptors 
IFNRG ifn ɣ receptors 
IL interleukin 
IM inhibitory motif 
IPS-1 interferon promoter stimulator 
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IRAKs interleukin-1 receptor-associated kinases 
IRF interferon regulatory factor 
ISGF3 ifn-stimulated gene factor 3 
ISGs interferon stimulated genes 
ISREs ifn-stimulated response elements 
Iκβ inhibitor of kappa b  
Iκβα inhibitor of kappa b alpha  
JAK cytoplasmic –associated protein from the janus kinase 
JAK/STAT janus kinase/signal transducers and activators of transcription 
kb kilobase  
kDa kilodalton  
LB luria both  
LGP2 laboratory of genetics and physiology 2 
LRR leucine-rich repeat 
MAPKs mitogen-activated protein kinases 
MAVS mitochondrial antiviral-signalling protein 
MDA5 melanoma differentiation-associated antigen 5 
MEFs mouse embryonic fibroblast 
mg milligram 
min minute 
ml millilitre  
mL millilitre 
mM millimolar 
mRNA Messenger RNA 
MVA Modified Vaccinia Virus Ankara 
MxA Myxovirus resistance gene a 
MyD88 myeloid differentiation primary response gene 88 
N/A not applicable 
NF-κB nuclear factor kappa-light-chain-enhancer of activated b cells 
ng nanogram  
NLRs nucleotide-binding oligomerization domain-like receptors nod-like 
receptors 
Npro n-terminal autoprotease  
NS viral non-structural protein 
ORF open reading frame 
PABP poly-a binding protein 
PABP cellular poly-a binding protein 
PAGE polyacrylamide gel electrophoresis 
PAMPs pathogen-associated molecular patterns 
PBS phosphate buffered saline 
pCDs plasmacytoid dendritic cells 
PCR polymerase chain reaction  
PD phosphodegron motif 
PDL phosphodegron-like motif 
Pm picommolar  
PRDs positive regulatory domains 
PRRs pattern recognition receptors 
QDO quadruple drop-out 
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RD repressor domain 
RdRp RNA dependent RNA polymerase 
RER rough endoplasmic reticulum 
RHD rel homology domain 
RI replication intermediates 
RIG-I retinoic acid-inducible gene i product 
RIP-1 receptor-interacting protein 1  
RLRs RIG-I-like receptors 
RNA ribonucleic acid 
RNAi RNAinterference 
rpm revolution per minute  
RT room temperature 
RV rotaviruses 
RVA group A rotaviruses 
RVGE Rotavirus-induced acute and recurrent gastroenteritis 
s second 
SDS-PAGE sodium dodecyl sulphate polyacrylamide gel electrophoresis 
SeV Sendai Virus 
siRNA small interfering RNA  
SLP single layered particle 
ssRNA single stranded rna 
STAT signal transducer and activator of transcription 
TADs transactivation domains 
TAE tris-acetate edta 
TBE tris-borate edta  
tc tissue-culture adapted 
TD transcriptional-activation domain 
TDO triple drop-out  
TF transcriptional factor  
TGF-β tumour growth factor beta 
TLP triple layered particle 
TLRs membrane-bound toll-like receptors 
TLRs toll-like receptors 
TM transmembrane domain 
TNFα tumour necrosis factor alpha 
TnT transcription and translation 
TRAF6 tnf receptor-associated factor 6 
TRIF tir-domain-containing adapter-inducing interferon-β 
TRR tetratricopeptide repeat region 
UTRs untranslated regions 
VISA virus-induced signalling adapter 
VP viral structural protein 
WT wild type  
Y-2-H yeast-2-hybrid 
β-TrCP β-transducin repeat-containing protein 
μg microgram  
μl microliter 
μM micromolar 
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